[go: up one dir, main page]

TW200817471A - Wettable silicone hydrogel contact lenses and related compositions and methods - Google Patents

Wettable silicone hydrogel contact lenses and related compositions and methods Download PDF

Info

Publication number
TW200817471A
TW200817471A TW96121940A TW96121940A TW200817471A TW 200817471 A TW200817471 A TW 200817471A TW 96121940 A TW96121940 A TW 96121940A TW 96121940 A TW96121940 A TW 96121940A TW 200817471 A TW200817471 A TW 200817471A
Authority
TW
Taiwan
Prior art keywords
weight
contact lens
poly
hydrogel contact
lens
Prior art date
Application number
TW96121940A
Other languages
Chinese (zh)
Other versions
TWI429713B (en
Inventor
Charlie Chen
Ye Hong
Nick Manesis
Original Assignee
Coopervision Int Holding Co Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coopervision Int Holding Co Lp filed Critical Coopervision Int Holding Co Lp
Publication of TW200817471A publication Critical patent/TW200817471A/en
Application granted granted Critical
Publication of TWI429713B publication Critical patent/TWI429713B/en

Links

Landscapes

  • Eyeglasses (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Silicone hydrogel contact lenses having ophthalmically acceptable surface wettabilities are obtained from pre-extracted polymerized silicone hydrogel contact lens products produced from a polymerizable composition comprising a combination of particular components. The silicone hydrogel contact lenses can be obtained from non-polar resin based contact lens molds and without surface treatments or an interpenetrating polymeric network of a polymeric wetting agent. Related lens products, polymerizable compositions, and methods are also described.

Description

200817471 九、發明說明: 【發明所屬之技術領域】 本發明尤其係針對矽氧水凝膠眼科裝置及相關組合物及 方法。更特定言之,本發明係關於經模製之可濕性矽氧水 凝膠隱形眼鏡及相關組合物及方法。 ’ 【先前技術】 • 矽氧水凝膠隱形眼鏡已普及,此係由於與非矽氧水凝膠 隱形眼鏡相比,隱形眼鏡配戴者在其眼睛上配戴該等眼鏡 f) 持續更長時間的能力。舉例而言,視特定眼鏡而定,矽氧 水凝膠隱形眼鏡可經每天配戴、每週配戴、雙週配戴或每 月配戴而磨損或規定為每天配戴、每週配戴、雙週配戴或 母月配戴。與石夕氧水凝膠隱形眼鏡相關之對眼鏡配戴者之 盈處可至少部分歸因於隱形眼鏡之親水性組份與含石夕聚合 物質疏水特性的組合。 非石夕氧水凝膠隱形眼鏡(諸如基於甲基丙烯酸2_羥乙酯 0 (HEM A)之水凝膠隱形眼鏡)常在非極性樹脂隱形眼鏡模具 (例如自聚烯烴基樹脂產生之隱形眼鏡模具)中產生。用於 非矽氧水凝膠隱形眼鏡之眼鏡前驅體組合物在非極性樹脂 隱形眼鏡模具中聚合以產生基於HEMA之聚合眼鏡產物。 由於基於HEMA之隱形眼鏡之聚合組份的親水性質,即使 儘官使用非極性樹脂模具產生,但基於HEma之眼鏡在眼 睛上仍相容且具有眼用可接受之表面可濕性。 相比之下’自非極性樹脂模具所獲得之現有矽氧水凝膠 隱形眼鏡具有疏水性眼鏡表面。換言之,該等矽氧水凝膠 121842.doc 200817471 隱形眼鏡之表面具有低可濕性,且因此在眼睛上不相容或 為眼睛所不可接受。舉例而言,該等石夕氧水凝膠隱形眼鏡 可與較不理想之特徵相關,該等特徵諸如增加之脂質沈 積、蛋白質沈積、眼鏡盥眼日主本& > Λ丄人 、 兄/、眼目月表面之結合及對眼鏡配戴者 之普遍刺激。 在努力克服此等問題中,已嘗試採㈣石夕氧水凝膠隱形 眼鏡或眼鏡產物進行表面康碰+主 仃衣面處理或表面改質以增加眼鏡表面 Ο 之親水性及可濕性。石夕氧水凝膠眼鏡之表面處理的實例包 括塗佈眼鏡表面,將化學物質吸附至眼鏡表面上,且改變 眼鏡表面上化學基團之化學性質或靜電電荷。已描述表面 處理,其包括使用電漿氣體塗佈聚合眼鏡表面,或在隱形 眼鏡模具表面上使用電漿氣體以在形成聚合眼鏡之前處理 杈具。不幸的是’若干缺點與此方法相關。與不使用表面 處理或改質之製造方法相比,隱料鏡之表面處理需要更 多機械及時間來產生隱形眼鏡。此外,當眼鏡由眼鏡配戴 u 者配戴及/或觸摸時,經表面處理之魏水㈣隱形眼鏡 可展不減少之表面可濕性。舉例而言,增加對經表面處理 之眼鏡的觸摸可導致親水性表面降解或磨損。 另一種增㈣氧水凝膠眼鏡之可濕性及眼睛相容性的方 法為在包含聚合濕潤劑(諸如聚乙烯吡咯㈣(PVP》之第二 組合物存在下聚合石夕氧水凝膠隱形眼鏡前驅體組合物。該 專類型之眼鏡在本文中猶為呈古s 甲%為具有聚合内部濕潤劑之矽氧水 凝穋隱形眼鏡,且通常包含包括高分子量聚合物(諸如 pvp)之互穿聚合物網路(IpN)。如—般熟習此項技術者所 121842.doc 200817471 瞭解,IPN係指兩種或兩種以上不同聚合物以網路形式之 組合,其中至少一種聚合物在另一種聚合物存在下合成 及/或交聯,兩者之間無任何共價鍵。IpN可由兩種形成兩 個獨立但毗鄰或互穿之網路的鏈組成。IpN之實例包括分 步Π>Ν、同步IPN、半IPN及均。雖然包括聚合濕潤二 IPN之矽氧水凝膠隱形眼鏡避免與表面處理相關之問題, 但該等眼鏡歷時延長之時間可能無法保留其眼睛相容性, 包括表面可濕性。舉例而言,由於内部濕潤劑未共價結合 形成聚合眼鏡之其他組份,因此當由眼鏡配戴者配戴時, 其可能自眼鏡浸出,且藉此隨時間推移導致表面可濕性降 低及眼鏡配戴者之不適感增加。 作為如上所述之表面處理或使用聚合濕潤劑IPN之替代 方式’已發現可使用極性樹脂模具代替非極性樹脂模具來 產生具有眼用可接受之表面可濕性的矽氧水凝膠隱形眼 鏡。舉例而言,在乙烯-乙烯醇基或聚乙烯醇基模具中形 成之矽氧水凝膠隱形眼鏡具有所需之表面可濕性。適用於 製造用於產生無聚合濕潤劑IPN之未經表面處理的石夕氧水 凝膠隱形眼鏡之隱形眼鏡模具的極性樹脂之一種實例為乙 烯-乙稀醇共聚物之樹脂,諸如由Nippon Gohsei,Ltd以商 標名稱SOARLITE™出售之乙烯-乙烯醇共聚物樹脂。除其 極性之外,SOARLITEtm描述為具有以下特徵:極高機械 強度、抗靜電性、當用於模製過程時的低收縮性、優良抗 油性及抗溶劑性、小的熱膨脹係數及良好耐磨性。 雖然基於SOARLITE™之模具對於在不使用表面處理或 121842.doc 200817471 聚合濕潤劑IP N下產生眼睛上相容之矽氧水凝膠隱形眼鏡 提供有利之替代方式,但S0ARLITETM模具與非極性樹脂 模具(諸如聚丙烯模具)相比之可變形性或可撓性較小,且 與非極性樹脂模具相比相對較難以工作。200817471 IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention is particularly directed to helium oxygenated hydrogel ophthalmic devices and related compositions and methods. More particularly, the present invention relates to molded wettable hydrogel hydrogel contact lenses and related compositions and methods. [Prior Art] • Hydrogenated hydrogel contact lenses have become popular because contact lens wearers wear these glasses on their eyes for longer than non-oxygenated hydrogel contact lenses. The ability of time. For example, depending on the particular lens, the oxygenated hydrogel contact lens can be worn daily, worn weekly, bi-weekly or worn on a monthly basis or worn or worn every day. , wear in two weeks or wear on the mother's moon. The wearer of the lens wearer associated with the Shixi oxygen hydrogel contact lens can be at least partially attributed to the combination of the hydrophilic component of the contact lens and the hydrophobic character of the stone-containing polymeric material. Non-stone-oxygen hydrogel contact lenses (such as hydrogel contact lenses based on 2-hydroxyethyl methacrylate 0 (HEM A)) are often found in non-polar resin contact lens molds (eg, invisible from polyolefin-based resins) Produced in the glasses mold). A lens precursor composition for a non-oxygenated hydrogel contact lens is polymerized in a non-polar resin contact lens mold to produce a HEMA-based polymeric lens product. Due to the hydrophilic nature of the polymeric components of HEMA-based contact lenses, HEMA-based lenses are still eye-compatible and have an ophthalmically acceptable surface wettability, even if they are produced using a non-polar resin mold. In contrast, prior art oxygenated hydrogel contact lenses obtained from non-polar resin molds have hydrophobic eyeglass surfaces. In other words, the surface of the hydrogen peroxide hydrogel 121842.doc 200817471 has a low wettability and is therefore incompatible or unacceptable to the eye. For example, such a oxy-hydrogel contact lenses can be associated with less desirable features such as increased lipid deposition, protein deposition, spectacles, and the following: > /, the combination of the eye surface and the general stimulation of the glasses wearer. In an effort to overcome these problems, attempts have been made to use (4) Shixi oxygen hydrogel contact lenses or spectacles products for surface treatment + main enamel treatment or surface modification to increase the hydrophilicity and wettability of the enamel surface. Examples of surface treatment of Shixi oxygen hydrogel glasses include coating the surface of the lens, adsorbing chemicals onto the surface of the lens, and changing the chemical nature or electrostatic charge of the chemical groups on the surface of the lens. Surface treatments have been described which include coating the surface of the polymeric lens with a plasma gas or using a plasma gas on the surface of the contact lens mold to treat the cookware prior to forming the polymeric lens. Unfortunately, several disadvantages are associated with this approach. The surface treatment of the hidden mirror requires more mechanical and time to produce the contact lens than a manufacturing method that does not use surface treatment or modification. In addition, the surface treated Weishui (4) contact lens can exhibit no reduced surface wettability when the glasses are worn and/or touched by the glasses. For example, increasing the touch on surface treated glasses can result in degradation or wear of the hydrophilic surface. Another method for increasing the wettability and eye compatibility of (IV) oxygen hydrogel glasses is to polymerize the invisible hydrogel in the presence of a second composition comprising a polymeric wetting agent such as polyvinylpyrrole (tetra) (PVP). A lens precursor composition. This type of lens is herein referred to as a hydrogenated hydrogel contact lens having a polymeric internal wetting agent, and typically comprises a high molecular weight polymer (such as pvp). Wearing a polymer network (IpN). As is familiar to the skilled person, 121842.doc 200817471 understands that IPN refers to a combination of two or more different polymers in a network form, at least one of which is in another Synthesizing and/or cross-linking in the presence of a polymer without any covalent bond between the two. IpN can be composed of two chains that form two separate but adjacent or interpenetrating networks. Examples of IpN include stepwise Π> Ν, Synchronous IPN, Semi-IPN, and both. Although helium-hydrogel contact lenses including polymeric wet IPN avoid problems associated with surface treatment, such glasses may not retain their eye compatibility for extended periods of time, including table Humidity. For example, since the internal humectant is not covalently bonded to form other components of the polymeric spectacles, it may be leached from the spectacles when worn by the spectacles wearer, and thereby the surface may be rendered over time Reduced wetness and increased discomfort of the wearer of the lens. As an alternative to the surface treatment or the use of polymeric wetting agent IPN as described above, it has been found that a polar resin mold can be used instead of a non-polar resin mold to produce an ophthalmically acceptable Surface wettable hydrogel contact lenses. For example, hydroxyl hydrogel contact lenses formed in ethylene-vinyl alcohol based or polyvinyl alcohol based molds have the desired surface wettability. An example of a polar resin for producing a contact lens mold for producing a non-polymerized wetting agent IPN without surface treatment, is an ethylene-ethylene alcohol copolymer resin such as Nippon Gohsei, Ltd. The ethylene-vinyl alcohol copolymer resin sold under the trade name SOARLITETM. In addition to its polarity, SOARLITEtm is described as having the following characteristics: extremely high mechanical strength, resistance Electrostatic, low shrinkage when used in the molding process, excellent oil and solvent resistance, small coefficient of thermal expansion and good wear resistance. Although SOARLITETM based molds are used without surface treatment or 121842.doc 200817471 The polymeric wetting agent IP N produces an eye-compatible oxygenated hydrogel contact lens that provides an advantageous alternative, but the S0ARLITETM mold is more deformable or flexible than a non-polar resin mold such as a polypropylene mold. Small and relatively difficult to work with non-polar resin molds.

根據上文,可見需要眼睛上相容之矽氧水凝膠隱形眼 鏡,其與自soarute™隱形眼鏡模具獲得之矽氧水凝膠 隱形眼鏡相比更易於產生,且無需表面處理或使用聚合濕 潤劑IPN(包括PVP IPN)來達成眼睛相容性。此外,極為需 要提供一種自非極性樹脂或聚烯烴基隱形眼鏡模具構件產 生眼睛上相容之矽氧水凝膠隱形眼鏡(諸如具有眼睛上相 有有助於長期舒適感之特徵的眼鏡產物。本發明滿足該等 需要。 容之表面可濕性的矽氧水凝膠隱形眼鏡)的方法,該方法 克服現有製造方法之缺點。亦即,需要—種用於製備眼睛 上相容之碎氧水凝«形眼鏡之改良方法,其既無需表面 處理所得隱形眼鏡產物,亦無需使用聚合濕_测作為 可聚合矽氧水凝膠隱形眼鏡前驅體組合物之部分來提供具 【發明内容】 本發明之隱形眼鏡、眼鏡產物、組合物及方法解決與現 有矽氧水凝膠隱形眼鏡及其目前之生產方法相關的需要及 問題H地發現,眼睛幼容之錢錢㈣形眼鏡 係藉由組合某些組份以提供在聚合時提供具有一或多種尤 其需要之特徵之預萃取聚切氧水凝膠隱形眼鏡產物的可 聚合組合物來獲得。在一或多個實施财,在$取之前, 121842.doc 200817471 水凝膠隱形眼鏡產物具有約ίο重量%或更多之可萃取組 份。在某些實施例中,預萃取之矽氧水凝膠隱形眼鏡產物 之可萃取物含量為至少約20重量%。舉例而言,預萃取之 矽氧水凝膠隱形眼鏡產物可具有約22重量%至約3〇重量% 之可萃取物含量。在至少一特定實施例中,預萃取之石夕氧 水凝膠隱形眼鏡產物具有約26重量%之可萃取物含量。在 本發明之產物及方法的一或多個實施例中,本文提供一種 石夕氧水凝膠隱形眼鏡產物,其未採用聚氧化浠矽氧可萃取 組份,但其有利地導致與現有眼鏡相比具有不同且需要之 特徵的組合物及眼鏡。 本文所提供之矽氧水凝膠隱形眼鏡的特徵包括如本文所 述之眼用可接受之表面可濕性。此外,本發明之矽氧水凝 膠隱形眼鏡具有透氧性、表面可濕性、模數、水含量、離 子流及設計,其使得本發明之眼鏡適合患者眼睛舒適地配 戴延長之時期,諸如至少一天、至少一週、至少兩週或約 一個月,而無需自眼睛中移除眼鏡。 在一態樣中,本發明係針對可聚合矽氧水凝膠隱形眼鏡 前驅體組合物。該等前驅體組合物有效地形成矽氧水凝膠 隱形眼鏡。 在一特定態樣中,本文提供一種可聚合組合物,其包含 以下組伤、基本上由其組成或完全由其組成:雙(甲基 丙烯醯氧基乙基亞胺基羧基乙氧基丙基)_聚(二曱基矽氧 烷)_聚(三氟丙基甲基矽氧烷聚(ω-甲氧基-聚(乙二醇)丙 基甲基矽氧烷)、Ν_乙烯基-Ν_甲基乙醯胺、甲基丙烯酸甲 121842.doc 200817471 酯、二甲基丙烯酸乙二醇酯、烯丙氧基醇及自由基引發 劑。 在一或多個實施例中,可聚合組合物進一步包含紫外線 吸收劑,諸如2-羥基_4_丙烯醯氧基乙氧基二苯甲酮。 在一或多個其他實施例中,可聚合組合物進一步包含著 色劑,例如酞菁顏料,諸如酞菁藍。 在一或多個其他實施例中,可聚合組合物中所包含之自 由基引發劑為2,2’-偶氮二異丁腈。 本發明進一步包括以上所述之可聚合組合物中之任一或 多者,其包含約34重量%之α_ω_雙(甲基丙稀醯氧基乙基亞 胺基缓基乙氧基丙基)_聚(二甲基矽氧院)_聚(三氣丙基甲基 矽氧烷)-聚(ω_甲氧基-聚(乙二醇)丙基曱基矽氧烷)。 在一或多個其他實施例中,可聚合組合物可包含以下之 任一或多者:⑴約46重量%之沁乙烯基_Ν_甲基乙醯胺、 (ii)約17重量%之甲基丙烯酸甲酯、(丨11)約〇 5重量%之二甲 基丙烯酸乙二醇酯及(丨幻約丨重量%之烯丙氧基醇。 在一或多個其他實施例中,可聚合組合物包含約q9重 量%之2-羥基-4-丙烯醯氧基乙氧基二苯甲酮。 在一或多個其他實施例中,可聚合組合物包含約01重 量%之酞菁藍。 在一或多個其他實施例中,可聚合組合物包含約0.3重 量%之自由基引發劑。 在另一特定實施例中,可聚合組合物包含34重量。/。之心 ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)_聚(二 121842.doc 11 200817471 曱基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚(0)_甲氧基-聚(乙 二醇)丙基甲基矽氧烷)、約46重量%之&gt;1•乙烯基_N_甲基乙 醯胺、約17重量%之甲基丙烯酸甲酯、約〇·5重量%之二甲 基丙烯酸乙二醇酯、約i重量%之烯丙氧基醇、約〇·9重量 %之2-羥基-4-丙烯醯氧基乙氧基二苯曱酮、約〇1重量%之 酜菁藍及約0·3重量%之2,2,-偶氮二異丁腈。 在另一實施例中,提供本文所述之不含聚氧化烯矽氧可 萃取組份的可聚合組合物中之任一或多者。 在另一態樣中,提供自如本文所提供之可聚合組合物產 生之矽氧水凝膠隱形眼鏡。 亦提供由如本文所述之實質上無可萃取組份之可聚合組 合物所形成之矽氧水凝膠隱形眼鏡。 亦構成本發明之部分者為藉由以下步驟所產生之石夕氧水 凝膠隱形眼鏡:聚合如本文所提供之可聚合組合物以形成 包含可萃取組份之預萃取聚合矽氧水凝膠隱形眼鏡,自預 萃取之隱形眼鏡萃取可萃取組份以形成經萃取之聚合眼鏡 產物,且使經萃取之聚合眼鏡產物水合以形成矽氧水凝膠 隱形眼鏡。 在一或多個實施例中,如上所述產生之矽氧水凝膠隱形 眼鏡具有在約42重量%至約50重量%之範圍内的平衡水含 量及在約80-110 barrer之範圍内的透氧性ργίο·11)。 在一或多個其他實施例中,如上所述產生之矽氧水凝膠 隱形眼鏡具有約0.6至約1.2 MPa之模數。 在一或多個其他實施例中,提供如上所述產生之矽氧水 121842.doc -12- 200817471 聚合組合物加熱至 凝膠隱形眼鏡,其中聚合步驟包含將可 大於約65°C之溫度。 在另-態樣中,本文提供—種平衡水含量在約42重量。a 至約50重量%之範圍内、透氧性(一)在約8(M10 範圍内、模數為輪至約。奶、離子流為約卜 5(xl〇 mmVimn)、前進接觸角為約52。至約62。、後退接觸 角為約40。至60。及滞後為約5。至約15。的石夕氧水凝膠隱形眼 鏡0From the above, it can be seen that there is a need for an ophthalmically compatible hydroxyl hydrogel contact lens that is easier to produce than a hydrogel contact lens obtained from a soaruteTM contact lens mold, and that does not require surface treatment or polymerization. Agent IPN (including PVP IPN) to achieve eye compatibility. In addition, it is highly desirable to provide an ophthalmicly compatible hydroxyl hydrogel contact lens from a non-polar or polyolefin-based contact lens mold member, such as a lens product having features on the eye that contribute to long-term comfort. The present invention satisfies the need for such surface wettable hydrogel contact lenses, which overcomes the shortcomings of prior art manufacturing methods. That is, there is a need for an improved method for preparing a compatible oxygenated water-eye lens on the eye which does not require surface treatment of the resulting contact lens product, and does not require the use of polymeric wet-test as a polymerizable hydrogel. Portions of Contact Lens Precursor Compositions Provided </ RTI> The present invention provides contact lenses, spectacles products, compositions and methods that address the needs and problems associated with prior oxyhydrogel contact lenses and their current methods of production. It has been found that eye-sharing money (four) shaped glasses are by combining certain components to provide a polymerizable combination of pre-extracted poly-hydrogenated hydrogel contact lens products having one or more particularly desirable characteristics upon polymerization. Things to get. In one or more implementations, prior to the withdrawal, the 121842.doc 200817471 hydrogel contact lens product has an extractable component of about 9% by weight or more. In certain embodiments, the pre-extracted neohydrogen hydrogel contact lens product has an extractable content of at least about 20% by weight. For example, the pre-extracted hemioxy-hydrogel contact lens product can have an extractables content of from about 22% to about 3% by weight. In at least one specific embodiment, the pre-extracted oxalate hydrogel contact lens product has an extractables content of about 26% by weight. In one or more embodiments of the products and methods of the present invention, provided herein is a rock oxide oxygen gel contact lens product that does not utilize a polyoxyn oxide oxygen extractable component, but which advantageously results in an existing lens Compositions and glasses having different and desirable characteristics. Features of the oxygenated hydrogel contact lenses provided herein include ophthalmically acceptable surface wettability as described herein. In addition, the oxygenated hydrogel contact lenses of the present invention have oxygen permeability, surface wettability, modulus, water content, ion flow, and design, which make the glasses of the present invention suitable for comfortable stretching of the patient's eyes. Such as at least one day, at least one week, at least two weeks, or about one month without removing the glasses from the eyes. In one aspect, the invention is directed to a polymerizable silicone hydrogel contact lens precursor composition. The precursor compositions effectively form a helium oxygen hydrogel contact lens. In a particular aspect, provided herein is a polymerizable composition comprising, consisting essentially of, or consisting entirely of: bis(methacryloxyethylethylamino carboxy ethoxy propyl) ()) poly(didecyloxyne)_poly(trifluoropropylmethyl decane poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), Ν_ethylene Ν-Ν_methylacetamide, methacrylic acid A 121842.doc 200817471 ester, ethylene glycol dimethacrylate, allyloxy alcohol and a free radical initiator. In one or more embodiments, The polymeric composition further comprises a UV absorber such as 2-hydroxy-4-pyreneoxyethoxybenzophenone. In one or more other embodiments, the polymerizable composition further comprises a colorant, such as phthalocyanine a pigment, such as phthalocyanine blue. In one or more other embodiments, the free radical initiator included in the polymerizable composition is 2,2'-azobisisobutyronitrile. The invention further includes the above Any one or more of the polymerizable compositions comprising about 34% by weight of alpha _ _ bis (methyl propylene) Oxyethylimide sulfoethoxypropyl)-poly(dimethyloxoxime)_poly(trimethylpropylmethyloxane)-poly(ω_methoxy-poly(B) Glycol) propyl fluorenyl oxane. In one or more other embodiments, the polymerizable composition can comprise any one or more of the following: (1) about 46% by weight of hydrazine vinyl Ν Ν methyl Acetamide, (ii) about 17% by weight of methyl methacrylate, (丨11) about 5% by weight of ethylene glycol dimethacrylate, and (% by weight of allyloxyl alcohol) In one or more other embodiments, the polymerizable composition comprises about q9% by weight of 2-hydroxy-4-propenyloxyethoxybenzophenone. In one or more other embodiments, The polymeric composition comprises about 01% by weight of phthalocyanine blue. In one or more other embodiments, the polymerizable composition comprises about 0.3% by weight of a free radical initiator. In another particular embodiment, the polymerizable composition Containing 34% by weight of ω-bis(methacryloxyethylethylimidocarboxyethoxypropyl)-poly (二121842.doc 11 200817471 曱 矽 矽 )) (trifluoropropylmethyl decane)_poly(0)-methoxy-poly(ethylene glycol) propylmethyl decane), about 46% by weight &gt; 1 • Vinyl _N_ Methylacetamide, about 17% by weight of methyl methacrylate, about 5% by weight of ethylene glycol dimethacrylate, about i% by weight of allyloxy alcohol, about 9% by weight 2-hydroxy-4-propenyloxyethoxybenzophenone, about 1% by weight of phthalocyanine blue and about 0.3% by weight of 2,2,-azobisisobutyronitrile. In one embodiment, any one or more of the polymerizable compositions of the polyoxyalkylene oxide-free extractable components described herein are provided. In another aspect, a polymerizable combination as provided herein is provided. Hydrogenated hydrogel contact lenses produced by the substance. Hydroxyl hydrogel contact lenses formed from polymerizable compositions substantially free of extractable components as described herein are also provided. Also contemplated as part of the present invention is a rock oxide hydrogel contact lens produced by the following steps: polymerizing a polymerizable composition as provided herein to form a pre-extracted polymeric hemo-hydrogel comprising an extractable component Contact lenses, extractable components are extracted from pre-extracted contact lenses to form an extracted polymeric lens product, and the extracted polymeric lens product is hydrated to form a hydroxyl hydrogel contact lens. In one or more embodiments, the hydroxyl hydrogel contact lens produced as described above has an equilibrium water content in the range of from about 42% to about 50% by weight and is in the range of from about 80 to 110 barrer. Oxygen permeability ργίο·11). In one or more other embodiments, the hydroxyl hydrogel contact lens produced as described above has a modulus of from about 0.6 to about 1.2 MPa. In one or more other embodiments, the oxygenated water produced as described above is provided 121842.doc -12-200817471 The polymeric composition is heated to a gel contact lens wherein the polymerization step comprises a temperature which will be greater than about 65 °C. In another aspect, the equilibrium water content is provided at about 42 weights. a to about 50% by weight, oxygen permeability (1) in about 8 (M10 range, modulus is round to about. Milk, ion current is about 5 (xl〇mmVimn), advancing contact angle is about 52. to about 62., receding contact angle is about 40. to 60. and hysteresis is about 5. to about 15. Shishi oxygen hydrogel contact lens 0

ϋ 在一或多個實施财’如本文所述之錢水凝膠隱形眼 鏡額外表徵為具有圓形外周邊緣之鏡體。 在一或多個其他實施例中,本發明之⑦氧水凝膠隱形眼 鏡可為:⑴球面眼鏡、⑼非球面眼鏡、(出)單焦點眼鏡、 (iv)多焦點眼鏡或(v)旋轉穩定複曲面隱形眼鏡。 在或多個其他實施例中,本發明之石夕氧水凝膠隱形眼 鏡在密封包裝内。 在一或多個其他實施财ϋ文所提供之石夕氧水凝膠 隱形眼鏡係未經表面處理。 在另一態樣中,本文提供一種產生可聚合矽氧水凝膠隱 形眼鏡前驅體組合物之方法。在一或多個實施例中,該方 法包合組合心〜雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基 丙基)聚(一甲基矽氧烷)_聚(三氟丙基甲基矽氧烷)_聚(①_ 甲氧基-聚(乙一醇)丙基甲基矽氧烷)、Ν_乙烯基-Ν_甲基乙 醯胺甲基丙烯酸甲酯、二甲基丙烯酸乙二醇酯、烯丙氧 基醇及自由基引發劑,以藉此產生可聚合之矽氧水凝膠隱 121842.doc -13- 200817471 形眼鏡前驅體組合物。 在該方法之或多個實施例中,組合步驟額外包括紫外 線吸收劑。 在一或多個特定實施例中,組合步驟額外包括2_羥基 丙烯醯氧基乙氧基二苯甲_。 在該方法之一或多個其他實施例中,組合步驟額外包括 - 著色劑,例如酞菁顏料,諸如酞菁藍。 在該方法之一或多個特定實施例中,自由基引發劑為 Γ) 2,2’-偶氮二異丁腈。 在一或夕個特疋實施例中,該方法包含組合以下各物: (1)約30重量%至4〇重量%之α_ω_雙(曱基丙烯醯氧基乙 基亞胺基羧基乙氧基丙基聚(二曱基矽氧烷)_聚(三氟丙基 甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷), (ii)約40重量%至50重量%之Ν_乙烯基-Ν-甲基乙醯 胺, (ϋ〇約10重量%至25重量%之甲基丙烯酸甲酯,及钱 The one or more implementations of the money hydrogel contact lens as described herein are additionally characterized as a mirror body having a rounded peripheral edge. In one or more other embodiments, the 7 oxygen hydrogel contact lenses of the present invention can be: (1) spherical glasses, (9) aspherical glasses, (out) single focus glasses, (iv) multifocal glasses, or (v) rotation. Stable toric contact lenses. In one or more other embodiments, the Shixia oxygen hydrogel contact lenses of the present invention are in a sealed package. The Shixia Oxygen Hydrogel contact lens system provided in one or more other implementations has not been surface treated. In another aspect, provided herein is a method of producing a polymerizable silicone hydrogel contact lens precursor composition. In one or more embodiments, the method comprises a combination of heart-bis(methacryloxyethylethyliminocarboxyethoxypropyl)poly(monomethyloxane)-poly(trifluoro Propylmethyl decane) _ poly (1 - methoxy-poly (ethyl alcohol) propyl methyl oxiranane), Ν _ vinyl - Ν _ methyl acetamide methyl methacrylate, dimethyl Ethylene glycol acrylate, allyloxy alcohol and a free radical initiator to thereby produce a polymerizable oxime hydrogel cryptic 121842.doc-13-200817471 spectacles precursor composition. In one or more embodiments of the method, the combining step additionally includes an ultraviolet absorber. In one or more specific embodiments, the combining step additionally includes 2-hydroxypropenyloxyethoxybenzonitrile. In one or more other embodiments of the method, the combining step additionally comprises - a colorant, such as a phthalocyanine pigment, such as phthalocyanine blue. In one or more specific embodiments of the method, the free radical initiator is Γ) 2,2'-azobisisobutyronitrile. In one or more specific embodiments, the method comprises combining the following: (1) about 30% to about 4% by weight of α_ω_bis(mercaptopropenyloxyethyliminocarboethoxy) Propyl poly(didecyloxyl)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol)propylmethyl decane), ( Ii) from about 40% to about 50% by weight of Ν-vinyl-indole-methylacetamide, (about 10% to 25% by weight of methyl methacrylate, and

U (IV)小於約5重量。/。之二甲基丙烯酸乙二醇酯、烯丙氧 基醇、2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、酞菁藍與 • 2,2^偶氮二異丁腈之組合。 在該方法之一或多個其他實施例中,組合步驟包含組合 約34重量%之α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧 基丙基)-聚(二甲基石夕氧烧)-聚(三氟丙基甲基石夕氧燒)_聚 (co-曱氧基-聚(乙一醉)丙基曱基碎氧烧)、約46重量%之]^_ 乙烯基-Ν-甲基乙醯胺、約17重量〇/〇之曱基丙烯酸甲酯、約 121842.doc -14- 200817471 0·5重量%之二甲基丙烯酸乙二醇酯、約1重量%之烯丙氧 基醇、約〇·9重量%之2_羥基_4_丙烯醯氧基乙氧基二苯甲 酮、約0.1重量%之酞菁藍及約〇.3重量%之2,2,-偶氮二異丁 腈’以藉此提供可聚合之矽氧水凝膠隱形眼鏡前驅體組合 物。 在一或多個其他實施例中,該方法進一步包含聚合可聚 合之眼鏡前驅體組合物以形成預萃取之聚合矽氧水凝膠隱 形眼鏡。 在該方法之一或多個特定實施例中,聚合步驟包含加熱 可聚合之眼鏡前驅體組合物。 在一或多個其他實施例中,該方法進一步包含在聚合步 驟之前將彳聚合《眼鏡前驅體組合物置放於非極性樹脂隱 形眼鏡模具中。 在-或多個其他實施例中,該方法進一步包含萃取預萃U (IV) is less than about 5 by weight. /. Ethylene glycol dimethacrylate, allyloxy alcohol, 2-hydroxy-4-propenyloxyethoxybenzophenone, phthalocyanine blue and 2,2^ azobisisobutyronitrile combination. In one or more other embodiments of the method, the combining step comprises combining about 34% by weight of α-ω-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly (two Methyl oxy-oxygen)-poly(trifluoropropylmethyl-osinoxy)-poly(co-decyloxy-poly(ethyl-drug) propyl sulfhydryl oxy-combustion), about 46% by weight] ^_ vinyl-oxime-methylacetamide, about 17 weights of hydrazine/methyl methacrylate, about 121842.doc -14-200817471 0.5% by weight of ethylene glycol dimethacrylate, about 1% by weight of allyloxy alcohol, about 9% by weight of 2-hydroxyl-4-acryloxyethoxybenzophenone, about 0.1% by weight of phthalocyanine blue and about 0.3% by weight 2,2,-Azobisisobutyronitrile is used to thereby provide a polymerizable oxygenated hydrogel contact lens precursor composition. In one or more other embodiments, the method further comprises polymerizing the polymerizable lens precursor composition to form a pre-extracted polymeric oxygenated hydrogel contact lens. In one or more particular embodiments of the method, the polymerizing step comprises heating the polymerizable lens precursor composition. In one or more other embodiments, the method further comprises placing the ruthenium polymerization "glasses precursor composition" in a non-polar resin contact lens mold prior to the polymerization step. In - or a plurality of other embodiments, the method further comprises extracting the pre-extraction

矽氧水凝膠隱形眼鏡。 在另㉟樣中,本文提供一種矽氧水凝膠隱形眼鏡,其 包含如本文所述之實質上無可萃取組份 反應產物。 之可聚合組合物的Hydrogenated hydrogel contact lenses. In another 35 examples, provided herein is a hydroxyl hydrogel contact lens comprising substantially no extractable component reaction product as described herein. Polymerizable composition

以上及以下描述可瞭解, 等特徵中之兩者或兩者以 、組合物及方法之其他實施例 實例及申請專利範圍顯而易見。如由 ’本文所述之各個及每一特徵及該 以上之各個及每一組合均包括在本 121842.doc 15- 200817471 發明之範脅内,其限制條件為該組合中所包括之特徵彼此 -致。此外’任何特徵或特徵組合可特定排除在本發明之 任何實施例之外。尤其當結合隨附實例及圖示考慮時,本 發明之其他態樣及優勢在以下實施方式及中請專利範圍中 闡明。 【實施方式】 Ο Ο 本發明現將在下文中更全面地描述。然而,本發明可以 多種不同形式具體化,且不應理解為限於本文所提出之實 施例;相反,提供該等實施例以使本揭示案詳盡且完整, 且對熟習此項技術者完全傳達本發明之範疇。 定義 須注意,除非上下文另外明確指示,否則如本說明書中 所用之單數形式”一&quot;及&quot;該&quot;包括複數指示物。因此,舉例 而言’提及&quot;隱形眼鏡,,包括單一眼鏡以及兩個或兩個以上 相同或不同之眼鏡,提及&quot;前驅體組合物&quot;係指單一組合物 以及兩種或兩種以上相同或不同之組合物,及其類似物。 在描述且主張本發明時’以下術語將根據下文所述之定 義來使用。 如本文所用之術語”水凝膠,,係指通常為聚合物鏈網路或 t質之能夠在水中膨脹或遇水膨脹之聚合物質。網路或基 、口 、$或可不父聯。水凝膠係指遇水可膨脹或遇水膨脹 歜口物質,包括隱形眼鏡。因此,水凝膠可⑴未經水合 L尺可艮脹,或⑴)部分水合且遇水膨脹,或(iii)完全水 合且遇水膨脹。 121842.doc -16- 200817471 如(例如)’’經取代之烷基’’中之術語”經取代”係指經一戋 多個非干擾取代基取代之部分(例如烷基),該等取代基諸 如(但不限於)CrC8環烷基(例如環丙基、環丁基及其類似 物)、_基(例如氟基、氣基、溴基及碘基)、氰基、烷氧 基、低碳苯基、經取代之苯基及其類似物。對於苯環上之 取代而言,取代基可在任何方位上(亦即鄰、間或對)。 術語&quot;矽氧水凝膠,,或”矽氧水凝膠物質&quot;係指包括矽(si) 組份或矽氧組份之特定水凝膠。舉例而言,矽氧水凝膠通 常係藉由將含矽物質與習知親水性水凝膠前驅體組合來製 備。矽氧水凝膠隱形眼鏡為包含矽氧水凝膠物質之隱形眼 鏡,包括矯正視力之隱形眼鏡。矽氧水凝膠隱形眼鏡之特 性不同於習知之水凝膠基眼鏡。 ”含矽氧組份,,為在單體、大分子單體或預聚物中含有至 少一個[-Si-0-Si]鍵聯之组份,其中各矽原子視情況可具有 一或多個可相同或不同之有機基團取代基(Ri、D或經取 代之有機基團取代基,例如-SiRiR^O-。 可選’’或’’視情況&quot;意謂隨後所述之事件可能發生或可能 不發生’以使得此描述包括事件發生之情況及事件不發生 之情況。 在本發明聚合物之情形下的,,分子質量&quot;係指聚合物之標 稱平均分子質量,通常藉由尺寸排阻層析法、光散射技術 或在1,2,4-三氣苯中之内在速度測定法來測定。在聚合物 情形下之分子量可表述為數量平均分子量或重量平均分子 量,且在廠商供應之物質的情況下,將視供應商而定。若 121842.doc -17· 200817471 並非以封裝物質形式提供,則任何該等分子量測定之基礎 均可易於由供應商提供。通常本文提及之大分子單體:聚 合物之分子量在本文中係指重量平均分子量。數量平均分 子里及重量平均分子量之分子量敎均可使用凝膠渗透層 析技術或其他液相層析技術來量測。亦可使用其他量測: 子量值之方法,諸如制端基分析或量測依數性(例如: 固點下降 '沸點升高或渗透壓)來測定數量平均分子旦It will be apparent from the above and following description that the two or both of the features, the examples of the composition and the method, and the scope of the claims are obvious. Each and every feature described herein and each and every combination of the above are included in the scope of the invention of the present invention. The limitation is that the features included in the combination are To. Furthermore, any feature or combination of features may be specifically excluded from any embodiment of the invention. Other aspects and advantages of the present invention are set forth in the following embodiments and claims. [Embodiment] The present invention will now be described more fully hereinafter. However, the present invention may be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein. Instead, the embodiments are provided so that this disclosure will be thorough and complete, and The scope of the invention. The singular forms "a" and "the" are used in the singular <RTI ID=0.0> </RTI> <RTIgt; </RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; Glasses and two or more identical or different glasses, reference to &quot;precursor composition&quot; means a single composition and two or more identical or different compositions, and the like. And the following terms will be used in accordance with the definitions described below. As used herein, the term "hydrogel" refers to a polymer network or t-type that is typically capable of swelling or swelling in water. Polymeric. Network or base, port, $ or not. Hydrogel refers to a mouthwash that is swellable or expansive to water, including contact lenses. Thus, the hydrogel may (1) swell without being hydrated, or (1)) partially hydrated and swell with water, or (iii) fully hydrated and swell with water. 121842.doc -16- 200817471 The term "substituted" as in, for example, ''substituted alkyl'' refers to a moiety (eg, alkyl) substituted with one or more non-interfering substituents, such substitutions. Bases such as, but not limited to, CrC8 cycloalkyl (eg, cyclopropyl, cyclobutyl, and the like), yl (eg, fluoro, carbyl, bromo, and iodo), cyano, alkoxy, Low carbon phenyl, substituted phenyl and the like. For substitution on the phenyl ring, the substituents can be in any orientation (i.e., ortho, in between, or in pairs). The term &quot;hydrogenated hydrogel,&quot; or &quot;hydrogenated hydrogel material&quot; refers to a specific hydrogel comprising a bismuth (si) component or a bismuth component. For example, a hydroxyl hydrogel is typically It is prepared by combining a ruthenium-containing substance with a conventional hydrophilic hydrogel precursor. The oxime hydrogel contact lens is a contact lens comprising a silicone hydrogel material, including a contact lens for correcting vision. The characteristics of gel contact lenses are different from those of conventional hydrogel-based glasses. "The oxygen-containing component contains at least one [-Si-0-Si] bond in the monomer, macromer or prepolymer. a component wherein each hydrazine atom may have one or more organic group substituents which may be the same or different (Ri, D or substituted organic group substituents, for example, -SiRiR^O-. ''or ''as appropriate' means that the events described below may or may not occur 'so that this description includes the circumstances in which the event occurred and the event does not occur. In the case of the polymer of the present invention, Molecular mass &quot; refers to the nominal average molecular mass of a polymer, usually borrowed Size exclusion chromatography, light scattering technique or intrinsic velocity measurement in 1,2,4-tris benzene. The molecular weight in the case of a polymer can be expressed as a number average molecular weight or a weight average molecular weight, and The substance supplied by the manufacturer will depend on the supplier. If 121842.doc -17· 200817471 is not supplied in the form of a packaged substance, the basis of any such molecular weight determination can be easily provided by the supplier. The macromonomer: the molecular weight of the polymer herein refers to the weight average molecular weight. The molecular weight in the number average molecule and the weight average molecular weight can be measured using gel permeation chromatography or other liquid chromatography techniques. Other measurements can be used: sub-quantity methods such as end-group analysis or measurement-dependent (eg, descent drop 'boiling point rise or osmotic pressure) to determine the number average molecular size

Ο 或使用光散射技術、超速離心法或黏度測定法:旦 平均分子量。 里里 親水性聚合物之,,網路,,或&quot;基質&quot;通常意謂在聚合物鏈之 間由共價鍵或物理鍵(例如氫鍵)形成之交聯。 力= 水^物質為喜水性物質。料化合物對水具有親和 予π電或具有吸引水之極性側鏈基團。 《月之親水性聚合物&quot;定義為能夠在水中膨脹但 在水中可溶之聚合物。 …、 ,,親水性組份&quot;為可為或^為聚合物之親水性物質。親 ==括在與剩餘反應性組份組合時能夠對所得水合 =、至少約(例如至少約2— 可配戴於人&quot; 水凝膠隱形眼鏡,,係指 了配戴於人眼上而人不經歷或報導實 刺激及類似不適)的矽氧 k(匕括眼目月 石夕氧水凝… 隱形眼鏡。眼睛上相容之 夕乳水轉鏡具有 常不引起顯著角媒腫脹、角膜脫二表面可濕性’且通 月膜脫水(乾眼病”)、上方角膜 121842.doc -18- 200817471 上皮弓狀病變(&quot;SEAL”)或其他顯著不適或與該等病 關。 實質上&quot;或”基本上&quot;或&quot;約&quot;意t胃幾乎全部或完全,例如 某一給定量之95%或95%以上。 &quot;實質上不存在&quot;或&quot;實質上無&quot;某—特徵或實體意謂幾乎 全部或完全不存在該特徵或實體,例如含有5%或少於5% 之某些給定實體。舉例而言,實質上無某一實體之組合物 可含有少於約5%或少於約4%、少於約3%、少於約2%或甚 至少於約1 %之某些給定實體。 ’’烷基”係指長度通常在約1至20個原子範圍内之烴鏈。 該等烴鏈較佳但並非必需飽和,且雖然通常直鏈較佳,但 可為支鏈或直鏈。例示性烷基包括甲基、乙基、丙基、丁 基、戊基、1·甲基T基、i-乙基丙基、3·甲基戊基及類似 烷基。當提及三個或三個以上碳原子時,如本文所用之 ’’烧基’’包括環烷基。 π寡聚物”為由有限數目之單體亞單元組成之分子,且通 常由约2至約8個單體亞單元組成。 π低碳烷基”係指含有1至6個碳原子之烷基,且可為直鏈 或支鏈,例如甲基、乙基、正丁基、異丁基、第三丁基。 其他定義亦可見於以下部分中。 綜述 如先則所淪述,本文提供之本發明至少部分基於以下發 現/調配物,即··可使用避免與極性樹脂模具相關之問 題、避免對複雜且昂貴之聚合後程序之需要且解決與聚合 121842.doc -19- 200817471 濕潤劑IPN相關之問題的方法來製備眼睛上相容之石夕氧水 凝膠隱形眼鏡。此外,本文所提供之調配物無需超過約 30%之可移除或可萃取組份,該組份基本上未併入聚合矽 氧水凝膠隱形眼鏡產物中且藉由萃取與其他未反應組份一 起自所得經模製之隱形眼鏡產物移除。舉例而言,眼睛上 相容之矽氧水凝膠隱形眼鏡可自具有至少1〇%且小於約 30。/。之如本文所論述之經脫水萃取之矽氧水凝膠隱形眼鏡 的可萃取内含物之預萃取聚合矽氧水凝膠隱形眼鏡產物而 獲得。在某些實施例中,眼鏡調配物無聚氧化烯矽氧組 份。 特定言之,產生眼睛上相容之矽氧水凝膠隱形眼鏡之方 法包括將組份之特定組合併入可聚合矽氧隱形眼鏡前驅體 組合物中。該等物質賦予所得最終隱形眼鏡所需之特徵, 從而提供經萃取之隱形眼鏡產物,接著將其水合以產生具 有眼用可接受之表面可濕性以及如本文所述之其他有益特 徵的最終矽氧水凝膠隱形眼鏡 在以下部分詳細描述且例示本發明之此等及其他重要態 樣。 可聚合矽氧水凝膠隱形眼鏡前驅體組合物之組份 本發明之矽氧水凝膠隱形眼鏡通常自本文稱為,,可聚合 矽氧水凝膠隱形眼鏡前驅體組合物”或”前驅體組合物π之 物質而產生。如驅體組合物為用以製備矽氧水凝膠隱形眼 鏡之各種試劑的混合物,亦即在反應(在本發明之狀況下 為聚合反應)前之反應混合物。 121842.doc -20- 200817471 本發明之前驅體組合物通常包含至少以下組份:α_ω雙 (曱基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)_聚(二甲基 矽氧烷)-聚(三氟丙基曱基矽氧烷)_聚(ω_甲氧基-聚(乙二 醇)丙基甲切氧烧)、Ν_乙烯基_N_f基乙醯胺、f基丙稀 酸甲醋、二甲基丙烯酸乙二醇醋、烯丙氧基醇及自由基引 發劑。在某些實施例中,組合物基本上由前述組份組成。 在其他實施例中,組合物完全由前述組份組成。或 Or use light scattering techniques, ultracentrifugation or viscosity measurements: denier average molecular weight. The hydrophilic polymer, network, or &quot;matrix&quot; generally means cross-linking formed by covalent bonds or physical bonds (e.g., hydrogen bonds) between polymer chains. Force = water ^ substance is a water-based substance. The compound has an affinity for water to give π or a polar side chain group with water attraction. "Monthmic hydrophilic polymer" is defined as a polymer that swells in water but is soluble in water. ..., ,, a hydrophilic component &quot; is a hydrophilic substance which can be or is a polymer. Pro == can be combined with the remaining reactive components to be able to hydrate the resulting =, at least about (for example at least about 2 - can be worn on a human &quot; hydrogel contact lens, refers to wearing on the human eye And people do not experience or report real stimulation and similar discomfort) 矽 oxygen k (including eyesight moonstone oxygen coagulation ... contact lenses. Eyes compatible with the eve milk mirrors often do not cause significant angular swelling, cornea Detachable surface wettability 'and dehydration of the lunate membrane (dry eye disease)), upper cornea 121842.doc -18- 200817471 epithelial arch lesion (&quot;SEAL") or other significant discomfort or related to these diseases. &quot;or" basically &quot; or &quot;about&quot; means that the stomach is almost all or completely, such as 95% or more of a certain given amount. &quot;Substantially non-existent&quot; or &quot;substantially no&quot; A feature or entity means that the feature or entity is substantially completely or completely absent, for example, containing 5% or less than 5% of a given entity. For example, a composition that is substantially free of an entity may contain Less than about 5% or less than about 4%, less than about 3%, less than about 2%, or at least About 1% of a given entity. ''Alkyl' refers to a hydrocarbon chain typically having a length in the range of from about 1 to 20 atoms. The hydrocarbon chains are preferably, but not necessarily, saturated, and although generally straight chain is preferred But may be branched or straight chain. Exemplary alkyl groups include methyl, ethyl, propyl, butyl, pentyl, 1 methylthio, i-ethylpropyl, 3·methylpentyl And a similar alkyl group. When referring to three or more carbon atoms, as used herein, ''alkyl group'' includes a cycloalkyl group. A π oligomer is a molecule composed of a finite number of monomeric subunits. And usually consists of from about 2 to about 8 monomeric subunits. π lower alkyl" means an alkyl group containing from 1 to 6 carbon atoms and may be straight or branched, such as methyl or ethyl. Other n-butyl, isobutyl, and tert-butyl groups. Other definitions can also be found in the following sections. Summary As set forth above, the invention provided herein is based, at least in part, on the following findings/formulations, ie, Avoid problems associated with polar resin molds, avoid the need for complex and expensive post-polymerization procedures, and resolve and polymerize 121842.doc -19- 200817471 Method of humectant IPN related problems to prepare an eye-compatible shixi oxygen hydrogel contact lens. Furthermore, the formulation provided herein does not require more than about 30% of the removable or extractable component, the group The fraction is substantially unincorporated into the polymerized hydrogel contact lens product and is removed from the resulting molded contact lens product by extraction with other unreacted components. For example, compatible oxygen on the eye. The hydrogel contact lens can be self-extracted polymeric helium oxygenated with an extractable inclusion of at least 1% and less than about 30% of the dehydrated extracted hydroxyl hydrogel contact lens as discussed herein. Obtained from the contact lens product. In certain embodiments, the lens formulation is free of polyoxyalkylene oxide components. In particular, a method of producing an eye-compatible oxygenated hydrogel contact lens comprises incorporating a particular combination of components into a polymerizable silicone contact lens precursor composition. The materials impart the desired characteristics to the resulting final contact lens to provide an extracted contact lens product which is then hydrated to produce a final enamel having an ophthalmically acceptable surface wettability and other beneficial characteristics as described herein. Oxygenated Hydrogel Contact Lenses are described in detail in the following sections and illustrate such and other important aspects of the present invention. Component of Polymerizable Hydroxyl Hydrogel Contact Lens Precursor Composition The hydroxyl hydrogel contact lens of the present invention is generally referred to herein as a polymerizable silicone hydrogel contact lens precursor composition or "precursor" The composition of the body composition π is produced. For example, the body composition is a mixture of various agents used to prepare a helium oxygen hydrogel contact lens, i.e., a reaction mixture prior to the reaction (polymerization in the context of the present invention). 121842.doc -20- 200817471 The precursor composition of the present invention generally comprises at least the following components: α_ω bis(mercapto propylene methoxyethyl imino carboxy ethoxy propyl) _ poly (dimethyl oxime) Alkyl)-poly(trifluoropropyldecyloxyl)-poly(ω_methoxy-poly(ethylene glycol)propylmethoxine), Ν_vinyl_N_f-acetamide, f Acrylic acid methyl vinegar, ethylene glycol methacrylate, allyloxy alcohol and a free radical initiator. In certain embodiments, the composition consists essentially of the foregoing components. In other embodiments, the composition consists entirely of the foregoing components.

Ο —雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)聚 (二曱基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚((〇甲氧基聚 (乙二醇)丙基甲基矽氧烷) 第一組份α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧 基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚 (ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)為反應性含氟丙烯 醯基矽氧大分子單體,通稱為”M3U,,(CAS登錄號為 697234_74_5)。如以下通用結構所示,該大分子單體為三 嵌段共聚物,亦即包含三種不同之矽氧烷聚合物嵌段。中 心嵌段具有三氟甲基取代基,而丙烯醯基部分存在於每一 末端處。Ο — bis(methacryloxyethyl imino carboxy ethoxypropyl) poly(didecyl fluorene oxide)-poly(trifluoropropylmethyl decane) _ poly((〇甲Oxypoly (ethylene glycol) propyl methyl oxirane) The first component of α-ω-bis(methacryloxyethylethylimidocarboxyethoxypropyl)-poly(dimethyl矽 烷)-poly(trifluoropropylmethyl decane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane) is a reactive fluoropropenyl hydrazine The macromonomer, commonly known as "M3U," (CAS Accession No. 697234_74_5). As shown in the general structure below, the macromonomer is a triblock copolymer, ie containing three different siloxane polymers. The central block has a trifluoromethyl substituent and the acryl fluorenyl moiety is present at each end.

ch2c HsCFs ΟΗ2ΟΗ2〇Η2(ΟΟΗ2ΟΗ2)ρΟΟΗ3 〇 /CH3 -(〇Η2)30 (ch2)』 ch3Ch2c HsCFs ΟΗ2ΟΗ2〇Η2(ΟΟΗ2ΟΗ2)ρΟΟΗ3 〇 /CH3 -(〇Η2)30 (ch2)』ch3

I 與下行結構連續 -Si—0 CH, o 續 -Si一ΟΙ CH3I is continuous with the downstream structure -Si—0 CH, o continued -Si ΟΙ CH3

Sj-〇 ChUSj-〇 ChU

Si ch3 NH(CH2)2〇C- CH3 :CH〇 121842.doc -21 - 200817471 變數η、m及h對應於各嵌段之重複單元的數目,且各自 獨立地在約3至約200之範圍内,而p(氧化乙烯重複單元的 數目)在約2至約12之範圍内。對應於以上結構之一種尤其 較佳大分子單體為其中η在50至200之範圍内、❿在之至5〇之 範圍内且h在1至15之範圍内的大分子單體。在一尤其較佳 • 實施例中,η為約121,m為約7.6,h為約4.4,且p為約 - 7.4。M3U可易於根據國際專利公開案第w〇 2006/026474 號實例1中提出之程序來合成。 Ο 視變數n、m、h及p之值而定,矽氧大分子單體組份(亦 即M3U)之分子量通常在約8,000道爾頓(dalton)至約25,000 道爾頓之範圍内,且較佳在約10,000道爾頓至約2〇,〇〇〇道 爾頓之範圍内。用於本發明中之一種尤其較佳矽氧烧大分 子單體具有約16,000道爾頓之分子量。舉例而言,大分子 單體可具有約16,200道爾頓之重量平均分子量(mw)及約 12,800道爾頓之數量平均分子量(Μη)。 本文所提供之可聚合矽氧水凝膠前驅體組合物通常含有 ^ 至少約25重量%之心〇〇_雙(甲基丙烯醯氧基乙基亞胺基羧基 乙氧基丙基)-聚(二甲基石夕氧烧)-聚(三氟丙基甲基石夕氧烧)_ , 聚(ω_甲氧基-聚(乙二醇)丙基甲基矽氧烷),且更佳含有至 少約30重量%之α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙 氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚 (ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)。甚至更佳地,本 發明之可聚合組合物含有約25重量%至約40重量%之α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)_聚(二曱 121842.doc -22- 200817471 基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚(ω_甲氧基_聚(乙二 醇)丙基甲基矽氧烷),或最佳含有約30重量%至約4〇重量 %之α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)· 聚(二甲基矽氧烷)_聚(三氟丙基甲基矽氧烷)_聚(〇_甲氧基_ 聚(乙二醇)丙基甲基石夕氧烧)。一種尤其較佳之可聚合組合 • 物包含約34重量°/。之α-ω-雙(甲基丙稀醯氧基乙基亞胺基羧 • 基乙氧基丙基聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧 烷)-聚(ω-曱氧基-聚(乙二醇)丙基甲基矽氧烷)。 (^ Ν·乙稀基-Ν-甲基乙酿胺 如本文所提供之可聚合組合物額外包含Ν-乙烯基甲 基乙醯胺(VMA),一種親水性含乙烯基(ch2=CH-)單體。 VMA之結構對應於 CH3C(0)N(CH3)-CH=CH2。 可併入本發明之眼鏡之物質中的其他親水性含乙烯基單 體包括以下各物· N-乙稀基内醯胺(例如N-乙稀基σ比略咬 酮(ΝΫΡ))、Ν_乙烯基_Ν-乙基乙醯胺、Ν-乙烯基-Ν-乙基曱 醯胺、Ν-乙烯基甲醯胺、胺基甲酸Ν_2-羥乙基乙烯醋、Ν- ^ 羧基-β-丙胺酸Ν-乙烯酯。 Ν-乙烯基-Ν-曱基乙醯胺較佳以約35重量。/〇至約55重量% 之用以製備石夕氧眼鏡產物之前驅體組合物範圍内的量存在 於可聚合組合物中,且甚至更佳以約40重量%至約50重量 %之則驅體組合物範圍内的量存在。Ν-乙稀基-Ν-甲基乙酿 胺之代表性重量包括以下各重量:約40重量%、41重量 %、42重量%、43重量%、44重量%、45重量%、46重量 %、47重量%、48重量%、49重量%或50重量%之前驅體組 121842.doc -23- 200817471 合物。在一較佳實施例中,如本文所提供之可聚合組合物 包含約46重量%之N-乙烯基-N-曱基乙醯胺。 曱基丙烯酸甲酯(MMA) 用於製備本發明之矽氧水凝膠隱形眼鏡產物的可聚合前 驅體組合物額外包含丙烯酸系單體,諸如甲基丙烯酸甲 酉旨。 甲基丙烯酸甲酯較佳以約10重量%至約25重量%之用以 製備矽氧水凝膠眼鏡產物之前驅體組合物範圍内的量存 在’且甚至更佳以約10重量%至約22重量%之前驅體組合 物範圍内的量存在。以全部前驅體調配物計,甲基丙烯酸 曱醋之代表性重量百分比包括以下各重量百分比:約1〇重 量%、11重量%、12重量%、13重量%、14重量%、15重量 %、16重量%、17重量%、18重量❶/❶、19重量%、2〇重量 %、21重量%、22重量%、23重量。/〇、24重量%及25重量 % 〇 二甲基丙烯酸乙二酵酯(EGDMA) 前驅體組合物額外包含丙烯酸酯官能化之氧化乙烯寡聚 物,亦即具有約i至約8個連續氧化乙烯(CH2CH2〇·)單體亞 單元且末知經反應性基團(諸如丙烯酸醋基)官能化之氧化 乙烯寡聚物。丙烯酸酯官能化之氧化乙烯寡聚物較佳為氧 化乙烯單體或一聚體,且為均雙官能性的,亦即在每二末 端經甲基丙烯酸酯基封端。通用結構提供於下文,其中變 數s對應於氧化乙烯單體之數目。 121842.doc -24- 200817471 c=r / \ / C\C,H2CH2)S’丫 II 〇 o 在以上結構中,S—般介於丨至約8之間,較佳為丨至約 4。亦即,s之較佳值包括i、2、3、4、5、6、7及8。丙烯 •豸S旨官能化之氧化乙烯募聚物較佳為氧化乙烯二甲基丙稀 酸酯,其中s具有值1。 丙烯酸s曰g旎化之氧化乙烯寡聚物(亦即egdma)通常以 〇 #對小之量存在於前驅體組合物中。舉例而言,寡聚物以 約0.05重量%至約10重量%、較佳約〇 〇75重量%至約$重量 %之範圍内的量存在於前驅體組合物中。腿财組份之代 表性量包括以下量:約〇·1重量%、0.2重量%、0.3重量%、 4重1 /〇、〇·5重1 %、〇·8重量。/❶、〇 9重量%、1重量。/。、2 重量。/〇、3重量%、4重量%或5重量%之前驅體組合物。在 車乂佳實施例中’本發明之前驅體組合物包含約〇.5重量% 之 EGDMA 〇 〇 烯丙氧基醇 除上述以外,本發明之可聚合組合物包含鏈轉移試劑。 Μ轉移3d為促進自由基物質與非自由基物質之間反應之 忒刈較佳用於本發明之鏈轉移試劑為浠丙氧基化合物, 亦卩匕3或夕個烯丙氧基部分之化合物。屬於此類之例 τ [生鏈轉移忒劑包括烯丙氧基醇。鏈轉移劑可個別或以混 合物形式使用。 έ至 個烯丙氧基部分之化合物具有以下通用結 121842.doc -25- 200817471 構· h2c: /CH2 *CH \ .Si ch3 NH(CH2)2〇C-CH3 : CH〇121842.doc -21 - 200817471 The variables η, m and h correspond to the number of repeating units of each block, and each independently ranges from about 3 to about 200. And p (the number of ethylene oxide repeating units) is in the range of from about 2 to about 12. A particularly preferred macromonomer corresponding to the above structure is a macromonomer in which η is in the range of 50 to 200, ruthenium is in the range of 5 Å, and h is in the range of 1 to 15. In a particularly preferred embodiment, η is about 121, m is about 7.6, h is about 4.4, and p is about -7.4. The M3U can be easily synthesized according to the procedure set forth in Example 1 of International Patent Publication No. WO 2006/026474. Ο Depending on the values of the variables n, m, h and p, the molecular weight of the oxime macromonomer component (ie M3U) is typically in the range of from about 8,000 daltons to about 25,000 daltons. And preferably in the range of from about 10,000 Daltons to about 2 inches, and Dalton. A particularly preferred oxygenated macromolecular monomer for use in the present invention has a molecular weight of about 16,000 Daltons. For example, the macromonomer can have a weight average molecular weight (mw) of about 16,200 Daltons and a number average molecular weight (?n) of about 12,800 Daltons. The polymerizable silicone hydrogel precursor compositions provided herein typically comprise at least about 25% by weight of cardio-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly (dimethyl oxalate)-poly(trifluoropropylmethyl oxynoxy) _ , poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), and more Preferably containing at least about 30% by weight of α-ω-bis(methacryloxyethyl iminocarboxyethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropyl A)矽 矽 ) _ _ poly (ω-methoxy-poly (ethylene glycol) propyl methyl oxirane). Even more preferably, the polymerizable composition of the present invention contains from about 25% by weight to about 40% by weight of α-ω-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly(二曱121842.doc -22- 200817471 矽 oxane)-poly(trifluoropropylmethyl decane)_poly(ω_methoxy-poly(ethylene glycol) propylmethyl decane) Or preferably containing from about 30% by weight to about 4% by weight of α-ω-bis(methacryloxyethyliminocarboxycarbonylpropyl)·poly(dimethyloxane) _ poly(trifluoropropylmethyl decane) _ poly (〇 _ methoxy _ poly (ethylene glycol) propyl methyl oxime). A particularly preferred polymerizable combination comprises about 34 weight percent. Α-ω-bis(methyl propyl methoxyethyl imino carboxy ethoxy propyl poly (dimethyl methoxy oxane) - poly (trifluoropropyl methyl oxirane) - Poly(ω-decyloxy-poly(ethylene glycol) propylmethyl decane). (^ 乙·Ethylene-fluorene-methyletheneamine. The polymerizable composition as provided herein additionally contains hydrazine. -vinylmethylacetamide (VMA), a hydrophilic vinyl-containing (ch2=CH-) monomer. The structure of VMA corresponds to CH3C(0)N(CH3)-CH=CH2. Other hydrophilic vinyl-containing monomers in the materials of the glasses include the following: N-ethylene decylamine (for example, N-ethylene σ than acetophenone (ΝΫΡ)), Ν_vinyl Ν -ethyl acetamide, hydrazine-vinyl-hydrazine-ethyl decylamine, hydrazine-vinyl carbamide, hydrazine hydrazide 2 - hydroxyethyl vinyl vinegar, hydrazine - ^ carboxy-β-alanine bismuth - Vinyl ester. The ruthenium-vinyl-oxime-mercaptoacetamide is preferably present in an amount ranging from about 35 weight percent to about 55 weight percent of the precursor composition used to prepare the as-receiving lens product. In the polymeric composition, and even more preferably from about 40% to about 50% by weight The amount in the range of the body composition is present. The representative weight of the Ν-ethylene-fluorene-methyletheneamine comprises the following weights: about 40% by weight, 41% by weight, 42% by weight, 43% by weight, 44 % by weight, 45% by weight, 46% by weight, 47% by weight, 48% by weight, 49% by weight or 50% by weight of the precursor group 121842.doc -23-200817471. In a preferred embodiment, as herein The polymerizable composition provided comprises about 46% by weight of N-vinyl-N-mercaptoacetamide. Methyl methacrylate (MMA) is useful for preparing the hydroxyl hydrogel contact lens product of the present invention. The polymeric precursor composition additionally comprises an acrylic monomer, such as methyl methacrylate. The methyl methacrylate is preferably used in an amount of from about 10% by weight to about 25% by weight to prepare the hydrogenated hydrogel lens product. The amount within the range of the bulk composition is present and is even more preferably present in an amount ranging from about 10% to about 22% by weight of the precursor composition. Representative of methacrylate vinegar as a whole precursor formulation Weight percentages include the following weight percentages: approximately 1 weight 11% by weight, 12% by weight, 13% by weight, 14% by weight, 15% by weight, 16% by weight, 17% by weight, 18% by weight/❶, 19% by weight, 2% by weight, 21% by weight, 22% by weight %, 23% by weight, / 24% by weight, and 25% by weight of bismuth dimethacrylate (EGDMA) precursor composition additionally comprising an acrylate functionalized ethylene oxide oligomer, i.e. having about i to Approximately 8 consecutive ethylene oxide (CH2CH2(R)·) monomer subunits and an ethylene oxide oligomer functionalized with a reactive group such as an acrylate acrylate. The acrylate functionalized ethylene oxide oligomer is preferably an oxyethylene monomer or a monomer and is homobifunctional, i.e., terminated at each terminal by a methacrylate group. A general structure is provided below, wherein the variable s corresponds to the number of ethylene oxide monomers. 121842.doc -24- 200817471 c=r / \ / C\C, H2CH2)S'丫 II 〇 o In the above structure, S is generally between 丨 and about 8, preferably 丨 to about 4. That is, preferred values of s include i, 2, 3, 4, 5, 6, 7, and 8. The propylene oxide polymer to be functionalized by propylene is preferably an oxyethylene dimethyl acrylate wherein s has a value of 1. Acrylic acid acrylate oligomers (i.e., egdma) are typically present in the precursor composition in a small amount. For example, the oligomer is present in the precursor composition in an amount ranging from about 0.05% to about 10% by weight, preferably from about 75% by weight to about $% by weight. The representative amount of the leg component includes the following amounts: about 1% by weight, 0.2% by weight, 0.3% by weight, 4% by weight, 1% by weight, 1% by weight, 〇·8 by weight. /❶,〇 9 wt%, 1 weight. /. 2 weight. /〇, 3% by weight, 4% by weight or 5% by weight of the precursor composition. In the preferred embodiment, the precursor composition of the present invention comprises about 5% by weight of EGDMA decyl allyloxy alcohol. In addition to the above, the polymerizable composition of the present invention comprises a chain transfer agent. ΜTransfer 3d is a compound which promotes the reaction between a radical substance and a non-radical substance, and is preferably used in the chain transfer agent of the present invention as a fluorenyloxy compound, a compound of 卩匕3 or an allylicoxy moiety. . Examples of this type τ [The raw chain transfer tanning agent includes allyloxy alcohol. The chain transfer agents can be used individually or in the form of a mixture. The compound having an allylicoxy moiety has the following generalized structure 121842.doc -25- 200817471 constituting h2c: /CH2 *CH \ .

··· °rQ 其中框符部分對應於婦丙氧基部分, 剩餘物或殘基,例如 Q表不母體为子之 妁如知或任何有機小分者 基部分連接在一起時,能 -其與烯丙氧 醇,諸如乙醇、丙醇、丁醇及=轉移齊卜Q較佳衍生自 式。Q較佳為乙醇之殘基,且且有:或其經取代之形 使得_試«應構(偶⑶卿,以 本發明者已發現,包括鏈轉移試劑(諸如稀丙氧基化合 物)有效地提供尺寸及物理特性可變性減少之經萃取水合 矽氧隱形眼鏡體。因此’添加鏈轉移劑用以&quot;正規化&quot;或&quot; 微調&quot;前驅體眼鏡組合物,以使得所得經萃取水合隱形眼 鏡群體通常具有任一或多種以下特徵之各批次之間的減少 可變性:平衡水含量、透氧性、靜態接觸角、動態接觸角 (前進接觸角或後退接觸角)' 滯後、折射率、離子流、模 數、拉伸強度及其類似特徵。 如本文所用之批次或群體係指複數個隱形眼鏡。可瞭 解,當隱形眼鏡批次或群體中之隱形眼鏡數量足以提供有 意義之標準誤差時,達成經改良之統計學數值。在某些情 況下,一批隱形眼鏡係指至少10個隱形眼鏡、至少1 〇〇個 隱形眼鏡、至少1 〇〇〇個隱形眼鏡或更多。 一般而言,如本文所提供之可聚合組合物含有約0.1重 121842.doc -26- 200817471 η㈣量。之稀丙氧基醇。本發明之可聚合組合物較 佳含有約0.5重置%至約3重量%之烯丙氧基醇。亦即,可 聚合組合物較佳可含有烯丙氧基醇(諸如烯丙氧基乙醇)之 以下例示性重量百分比中的任一者:〇1、〇2、〇3、〇4、 0.5 、 0.6 、 0.7 、 0.8 、 0.9 、 ! 、 !」、1 2 、 ι 3 、 ι 4 … 2.7、2.8、2.9或 3 重量 %。 自由基引發劑 Ο··· °rQ where the box portion corresponds to the p-propoxy moiety, residue or residue, such as Q, if the parent is not a parent, or if any of the organic small members are connected together, It is preferred to derive from the formula with allyloxy alcohols such as ethanol, propanol, butanol and =. Q is preferably a residue of ethanol, and has: or a substituted form thereof, such that it is effective (including (3), as the inventors have discovered, including chain transfer agents (such as dilute propoxy compounds) An extracted hydrated xenon contact lens body having reduced variability in size and physical properties is provided. Therefore, 'adding a chain transfer agent to &quot;normalize&quot; or &quot;fine tune&quot; precursor lens composition to obtain the resulting extracted The hydrated contact lens population typically has reduced variability between batches of any one or more of the following characteristics: equilibrium water content, oxygen permeability, static contact angle, dynamic contact angle (forward contact angle or receding contact angle) 'lag, Refractive index, ion current, modulus, tensile strength, and the like. As used herein, a batch or group system refers to a plurality of contact lenses. It is understood that the number of contact lenses in a contact lens batch or population is sufficient to provide meaningful A modified statistical value is achieved in the standard error. In some cases, a batch of contact lenses refers to at least 10 contact lenses, at least 1 contact lens, to 1 contact lens or more. In general, the polymerizable composition as provided herein contains about 0.1 weight of 121842.doc -26-200817471 η (four) amount of diloxypropanol. Preferably, the composition contains from about 0.5% by weight to about 3% by weight of allyloxy alcohol. That is, the polymerizable composition preferably contains the following exemplary allylic alcohol (such as allyloxyethanol). Any of the weight percentages: 〇1, 〇2, 〇3, 〇4, 0.5, 0.6, 0.7, 0.8, 0.9, !, !", 1 2, ι 3, ι 4 ... 2.7, 2.8, 2.9 or 3% by weight. Free radical initiatorΟ

除上述以外,本發明之前驅體組合物通常包含一或多種 引發劑化合物,亦即能夠引發前驅體組合物聚合之化合 物。較佳為熱引發劑,亦即具有”聚合開始,,溫度之引發 劑。藉由選擇具有較高開始分解溫度之熱引發劑且使用相 對小量之引發劑,可能減少本發明之眼鏡之離子流,藉此 可影響在萃取步驟中移除或萃取之可移除物質的量。 舉例而σ可採用之一種例示性熱引發劑為VAZO®_ 64,其對應於2,2,·偶氮二異丁腈(AIBN),可購自Dup〇nt (Wilmington, DE)。本文所述之所有VAZ〇⑨熱引發劑均購 自DuPont(Wilmington,DE),且適用於本文所提供之組合 物中。VAZO®熱引發劑為經取代之偶氮腈化合物,其經熱 分解,每分子產生兩個自由基。VAZO®-64溶液在64°C下 之半衰期為1 0小時。各VAZO®引發劑之級數(例如前述實 例中之”64”)對應於溶液半衰期為10小時所處之攝氏溫度。 適用於本文所提供之組合物中之其他VAZO®引發劑包 括2,2’-偶氮雙(2,4-二甲基戊腈)(VAZO®-52)、2,2,-偶氮雙 121842.doc -27- 200817471 (2-甲基丙腈)(VAZO®67)及偶氮二異丁腈(VAZO⑧-88)。 VAZO®-52具有約50°C之開始分解溫度,而VAZO®_88具有 約90°C之開始分解溫度。適用於可聚合組合物中之其他熱 引發劑包括腈類,諸如1,1’_偶氮雙(環己腈)及2,2,-偶氮雙 (2-甲基丙腈)以及其他類型之引發劑,諸如購自 SigmaAldrich之引發劑。 • 眼睛上相容之矽氧水凝膠隱形眼鏡可自包含約〇·〇5重量 %至約1.0重量%或較佳約〇.〇7重量%至約〇·7重量❶/❻之自由 D 基引發劑(諸如上述VAZO®引發劑之一者)的前驅體組合物 而獲得。特定言之,如本文所述之前驅體組合物較佳含有 約 0.07、0.08、0.09、0.1、〇·2、0.3、0.4、0.5、0.6 或 〇·7 重量%之自由基引發劑。 矽氧水凝膠隱形眼鏡前驅體組合物之額外組份 本發明之眼鏡命驅體組合物亦可包括額外組份,例如紫 外線(UV)吸收劑或UV輻射或能量吸收劑及/或著色劑。 UV吸收劑可為(例如)在約320-380奈米之UV-A範圍内展 D 示相對高之吸收值,但在約380 nm以上相對透明之強υν 吸收劑。實例包括光可聚合之羥基二苯曱酮及光可聚合之 . 苯并三唑,諸如2·羥基-4-丙烯醯氧基乙氧基二苯甲酮(以 CYASORB® UV416 購自 Cytec Industries)、2_ 經基-4-(2 声 基-3·曱基丙稀醯氧基)丙氧基二苯甲酮及光可聚合之苯并 三唑(以NORBLOC® 7966購自Noramco)。適用於本發明之 其他光可聚合UV吸收劑包括可聚合之烯系不飽和三嘻、 水楊酸酯、經芳基取代之丙烯酸酯及其混合物。一般而 121842.doc •28- 200817471 言,UV吸收劑若存在,則以對應於約〇·5重量%之前驅體 組合物至約1.5重量%之組合物的量提供。尤其較佳者為包 括約0.6重量%至約1 ·〇重量% UV吸收劑之組合物。說明性 組合物可含有(例如)約〇·5重量%、0.6重量%、〇.7重量%、 0.8重量%、〇·9重量%、1.0重量%、1.1重量%、1·2重量 %、1.3重量%、1.4重量%或約1.5重量%之11乂吸收劑。 本發明之前驅體組合物亦可包括著色劑,儘管涵蓋彩色 眼鏡產物及透明眼鏡產物。著色劑較佳為對所得眼鏡產物 有效提供顏色之反應性染料或顏料。 反應性染料為與矽氧水凝膠眼鏡物質鍵結且不滲色之彼 等染料。例示性著色劑包括以下各物:苯磺酸、4-(4,5-二 氫-4-((2-甲氧基-5-甲基-4-((2-(磺氧基)乙基)磺醯基)笨基) 偶氮-3·甲基-5-側氧基-1H-吡唑-1-基);[2-萘磺酸,7-(乙 醯胺基)-4-羥基-3-((4-((磺氧基乙基)磺醯基)苯基)偶氮)_]; [5-((4,6·二氯-1,3,5·三嗪 _2_ 基)胺基-4-羥基-3-((1-磺基-2- 萘基)偶氮_2,7-萘-二磺酸,三鈉鹽];[銅,29H,31H_酞菁 基(2_)-&gt;129,仏(),&gt;131,:^32)-,磺基((4((2-磺氧基)乙基)磺醯基) 苯基)胺基)磺醯基衍生物]及[2,7-萘磺酸,4-胺基-5-羥基-3,6·雙((4-((2_(磺氧基)乙基)石黃醯基)苯基)偶氮卜四鈉鹽]。 用於本發明之尤其較佳著色劑為酞菁顏料,諸如酞菁藍 及酞菁綠、氧化鉻-氧化鋁-氧化亞鈷、氧化鉻及紅色、黃 色、棕色及黑色之各種鐵氧化物。一般而言,若採用,則 著色劑將佔組合物之約〇.〇5重量%至約〇.5重量%,或較佳 佔組合物之約〇·〇7重量%至約〇.3重量%。著色劑(例如酞菁 121842.doc -29- 200817471 顏料)之說明性重量百分比包括以下重量% : 〇 〇5重量%、 0.06重1 % ' 〇 〇7重量%、〇 〇8重量。〇 〇9重量%、重 里〇·2重里%、〇_3重量%、〇·4重量%、〇·5重量%及其類 似篁。亦可併入諸如二氧化鈦之不透明劑。對於某些應用 而吕’可採用顏色之混合物以更佳模擬自然虹膜之外觀。 代表性前驅體組合物包含約3〇重量❶/。至4〇重量%之心仍_ ’ 雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲 基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚((〇_曱氧基-聚(乙二 f) 醇)丙基甲基矽氧烷)、約40重量%至50重量%之义乙烯基- N-甲基乙醯胺、約丨〇重量%至25重量%之甲基丙稀酸甲酯 及少於約5重量%之二甲基丙烯酸乙二醇酯、烯丙氧基 醇、2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、酞菁藍與2,2,_ 偶氮二異丁腈之組合,亦即藉由組合以上組份而產生。 例示性前驅體組合物提供於實例1中。在一尤其較佳之 實施例中,可聚合組合物可包含以下量(以重量%計)之各 以下組份、基本上由其組成或完全由其組成:約34重量0/〇 ί ) ^ 之α·ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)_聚 (二甲基矽氧烷)_聚(三氟丙基甲基矽氧烷)-聚卜甲氧基_聚 • (乙二醇)丙基曱基石夕氧烧)、約46重量%之]^-乙浠基甲 基乙醯胺、約17重量%之甲基丙稀酸曱酯、約〇·5重量〇/〇之 二甲基丙烯酸乙二醇酯、約1重量%之稀丙氧基醇、約0.9 重量%之2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、約〇1重量 %之酜菁藍及約0·3重量%之2,2’-偶氮二異丁腈。 本發明刖驅體組合物之某些實施例包括於非極性樹脂隱 121842.doc •30- 200817471 形眼鏡模具中所提供之可聚合石夕氧水凝膠隱形眼鏡前驅體 組合物。其他實施例包括在儲存容器(諸如瓶子及其類似 物)中或分配裝置(諸如人工或自動移液裝置)中之該等組合 物。 ° 形成發氧水凝膠隱形眼鏡之方法 般而σ在產生石夕氧水凝膠隱形眼鏡中,將石夕氧水凝 膠隱形眼鏡前驅^組合物之組份各自冑重且#著組合。接 者通常(例如)使用磁力或機械混合來混合所得前驅體組合 物’且視情況過濾以移除微粒。 本發明之眼鏡可(例如)如圓j中所說明來產生。 囷1為說明產生矽氧水凝膠隱形眼鏡之方法的方塊圖。 特定言之,囷1說明一種澆鑄成型矽氧水凝膠隱形眼鏡之 方法。澆鑄成型隱形眼鏡可自身以適於直接置放於人眼上 之形式產生,而無需進一步加工來改質眼鏡而使眼鏡適用 於眼睛上。冑用諸如圖1所說明之程序的洗鑄成型程序而 產生的本發明之矽氧水凝膠隱形眼鏡在本文被認為係&quot;逢 鑄成型矽氧水凝膠隱形眼鏡&quot;。若不使用加工來改變使眼 鏡產物自模具構件脫鏡後之眼鏡設計,則將本發明之眼鏡 理解為’’完全成型之矽氧水凝膠隱形眼鏡,,。 用於產生隱形眼鏡(諸如矽氧水凝膠隱形眼鏡)之說明性 方法描述於至少以下專利中:美國專利第4,121,896號、第 4,495,313號、第 4,565,348號、第 4,64G,489號、第 4,889,664 諕、第 4,985,186號、第 5,039,459 號、第 5,080,839 號、第 5,〇94,609號、第 5,260,000號、第 5,6〇7 518號、第 5,76〇1〇〇 121842.doc -31- 200817471 號、第 5,850,107號、第 5,935,492 號、第 6,099,852 號、第 6,367,929號、苐 6,822,016號、第 6,867,245號、第 6,869,549 说、弟6,939,487说及美國專利公開案第20030125498號、 第 20050154080 號及第 20050191335 號。 .......Α V 5兀&quot;乃々 Ο Ο 方法包括步驟102,即:將可聚合矽氧水凝膠眼鏡前驅體 組合物(202,如圖2中所示)置放於隱形眼鏡模具構件上或 内部。可聚合石夕氧水凝膠眼鏡前驅體組合物係指適於聚合 之預聚合或預固化組合物。如本文所用之本發明之可聚合 組合物亦可稱為”單體混合物,,或,,反應混合物”。在組合2 固化或聚合之前,可聚合組合物或眼鏡前驅體組合物較佳 未經聚合至任何顯著程度。然而,在某些情況下,可聚合 組合物或眼鏡前驅體組合物可在經受固化之前部分聚合。 在固化或聚合程序之前,本發 +知月之眼鏡别驅體組合物可 θ供於容器、分配裝置或隱形眼鏡模具中。 回到囷1步驟1 〇2,將眼鏡前驅體人 目P於伊曰^ 餸、、且。物置放於凹形隱形 艮鏡杈具構件之眼鏡形成表 外 凹形鼬形眼鏡模具構件 件。舉^&amp; 件切部隱料鏡模具構 ® ^ ^ ^ ^ 兄衩具構件具有眼鏡形成表 面。 减具所產生之隱形眼鏡的前表 第一隱形眼鏡模具構件與第 放以形成具有隱形眼鏡狀空腔 1中所說明之方法包括步騾1〇4 一隱形眼鏡模具構件接觸置 之隱形眼鏡模具。因此,囷 ,即··藉由將兩隱形眼鏡模 121842.doc • 32 · 200817471 具構件彼此接觸置放以形成隱形眼鏡狀空腔來封閉隱形眼 鏡模具。可聚合石夕氧水凝膠眼鏡前驅體組合物202位於隱 形眼鏡狀空腔中。第二隱形眼鏡模具構件係指凸形隱形眼 鏡模具構件或後部隱形眼鏡模具構件。舉例而言,第二隱 形眼鏡模具構件包括眼鏡形成表面,該表面界定隱形眼鏡 模具中所產生之隱形眼鏡的後表面。 Ο ί) 如本文所用之”非極性樹脂隱形眼鏡模具”或”疏水性樹 月曰开&gt; 眼鏡模具’’係指由非極性或疏水性樹脂形成或產生 之隱形眼鏡模具。因此,非極性樹脂基隱形眼鏡模具可包 含非極性或疏水性樹脂。舉例而言,該等隱形眼鏡模具可 包含一或多種聚烯烴,或可由聚烯烴樹脂物質形成。用於 本申請案之情形中的非極性樹脂隱形眼鏡模具之實例包括 聚乙烯隱形眼鏡模具、聚丙婦隱形眼鏡模具及聚苯乙稀隱 形眼鏡模具。非極性樹脂基隱形眼鏡模具通常具有疏水性 表面。舉例而言,如使用俘獲氣泡法所測定,非極性樹脂 模具或疏水性樹脂模具可具有約90。或更大之靜態接觸 角。在該等接觸角下,該等模具中所產生之習知碎氧水凝 膠隱形眼鏡具有臨床上不可接受之表面可濕性。 :方:進一步包括固化106可聚合之石夕氧水凝膠眼鏡前 驅體組合物以形成預萃取之聚合矽氧水怒m 7虱水凝膠隱形眼鏡產物 L 2人中所示)°在固化期間’可聚切氧水凝膠眼鏡 =體二:物之眼鏡形成組份聚合以形成聚合眼鏡產物。 亦可理解為聚合步驟。固化1〇6可包括將可聚 眼鏡别驅體組合物暴露於輻射,諸如熱輻射或任何盆 121842.doc -33- 200817471 他有效5^合眼鏡如驅體組合物之組份的方式。舉例而言, 固化106可包括將可聚合之眼鏡前驅體組合物暴露於聚合 里之熱或紫外(UV)光。固化可視情況在無氧環境中進行。 舉例而a,固化可在惰性氣氛下(例如在氮、氬或其他惰 性氣體下)進行。在一特定實施例中,固化包含將如本文 所知:供之可聚合組合物加熱至大於約5 5之溫度。 預萃取之聚合矽氧水凝膠隱形眼鏡產物2〇4係指在經受 自聚合產物移除實質上所有可移除/可萃取組份之萃取程 序之刚的聚合產物。在與萃取組合物接觸之前,預萃取之 聚合矽氧水凝膠隱形眼鏡產物可提供於隱形眼鏡模具、萃 取盤或其他裝置上或内部。舉例而言,在固化程序之後, 預萃取之聚合矽氧水凝膠隱形眼鏡產物可提供於隱形眼鏡 模〃之眼鏡狀空腔中;在隱形眼鏡模具脫模之後,可提供 於種形眼鏡模具構件上或内部;或在脫鏡程序之後且 在:取私序之刖’可提供於萃取盤或其他裝置上或内部。 〇 預萃取之聚合矽氧水凝膠隱形眼鏡產物包括眼鏡形成組份 (諸如呈眼鏡狀之含石夕聚合網路或基質)及可自眼鏡形成組 7移除之可移除組份。可移除組份包括未反應之單體、寡 聚物邛分反應之單體或相對於眼鏡形成組份未共價連接 2 口疋之其他藥劑。可移除組份亦可包括一或多種添加 4:包括有機添加劑,包括稀釋劑,其可如先前論述在萃 个、序』間自聚合眼鏡產物萃取。因此,可包含可移除組 上勿貝、包括相對於鏡體之聚合物主鏈、網路或基質而言 气或固定之可萃取物質的線性未交聯、交聯及/或分 121842.doc -34- 200817471 枝聚合物。 此外可移除組份可包括其他物質,諸如揮發性物質, 其可在萃取之前自預萃取之聚合矽氧水凝膠隱形眼鏡產物 被動或主動地移除。舉例而言’一部分可移除組份可在脫 模步驟與萃取步驟之間蒸發。 在口化可聚合之眼鏡前驅體組合物之後,進行隱形眼鏡 杈具之脫杈108。脫模係指分離含有預萃取之聚合隱形眼 鏡產物之模具或聚合裝置的兩個模具構件(諸如凸形及凹 形模具構件)之方法。預萃取之聚合矽氧水凝膠隱形眼鏡 產物位於經脫模之模具構件之一者上。舉例而言,聚合矽 氧水凝膠隱形眼鏡產物可位於凸形模具構件或凹形模具構 件上。 接著在脫鏡步驟110(如圖i所示)期間將預萃取之聚合矽 氧水凝膠隱形眼鏡產物204自其所定位之隱形眼鏡模具構 件分離。預萃取之聚合隱形眼鏡產物可自凸形模具構件或 凹形模具構件脫鏡,此取決於聚合隱形眼鏡產物在隱形眼 鏡模具脫模期間保持黏附之模具構件。 在預萃取之矽氧水凝膠隱形眼鏡產物脫鏡之後,該方法 包括自預萃取之矽氧水凝膠隱形眼鏡產物萃取112可萃取 物質。萃取步驟112導致經萃取之矽氧水凝膠隱形眼鏡產 物206(如圖2所示)。萃取步驟112係指使預萃取之聚合矽氧 水凝膠隱形眼鏡產物與一或多種萃取組合物接觸之程序, 且可包括單一萃取步驟或若干次連續萃取。舉例而言,聚 a石夕氣水破膠形眼鏡產物或一批聚合碎氧水凝膠隱形眼 121842.doc -35- 200817471 鏡產物與一或多體積之液體萃取介質接觸。萃取介質通常 包括一或多種溶劑。舉例而言,萃取介質包括乙醇、甲 醇、丙醇及其他醇。萃取介質亦可包括醇類與水之混合 物,諸如50%乙醇與50%去離子水之混合物,或7〇%乙醇 與30%去離子水之混合物,或9〇%乙醇與1〇%去離子水之 混合物。或者,萃取介質可實質上或完全無醇,且可包括 或夕種有利於自I合石夕乳水凝膠眼鏡產物移除疏水性未 反應組份之藥劑。舉例而言,萃取介質可包含水、緩衝溶 液及其類似物、基本上由其組成或完全由其組成。萃取 112可在各種溫度(包括室溫)下進行。舉例而言,萃取可在 室溫(例如約20。〇下發生,或其可在高溫(例如約25。〇至約 1〇〇 c)下發生。此外,在某些實施例中,萃取步驟可包 括使眼鏡產物與醇與水之混合物接觸,在某些情況下,其 可包含多步萃取程序之最後一步。 在萃取預萃取之聚合矽氧水凝膠隱形眼鏡產物以提供經 萃取之聚合矽氧水凝膠隱形眼鏡產物之後,該方法包括水 合114經萃取之聚合矽氧水凝膠隱形眼鏡產物。水合步驟 114例如可包括使經萃取之聚合矽氧水凝膠隱形眼鏡產物 或一或多批該等產物與水或水溶液接觸以形成水合石夕氧水 凝膠隱形眼鏡208(如囷2中所示)。例如,經萃取之聚合石夕 氧水凝膠隱形眼鏡產物可藉由置放於兩單獨體積或兩單獨 體積以上之水(包括去離子水)中來水合。在某些實施例 中,水合步驟114與萃取步驟ι12組合,以使得兩步驟在隱 形眼鏡生產線中之單一位置上進行。水合步驟114可在容 121842.doc -36- 200817471 器中於室溫或高溫下且必要時在高壓下進行。舉例而言, 水合可在約120°C(例如121¾)之溫度及1〇3 kPa(15 pSi)之 壓力下於水中發生。 因此,如由上文顯而易見,認為預萃取之聚合石夕氧水凝 膠隱形眼鏡產物及經萃取之聚合矽氧水凝膠隱形眼鏡產物 為水可知脹性之產物或元件,且認為水合矽氧水凝膠隱形 • 眼鏡為遇水可膨脹之產物或元件。如本文所用之矽氧水凝 膠形眼鏡係指已經歷水合步驟之石夕氧水凝膠元件。因 P 此石夕氧水/沒膠隱形眼鏡可為完全水合之石夕氧水凝膠隱形 眼鏡、部分水合之矽氧水凝膠隱形眼鏡或脫水之矽氧水凝 膠隱形眼鏡。脫水之矽氧水凝膠隱形眼鏡係指已經歷水合 知序且k後經脫水以自眼鏡移除水之隱形眼鏡。 在水合經萃取之矽氧水凝膠隱形眼鏡產物以產生矽氧水 凝膠隱形眼鏡之後,該方法包括封裝矽氧水凝膠隱形眼鏡 208之步驟116。舉例而言,矽氧水凝膠隱形眼鏡2〇8可置 放於包括一定體積液體(諸如生理食鹽水溶液,包括經緩 ◎ 衝之生理食鹽水溶液)之發泡包裝或其他合適容器中。適 合於本發明眼鏡之液體的實例包括磷酸鹽緩衝生理食鹽水 及棚酸鹽緩衝生理食鹽水。如步驟118所示,接著密封發 泡包裝或容器’且隨後殺菌。舉例而言,經封裝之石夕氧水 凝膠隱形眼鏡可諸如藉由高壓釜處理、γ輕射、電子束幸3 射或紫外輻射而暴露於殺菌量之輻射,包括熱轄射。 矽氧水凝膠眼鏡之特性 如上所論述,本文所提供之組合物及方法提供眼睛上相 121842.doc -37- 200817471 谷之石夕氧水凝膠隱形眼鏡。將預萃取之聚合石夕氧水凝膠眼 鏡產物萃取且水合以形成具有眼用可接受之表面可濕性的 石夕氧水凝膠隱形眼鏡。本發明之眼鏡具有透氧性、表面可 濕性、模數、水含量、離子流、設計及其組合,其使得本 發明之眼鏡適合患者眼睛舒適地配戴延長之時期,諸如至 少一天、至少一週、至少兩週或約一個月,而無需自眼睛 中移除眼鏡。 如本文所用之眼睛上相谷之矽氧水凝膠隱形眼鏡,,係指 可配戴於人眼上而人不經歷或報導實質性不適(包括眼睛 刺激及類似不適)的矽氧水凝膠隱形眼鏡。眼睛上相容之 ΟIn addition to the above, the precursor compositions of the present invention typically comprise one or more initiator compounds, i.e., compounds capable of initiating polymerization of the precursor composition. Preferably, it is a thermal initiator, that is, an initiator having a polymerization initiation temperature. It is possible to reduce the ions of the glasses of the present invention by selecting a thermal initiator having a higher initial decomposition temperature and using a relatively small amount of an initiator. Flow, whereby the amount of removable material removed or extracted during the extraction step can be affected. For example, an exemplary thermal initiator that can be used for σ is VAZO® _ 64, which corresponds to 2, 2, azo Diisobutyronitrile (AIBN), available from Dup〇nt (Wilmington, DE). All of the VAZ〇9 thermal initiators described herein are available from DuPont (Wilmington, DE) and are suitable for use in the compositions provided herein. The VAZO® thermal initiator is a substituted azonitrile compound which is thermally decomposed to produce two free radicals per molecule. The half-life of VAZO®-64 solution at 64 ° C is 10 hours. The number of stages (e.g., "64" in the foregoing examples) corresponds to the Celsius temperature at which the solution has a half-life of 10 hours. Other VAZO® initiators suitable for use in the compositions provided herein include 2,2'-azo Bis(2,4-dimethylvaleronitrile) (VAZO®-52), 2,2,-azobis 1 21842.doc -27- 200817471 (2-methylpropionitrile) (VAZO®67) and azobisisobutyronitrile (VAZO8-88). VAZO®-52 has an initial decomposition temperature of about 50 °C, while VAZO® _88 has an initial decomposition temperature of about 90° C. Other thermal initiators suitable for use in the polymerizable composition include nitriles such as 1,1'-azobis(cyclohexanecarbonitrile) and 2,2,-azobis. (2-Methylpropionitrile) and other types of initiators, such as those purchased from Sigma Aldrich. • Eye-compatible, oxygenated hydrogel contact lenses can contain from about 5% by weight to about 1.0% by weight. % or preferably obtained from a precursor composition of from about 7 wt% to about 7 wt%/❻ of a free D-based initiator such as one of the above-mentioned VAZO® initiators. The precursor composition described herein preferably contains about 0.07, 0.08, 0.09, 0.1, 〇2, 0.3, 0.4, 0.5, 0.6 or 〇·7 wt% of a free radical initiator. Hydroxyl hydrogel contact lenses Additional Components of the Precursor Composition The ophthalmic composition of the present invention may also include additional components such as ultraviolet (UV) absorbers or UV radiation. Or an energy absorbing agent and/or a coloring agent. The UV absorbing agent can exhibit a relatively high absorption value, for example, in the range of UV-A of about 320-380 nm, but is relatively transparent at about 380 nm or more. Υν Absorbent. Examples include photopolymerizable hydroxydibenzophenone and photopolymerizable. Benzotriazole, such as 2·hydroxy-4-propenyloxyethoxybenzophenone (purchased with CYASORB® UV416) From Cytec Industries), 2-based 4-(2-propenyl-3·mercaptopropyloxy)propoxybenzophenone and photopolymerizable benzotriazole (from Norramco® 7966 from Noramco) ). Other photopolymerizable UV absorbers suitable for use in the present invention include polymerizable ethylenically unsaturated triterpenes, salicylates, aryl substituted acrylates, and mixtures thereof. In general, 121842.doc • 28-200817471, the UV absorber, if present, is provided in an amount corresponding to from about 5% by weight of the precursor composition to about 1.5% by weight of the composition. Particularly preferred are compositions comprising from about 0.6% by weight to about 1% by weight of the UV absorber. The illustrative composition may contain, for example, about 5% by weight, 0.6% by weight, 〇.7% by weight, 0.8% by weight, 〇·9% by weight, 1.0% by weight, 1.1% by weight, 1.2% by weight, 1.3% by weight, 1.4% by weight or about 1.5% by weight of 11 乂 absorbent. The precursor compositions of the present invention may also include colorants, although encompassing colored eyeglass products and clear lens products. The colorant is preferably a reactive dye or pigment that effectively provides color to the resulting lens product. The reactive dyes are dyes that are bonded to the oxygenated hydrogel lens material and do not bleed. Exemplary colorants include the following: benzenesulfonic acid, 4-(4,5-dihydro-4-((2-methoxy-5-methyl-4-((2-(sulfooxy))) (sulfonyl)sulfonyl) azo-3.methyl-5-o-oxy-1H-pyrazol-1-yl); [2-naphthalenesulfonic acid, 7-(ethinyl)-4 -hydroxy-3-((4-((sulfooxyethyl))sulfonyl)phenyl)azo)-]; [5-((4,6·dichloro-1,3,5·triazine) _2_yl)amino-4-hydroxy-3-((1-sulfo-2-naphthyl)azo-2,7-naphthalene-disulfonic acid, trisodium salt]; [copper, 29H, 31H_ Phthalocyanine (2_)-&gt;129, 仏(),&gt;131,:^32)-, sulfo((4((2-sulfo)oxy)))))))) Sulfhydryl derivative] and [2,7-naphthalenesulfonic acid, 4-amino-5-hydroxy-3,6·bis((4-((2)(sulfooxy)ethyl) fluorenyl)benzene Azob tetrasodium salt]. Particularly preferred colorants for use in the present invention are phthalocyanine pigments such as phthalocyanine blue and phthalocyanine green, chromium oxide-alumina-cobalt oxide, chromium oxide, and red, yellow. , a variety of iron oxides of brown and black. In general, if used, the colorant will comprise from about 5% by weight to about 5% by weight of the composition, or Preferably, the composition comprises from about 7% by weight to about 3% by weight of the composition. The illustrative weight percentages of the colorant (for example, phthalocyanine 121842.doc -29-200817471 pigment) include the following weight %: 〇〇5 weight %, 0.06 weight 1% '〇〇7 wt%, 〇〇8 weight. 〇〇9 wt%, heavy 〇·2 weight%, 〇_3 wt%, 〇·4 wt%, 〇·5 wt% and Similar to bismuth. Opaque agents such as titanium dioxide may also be incorporated. For some applications, a mixture of colors may be used to better simulate the appearance of a natural iris. A representative precursor composition comprises about 3 〇 weight 。 / to 4 〇% by weight of heart _ 'bis(methacryloxyethyl iminocarboxyethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxyl) _ poly ((〇 曱 曱 - - - - - - ) ) 、 、 、 、 、 约 约), about 40% by weight to 50% by weight of vinyl-N-methyl acetamide, about丨〇% by weight to 25% by weight of methyl methacrylate and less than about 5% by weight of ethylene glycol dimethacrylate, allyloxy alcohol, 2-hydroxy- A combination of 4-propenyloxyethoxybenzophenone, phthalocyanine blue and 2,2,-azobisisobutyronitrile, ie by combining the above components. Exemplary precursor composition provided In Example 1. In a particularly preferred embodiment, the polymerizable composition can comprise, consist essentially of, or consist of the following amounts (in % by weight): about 34 weight 0/ 〇ί ) ^ α·ω-bis(methacryloxyethylethylimidocarboxyethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxime) Alkyl)-poly-p-methoxy-poly (ethylene glycol) propyl sulfhydryl), about 46% by weight of ^-ethyl decylmethyl acetamide, about 17% by weight of methyl propyl Dilute decyl ester, about 5 wt%/〇 of ethylene glycol dimethacrylate, about 1% by weight of diloxypropoxy alcohol, about 0.9% by weight of 2-hydroxy-4-propenyloxy B Oxybenzophenone, about 1% by weight of phthalocyanine blue, and about 0.3% by weight of 2,2'-azobisisobutyronitrile. Some embodiments of the oxime composition of the present invention include a polymerizable shiheyl hydrogel contact lens precursor composition provided in a non-polar resin occlusion 121842.doc • 30-200817471 eyeglass mold. Other embodiments include such compositions in storage containers such as bottles and the like, or in dispensing devices such as manual or automatic pipetting devices. ° Method of forming oxygenated hydrogel contact lenses As in the case of producing Shishi oxygen hydrogel contact lenses, the components of the Shixi oxygen hydrogel contact lens precursor composition are each weighted and combined. The carrier typically mixes the resulting precursor composition, e.g., using magnetic or mechanical mixing, and optionally filters to remove particulates. The spectacles of the present invention can be produced, for example, as illustrated in circle j.囷 1 is a block diagram illustrating a method of producing a helium oxygen hydrogel contact lens. In particular, Figure 1 illustrates a method of casting a silicone hydrogel contact lens. The cast contact lens can itself be produced in a form suitable for direct placement on the human eye without the need for further processing to modify the lens to make the lens suitable for use on the eye. The hydroxyl hydrogel contact lens of the present invention produced by a wash molding procedure such as that illustrated in Figure 1 is herein considered to be &quot;casting a hydrogel contact lens&quot;. The eyeglasses of the present invention are understood to be ''completely formed silicone hydrogel contact lenses') without the use of processing to modify the eyeglass design that causes the eyeglass product to be removed from the mold member. Illustrative methods for producing contact lenses, such as neohydrogenated hydrogel contact lenses, are described in at least the following patents: U.S. Patent Nos. 4,121,896, 4,495,313, 4,565,348, 4,64, 489 No. 4,889,664 第, 4,985,186, 5,039,459, 5,080,839, 5, 〇94,609, 5,260,000, 5,6〇7 518, 5,76〇1〇〇121842. Doc-31-200817471, 5,850,107, 5,935,492, 6,099,852, 6,367,929, 苐6,822,016, 6,867,245, 6,869,549, 6,969,487, and U.S. Patent Publication No. 20030125498, 20050154080 and 20050191335. . . . Α V 5兀&quot; 々Ο 々Ο Ο method includes the step 102 of placing a polymerizable silicone hydrogel lens precursor composition (202, as shown in Figure 2) Contact lens mold member on or inside. The polymerizable oxalate hydrogel lens precursor composition refers to a prepolymerized or precured composition suitable for polymerization. The polymerizable composition of the present invention as used herein may also be referred to as "monomer mixture, or, reaction mixture". The polymerizable composition or lens precursor composition is preferably not polymerized to any significant extent prior to the combination 2 curing or polymerization. However, in some cases, the polymerizable composition or lens precursor composition can be partially polymerized prior to being subjected to curing. Prior to the curing or polymerization procedure, the lens composition of the present invention can be supplied to a container, a dispensing device or a contact lens mold. Go back to 囷1, step 1 〇2, and the eyeglass precursors are P 曰 曰 、, and. The object is placed in a concave invisible frog mirror member to form an off-surface contact lens mold member. ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ The first contact lens mold member of the contact lens produced by the reduction lens and the contact lens mold that is placed in contact with the first embodiment to form the contact lens-like cavity 1 includes a contact lens mold member contacting the contact lens mold member . Therefore, 隐, that is, the contact lens mold is closed by placing the two contact lens molds 121842.doc • 32 · 200817471 in contact with each other to form a contact lens-like cavity. The polymerizable oxalate hydrogel lens precursor composition 202 is located in a contact lens shaped cavity. The second contact lens mold member refers to a convex invisible eye mold member or a rear contact lens mold member. For example, the second contact lens mold member includes a lens forming surface that defines a rear surface of the contact lens produced in the contact lens mold. Ο ί) "Non-polar resin contact lens mold" or "hydrophobic tree opening" &gt; glasses mold" as used herein refers to a contact lens mold formed or produced from a non-polar or hydrophobic resin. Therefore, non-polar The resin-based contact lens mold may comprise a non-polar or hydrophobic resin. For example, the contact lens molds may comprise one or more polyolefins or may be formed from a polyolefin resin material. Non-polar for use in the context of the present application. Examples of resin contact lens molds include polyethylene contact lens molds, polypropylene women contact lens molds, and polystyrene contact lens molds. Non-polar resin based contact lens molds typically have a hydrophobic surface. For example, if a trapping bubble method is used It is determined that the non-polar resin mold or the hydrophobic resin mold may have a static contact angle of about 90. or more. At these contact angles, the conventional broken oxygen hydrogel contact lenses produced in the molds have clinical properties. Unacceptable surface wettability: Side: further comprising curing 106 polymerizable oxime hydrogel lens precursor composition Forming a pre-extracted polymeric helium oxygen anger m 7 虱 hydrogel contact lens product L 2 as shown in the person) ° during the curing period, 'polyoxygenated hydrogel glasses = body two: the glasses forming component polymerization Forming a polymeric lens product. Also understood as a polymerization step. Curing 1〇6 may include exposing the polymerizable eyeglass composition to radiation, such as heat radiation or any basin 121842.doc-33-200817471 For example, the composition of the composition of the body composition. For example, the curing 106 can include exposing the polymerizable lens precursor composition to heat or ultraviolet (UV) light in the polymerization. The curing can be carried out in an oxygen-free environment as the case may be. For example, a, curing can be carried out under an inert atmosphere (eg, under nitrogen, argon, or other inert gas). In a particular embodiment, curing comprises, as is known herein, heating the polymerizable composition to greater than about The temperature of 5 5. The pre-extracted polymeric hydrogel contact lens product 2〇4 refers to the polymerized product of the extraction procedure subjected to the removal of substantially all of the removable/extractable components from the polymerized product. Contact with the extraction composition Previously, pre-extracted polymeric hydrogel contact lens products can be provided on or in contact lens molds, extraction trays, or other devices. For example, after the curing process, pre-extracted polymeric oxygenated hydrogel contact lenses The product may be provided in the lens-like cavity of the contact lens mold; after the contact lens mold is released, it may be provided on or inside the seed lens mold member; or after the mirror removal procedure and at: Can be provided on or in the extraction tray or other device. The pre-extracted polymeric oxygenated hydrogel contact lens product comprises a lens forming component (such as a spectacles-containing network or matrix) and can be formed from glasses. The removable component is removed from group 7. The removable component includes unreacted monomer, oligomeric monomer, or other agent that is not covalently linked to the lens forming component. The removable component can also include one or more additions 4: including organic additives, including diluents, which can be extracted from the polymeric lens product during the extraction, as discussed previously. Thus, linear uncrosslinking, cross-linking and/or fractionation 121842 may be included in the removable group, including extractable materials that are gas or fixed relative to the polymer backbone, network or matrix of the lens body. Doc -34- 200817471 Branch polymer. Additionally, the removable component can include other materials, such as volatile materials, that can be passively or actively removed from the pre-extracted polymeric hydrogel contact lens product prior to extraction. For example, a portion of the removable component can be evaporated between the demolding step and the extraction step. After the colloidal polymerizable lens precursor composition is applied, the release lens 108 of the contact lens is performed. Demolding refers to the method of separating two mold members (such as male and female mold members) of a mold or polymerization apparatus containing a pre-extracted polymeric contact lens product. The pre-extracted polymeric hemohydrogel contact lens product is located on one of the demolded mold members. For example, the polymeric oxygenated hydrogel contact lens product can be located on a male mold member or a female mold member. The pre-extracted polymeric oxygenated hydrogel contact lens product 204 is then separated from the contact lens mold member it is positioned during the mirror removal step 110 (shown in Figure i). The pre-extracted polymeric contact lens product can be removed from the convex mold member or the female mold member depending on the mold member that the polymeric contact lens product remains adhered during the release of the contact lens mold. After the pre-extracted deoxyhydrogel contact lens product is demired, the method includes extracting 112 extractable material from the pre-extracted neohydrogen hydrogel contact lens product. Extraction step 112 results in an extracted oxygenated hydrogel contact lens product 206 (shown in Figure 2). Extraction step 112 refers to the process of contacting the pre-extracted polymeric hydrogel contact lens product with one or more extraction compositions, and may include a single extraction step or several sequential extractions. For example, a poly-stone water-breaking gel-like eyeglass product or a batch of polymeric hydrogenated hydrogel invisible eye 121842.doc -35- 200817471 The mirror product is contacted with one or more volumes of liquid extraction medium. The extraction medium typically includes one or more solvents. For example, the extraction medium includes ethanol, methanol, propanol, and other alcohols. The extraction medium may also include a mixture of an alcohol and water, such as a mixture of 50% ethanol and 50% deionized water, or a mixture of 7% ethanol and 30% deionized water, or 9% ethanol and 1% deionized water. a mixture of water. Alternatively, the extraction medium can be substantially or completely alcohol free, and can include an agent that facilitates removal of the hydrophobic unreacted component from the Iwate hydrogel lens product. For example, the extraction medium can comprise, consist essentially of, or consist entirely of water, a buffer solution, and the like. Extraction 112 can be carried out at various temperatures, including room temperature. For example, the extraction can occur at room temperature (eg, about 20 Torr, or it can occur at elevated temperatures (eg, about 25 Torr to about 1 〇〇c). Further, in certain embodiments, the extraction step This may include contacting the lens product with a mixture of alcohol and water, and in some cases, may comprise the final step of a multi-step extraction procedure. Extracting the pre-extracted polymeric hydrogel contact lens product to provide an extracted polymerization After the oxygenated hydrogel contact lens product, the method comprises hydrating 114 the extracted polymeric oxygenated hydrogel contact lens product. The hydrating step 114 can comprise, for example, subjecting the extracted polymeric hydrogel hydrogel contact lens product or one or The plurality of batches of the products are contacted with water or an aqueous solution to form a hydrated oxalate hydrogel contact lens 208 (as shown in 囷 2). For example, the extracted polymeric oxime hydrogel contact lens product can be placed by Hydrating in two separate volumes or in two separate volumes of water, including deionized water. In some embodiments, the hydrating step 114 is combined with the extraction step ι12 to enable the two steps in contact lens production. The hydration step 114 can be carried out at room temperature or elevated temperature and, if necessary, under high pressure in a volume of 121842.doc -36 - 200817471. For example, the hydration can be at about 120 ° C (eg The temperature of 1212⁄4) and the pressure of 1〇3 kPa (15 pSi) occur in water. Therefore, as apparent from the above, it is considered that the pre-extracted polymeric rock-oxygen hydrogel contact lens product and the extracted polymeric hydrogen peroxide water are considered. The gel contact lens product is a product or component of water swellability and is considered to be invisible to the hydrated hydrogel. • The spectacles are water swellable products or components. As used herein, oxime hydrogel shaped glasses refer to The Shixi oxygen hydrogel component undergoing the hydration step. Because of this P Shixia Oxygen/Glue contact lens can be a fully hydrated Shixia oxygen gel contact lens, a partially hydrated hydrogel contact lens or dehydrated Oxygenated hydrogel contact lenses. Dehydrated hydrogel contact lenses are contact lenses that have undergone hydration and have been dehydrated to remove water from the glasses after hydration. Contact lens products to produce 矽After the hydrogel contact lens, the method includes the step 116 of encapsulating the oxygenated hydrogel contact lens 208. For example, the helium oxygen hydrogel contact lens 2 can be placed in a volume including a liquid (such as a physiological saline solution). In a blister pack or other suitable container, including a buffered physiological saline solution. Examples of liquids suitable for the spectacles of the present invention include phosphate buffered physiological saline and shed acid buffered physiological saline. Show, then seal the blister pack or container' and then sterilize. For example, the encapsulated oxaxy hydrogel contact lens can be treated, for example, by autoclave treatment, gamma light shot, electron beam stimuli or ultraviolet radiation. Exposure to sterilizing radiation, including thermal radiation. Characteristics of Hydroxy Hydrating Glasses As discussed above, the compositions and methods provided herein provide for the upper phase of the eye 121842.doc -37- 200817471 Glue contact lenses. The pre-extracted polymeric oxime hydrogel ophthalmic product is extracted and hydrated to form a shixi oxygen hydrogel contact lens having an ophthalmically acceptable surface wettability. The spectacles of the present invention have oxygen permeability, surface wettability, modulus, water content, ion flow, design, and combinations thereof, which make the spectacles of the present invention suitable for comfortable stretching of the patient's eyes, such as at least one day, at least One week, at least two weeks, or about one month, without removing the glasses from your eyes. As used herein, an oxygen-based hydrogel contact lens on the eye, which refers to a helium-oxygen gel that can be worn on the human eye without human experience or substantial discomfort (including eye irritation and similar discomfort). Contact lenses. Compatible with the eyes Ο

矽氧水凝膠隱形眼鏡具有眼用可接受之表面可濕性,且通 常不引起顯著角膜腫脹、角膜脫水(&quot;乾眼病,,)、上方角膜 上皮弓狀病變(&quot;SEAL”)或纟他顯著不適或與該等病狀不相 關。具有眼用可接受之表面可濕性之石夕氧水凝膠隱形眼鏡 係指不會不利影響眼鏡配戴者眼睛之淚膜至導致眼鏡配戴 者經歷或報導與眼睛上置放或配戴⑦氧錢膠隱形眼鏡相 關之不適之程度的石夕氧水凝膠隱形眼鏡。眼睛上相容之石夕 乳錢膠隱形眼鏡滿足針對每曰配戴或長期配戴隱形眼鏡 之臨床上可接受之要求。 :發明之石夕氧水凝膠隱形眼鏡包含鏡體,其具有具眼用 叉之表面可濕性(0ASW)的表面,諸如前表面及後表 二可錢係錢形眼鏡之_或多個表面的親水性。在一 里二方法中,若眼鏡在如下進行之可濕性檢定中得到3 乂上之評分,則可認為眼鏡表面為可濕性的,或可認 121842.doc &gt;38- 200817471 Γ Ο 為其具有眼用可接受之可濕性。將隱形眼鏡浸入蒸餾水 中自水中移除,且測定水膜自眼鏡表面後退所耗之時間 長度(例如水驅散時間(水Βυτ或WBUT))。檢定提供卜10之 線性範圍内的眼鏡等級,其中10分係指其中水滴需20秒或 更長時間自眼鏡後退之眼鏡。雖然㈣听之活體外評估僅 為對於QASW之-種量測方法或指示,但可認為具有⑽、 以上(諸如至少10秒或更理想為至少約丨5秒)水BUT之矽氧 水凝膠隱形眼鏡具有眼用可接受之表面可濕性。或者,可 在活體内評估OASW。若眼鏡可在患者眼睛上配戴至少6 夺而心者未報導不適或刺激,則認為眼鏡具有請。 一可濕性亦可藉由量測一或兩個眼鏡表面上之接觸角來測 定。接觸角可為動態或靜態接觸角。較低接觸角一般係指 隱形眼鏡表面之可濕性增加。舉例而言,如本文所提供之 石夕氧水凝膠隱形眼鏡之可濕性表面可具有小於約%。之接 觸角H在本發明眼鏡之某㈣施财,眼鏡具有不 ;0之接觸角’且在其他實施例中,本發明之矽氧水 凝膠隱形眼鏡具有小於約75。且甚至更佳小於約70。之前進 觸角在實%例中,眼鏡具有在約52。至約62。範圍内 之前進接觸角。 本發明之♦氧水凝㈣料鏡包含具有㈣可接受之表 :可濕性的鏡體。舉例而言,本發明之石夕氧水凝膠隱形眼 鏡體通常具有前表面及後表面,各表面均具有眼用可 接文之表面可濕性。 在-實施例中’㈣水凝膠隱形眼鏡之鏡體包含石夕氧水 121842.doc -39- 200817471 Γ Ο ㈣物f °鏡體具有不大於萃取前鏡體乾重嶋之乾重。 舉例而言’預萃取之聚切氧水凝膠隱形眼鏡產物之鏡體 可具有乾重χ°萃取程序之後’經萃取之聚切氧水凝膝 隱形眼鏡產物之鏡體具有小於或等於09Χ之乾重。如上所 論述,在萃取步驟期間,預萃取之聚切氧水凝膠隱形眼 鏡產物可與大量多種有機溶劑接觸,繼而進行水合步驟以 產生梦氧核㈣形眼鏡。接著,將水合魏水凝膠隱形 眼鏡脫水且稱重以測定矽氧水凝膠隱形眼鏡之鏡體乾重。 舉例而f,在某些方法中,冑預萃#之聚合石夕氧水凝膠 隱形眼鏡產物自隱形眼鏡模具構件脫鏡,且稱重以提供預 萃取之聚合矽氧水凝膠隱形眼鏡產物之乾重。接著使預萃 取之眼鏡產物與醇接觸約6小時,且接著與水進行水合。 接著在約80°C下乾燥水合眼鏡約1小時,且接著在真空下 於約80 C下乾燥約2小時。稱重經乾燥之眼鏡以測定矽氧 水凝膠隱形眼鏡之鏡體乾重。接著比較該等乾重以確定預 萃取之聚合石夕氧水凝膠隱形眼鏡產物中所存在之可萃取物 質的量。具有約40%可萃取組份含量之預萃取聚合眼鏡產 物產生乾重為預萃取眼鏡產物約60%之矽氧水凝膠隱形眼 鏡的鏡體。具有約70%可萃取組份含量之預萃取聚合眼鏡 產物產生乾重為預萃取眼鏡產物約30%之矽氧水凝膠隱形 眼鏡的鏡體,等等。 預萃取之聚合矽氧水凝膠隱形眼鏡產物中所存在之可萃 取物之量或可萃取組份含量可使用以下等式來確定: E=((預萃取眼鏡產物之乾重-經萃取及水合之隱形眼鏡 121842.doc -40 - 200817471 之乾重)/預萃取眼鏡產物之乾重)χΐ〇〇。 E為預萃取眼鏡產物中所存在之可萃取物的百分比。 舉例而言,預萃取之聚合矽氧水凝膠隱形眼鏡產物可具 有約20 mg之乾重。若自彼產物所獲得之矽氧水凝膠隱形 眼鏡具有約1 7 mg之乾重,則彼矽氧水凝膠隱形眼鏡包含 乾重為預萃取眼鏡產物乾重8 5%之鏡體。應瞭解,該預萃 取眼鏡產物具有約15%(重量比)之可萃取組份含量。作為 另一實例,預萃取之聚合矽氧水凝膠隱形眼鏡產物可具有 約18 mg之乾重,且若自該眼鏡產物所獲得之經脫水之矽 氧水凝膠隱形眼鏡具有約13 mg之乾重,則該石夕氧水凝膠 隱形眼鏡包含乾重為預萃取之眼鏡產物約72%之鏡體。該 預萃取之聚合矽氧水凝膠隱形眼鏡產物具有約28%(重量 比)之可萃取組份含量。 在某些實施例中,矽氧水凝膠隱形眼鏡(亦即已經受萃 取及水合程序之矽氧水凝膠隱形眼鏡)之鏡體乾重大於鏡 體在萃取前之乾重的70%。舉例而言,萃取後之鏡體乾重 可為預萃取之鏡體乾重的約70%至約90%。本發明眼鏡之 某些實施例包含乾重為預萃取鏡體乾重之約7〇%至約78〇/〇 的鏡體。在至少一實施例中,矽氧水凝膠隱形眼鏡具有預 萃取鏡體乾重約74%之的乾重。 雖然本發明之預萃取聚合矽氧水凝膠隱形眼鏡產物含有 可萃取物質,但本發明之矽氧水凝膠隱形眼鏡之經萃取形 式在所得鏡體中具有極小量(若非顯著量)之可萃取物質。 在某些實施例中,經萃取之眼鏡中剩餘之可萃取物質的量 121842.doc -41- 200817471 為約0.1%至約4%,諸如約〇·4%至約2%(重量比)。該等額 外可萃取物質可藉由使經萃取之隱形眼鏡與額外體積之強 溶劑(諸如氯仿)接觸來測定。 此外,由於可萃取組份存在且分布在整個可聚合之矽氧 水凝膠眼鏡前驅體組合物及預萃取之聚合矽氧水凝膠隱形 眼鏡產物中,因此本發明之眼鏡產物及隱形眼鏡可區別於 經表面處理之矽氧水凝膠隱形眼鏡。由於可萃取組份可自 眼鏡產物萃取且實質上不存在於經水合之隱形眼鏡中,因 此本發明之眼鏡產物及隱形眼鏡可區別於具有聚合濕潤劑 IPN之矽氧水凝膠隱形眼鏡。 本發明之矽氧水凝膠隱形眼鏡可包含自非極性樹脂隱形 眼鏡模具所獲得之鏡體,該等鏡體在水合及脫水狀態下檢 查時具有實質上相同之表面形態。此外,該等水合鏡體可 具有略微小於脫水鏡體之表面粗縫度的表面粗輪度。舉例 而言,本發明之眼鏡之鏡體可具有包括奈米大小峰之表 面,該等奈米大小峰在分析眼鏡表面之均方根(RMS)粗糙 度資料時顯而易見。鏡體可包含在各峰之間差異性隆起之 该等峰之間的區域,以提供減少之粗縫度而實質上類似之 表面形態。舉例而言,雖然在鏡體水合時峰高可減少,但 峰形狀實質上保持相同。 或者或另外,本發明之經非極性樹脂模製之矽氧水凝膠 隱形眼鏡的實施例可包含具有在用電子顯微鏡(諸如掃描 電子顯微鏡、透射電子顯微鏡或掃描透射電子顯微鏡)觀 察時可視覺辨別之富矽區及貧矽區的鏡體。基於化學分 121842.doc -42- 200817471 析,可瞭解貧矽區為實質上或完全無矽之眼鏡内區域。貧 矽區可能比經表面處理之矽氧水凝膠隱形眼鏡或包含聚合 濕潤劑IPN之矽氧水凝膠隱形眼鏡中的該等區大。可使用 病去〜像刀析車人體及裝置(諸如可購自Bi〇qUant(Tennessee) 之影像分析系統)測定富矽區、貧矽區或兩者之大小。影 像分析軟體系統可用以勾勒出富矽區及貧矽區之邊界輪廓 且測定該等區之橫截面積、直徑、體積及其類似物。在某 些實施例中,貧矽區具有比其他矽氧水凝膠隱形眼鏡之貧 矽區大至少50% '至少60%、至少7〇%、至少8〇%或至少 90%之橫截面積。 本發明之未經表面處理之鏡體通常提供眼用可接受之表 面可濕性。換言之,在一實施例中,本發明之矽氧水凝膠 隱形眼鏡之鏡體為未經表面處理之鏡體。換言之,在不進 行鏡體之表面處理下產生鏡體以提供眼用可接受之表面可 濕性。舉例而言,說明性鏡體不包括用以使鏡體表面在眼 睛上更可接受之電漿處理或額外塗層。而本發明之眼鏡具 有眼用可接受之表面可濕性,必要時某些實施例可包括表 面處理。 本發明之眼鏡之某些實施例包含自非極性樹脂隱形眼鏡 模具獲得之澆鑄成型元件鏡體。聚合矽氧水凝膠隱形眼鏡 產物係指在非極性樹脂隱形眼鏡模具中聚合或固化之產 物。或者,以另一種方式說明,聚合矽氧水凝膠隱形眼鏡 產物在非極性樹脂隱形眼鏡模具中產生。如本文所論述, 該等隱形眼鏡模具為使用非極性或疏水性樹脂物質或基於 121842.doc -43- 200817471 非極性或疏水性樹脂物質而 J, 0e ^ , 座生之杈具。該等物質通常在 其眼鏡形成表面上具有相對大之接觸角。 本發明之眼鏡可包含前表 A 傻表面或則及後表面上之 别進接觸角小於9〇。之經水合鏡體。鏡體通常具有小於75。 之鏡表面前進接觸角,例如鏡體具有約以下—者之鏡表面 前進接觸角(以。計):74、73、72、71、7〇、69、68、67、Hydroxyl hydrogel contact lenses have an ophthalmically acceptable surface wettability and generally do not cause significant corneal swelling, corneal dehydration (&quot;dry eye disease,), upper corneal epithelial arch lesion (&quot;SEAL") or显 He is significantly uncomfortable or unrelated to these conditions. The Oxygen Hydrogel Contact Lens with Ophthalmically Acceptable Surface Wetability means that the tear film of the eye of the wearer of the lens will not adversely affect the lens. The wearer experiences or reports the Shiyue Oxygen Hydrogel contact lens with the degree of discomfort associated with placing or wearing 7 oxygenated contact lenses on the eye. The eye-compatible Shishi milk gel contact lens meets for each Clinically acceptable requirements for wearing or long-term wear of contact lenses. The invention of a spectroscopy hydrogel contact lens comprises a lens body having a surface wettable (0ASW) surface with an ophthalmic fork, such as before The surface and the second table can be used for the hydrophilicity of the surface of the money-shaped glasses or the surfaces of the plurality of surfaces. In the second method, if the glasses are scored on the 3 乂 in the wettability test as follows, the glasses can be considered as glasses. The surface is wettable, or 121842.doc &gt;38- 200817471 Γ Ο for its eye-acceptable wettability. The contact lens is immersed in distilled water to remove it from the water and the length of time it takes for the water film to recede from the surface of the lens (eg water) Dispersion time (water Βυ or WBUT). The test provides the level of glasses in the linear range of Bu 10, where 10 points refers to the glasses in which the water droplets need 20 seconds or more to retreat from the glasses. Although (4) the in vitro evaluation of listening only Is a method or indication for QASW, but it can be considered that a hydrothermal gel contact lens having a water BUT of (10), above (such as at least 10 seconds or more preferably at least about 5 seconds) is ophthalmically acceptable. Surface wettability. Alternatively, OASW can be evaluated in vivo. If the eyeglasses can wear at least 6 on the patient's eyes and the person does not report discomfort or irritation, then the glasses are considered to have a dose. The contact angle on one or both of the glasses is measured to determine the contact angle. The contact angle can be a dynamic or static contact angle. A lower contact angle generally refers to an increase in the wettability of the contact lens surface. For example, a stone as provided herein. Xi The wettable surface of the oxygen hydrogel contact lens can have less than about %. The contact angle H is used in some (four) of the glasses of the present invention, the lens has a contact angle of 0; and in other embodiments, the present invention The hydroxyl hydrogel contact lens has a thickness of less than about 75. and even more preferably less than about 70. In the prior embodiment, the lens has a pre-contact angle in the range of from about 52 to about 62. The oxygen hydrogel (four) material mirror comprises a mirror body having (4) an acceptable surface: wettability. For example, the stone-oxygen hydrogel contact lens body of the present invention generally has a front surface and a rear surface, each surface having an eye The surface wettability of the tangible text is used. In the embodiment, the mirror body of the (4) hydrogel contact lens comprises Shi Xi oxygen water 121842.doc -39- 200817471 Γ Ο (4) The object f ° mirror body has no more than before extraction The dry weight of the mirror body is heavy. For example, the mirror body of the pre-extracted poly-cut oxygen hydrogel contact lens product may have a dry weight χ ° extraction procedure after the 'extracted poly-cut oxygen hydrocoagulated knee contact lens product has a mirror body of less than or equal to 09 Χ Dry weight. As discussed above, during the extraction step, the pre-extracted poly-cut oxygen hydrogel contact lens product can be contacted with a wide variety of organic solvents, followed by a hydration step to produce Dream Oxygen (tetra) shaped glasses. Next, the hydrated Wei hydrogel contact lenses were dehydrated and weighed to determine the dry weight of the lens body of the hydrogenated hydrogel contact lenses. By way of example, in some methods, the pre-extracted # 石 氧 氧 hydrogel contact lens product is unmirror from the contact lens mold member and weighed to provide a pre-extracted polymeric oxime hydrogel contact lens product. Dry weight. The pre-extracted lens product is then contacted with the alcohol for about 6 hours and then hydrated with water. The hydrated spectacles were then dried at about 80 ° C for about 1 hour and then dried under vacuum at about 80 C for about 2 hours. The dried glasses were weighed to determine the dry weight of the lens body of the hydrogel contact lens. The dry weights are then compared to determine the amount of extractable material present in the pre-extracted polymeric rock hydrogel contact lens product. The pre-extracted polymeric lens product having a level of extractable component of about 40% produces a lens body having a dry weight of about 60% of the oxygenated hydrogel invisible eyeglasses of the pre-extracted lens product. The pre-extracted polymeric lens product having an extractable component content of about 70% produces a lens body having a dry weight of about 30% of the oxygenated hydrogel contact lens of the pre-extracted lens product, and the like. The amount of extractable material or extractable component present in the pre-extracted polymeric hydrogel contact lens product can be determined using the following equation: E = ((dry weight of pre-extracted lens product - extracted and Hydrating contact lenses 121842.doc -40 - 200817471 dry weight) / pre-extracted lens product dry weight) χΐ〇〇. E is the percentage of extractables present in the pre-extracted lens product. For example, the pre-extracted polymeric oxygenated hydrogel contact lens product can have a dry weight of about 20 mg. If the oxygenated hydrogel contact lens obtained from the product has a dry weight of about 17 mg, the hydrogenated hydrogel contact lens comprises a lens body having a dry weight of 85% by dry weight of the pre-extracted lens product. It will be appreciated that the pre-extracted lens product has an extractable component content of about 15% by weight. As another example, the pre-extracted polymeric hydrogel contact lens product can have a dry weight of about 18 mg, and if the dehydrated hydrogel contact lens obtained from the lens product has about 13 mg On dry weight, the Asahi Hydrogel contact lens comprises a mirror body having a dry weight of about 72% of the pre-extracted lens product. The pre-extracted polymeric hydrogel contact lens product has an extractable component content of about 28% by weight. In certain embodiments, the mirror body of the helium-oxygen hydrogel contact lens (i.e., the oxygenated hydrogel contact lens that has been subjected to the extraction and hydration procedures) is substantially more than 70% of the dry weight of the lens prior to extraction. For example, the dry weight of the lens body after extraction can be from about 70% to about 90% of the dry weight of the pre-extracted lens body. Some embodiments of the spectacles of the present invention comprise a lens body having a dry weight of from about 7% to about 78 Å/〇 of the dry weight of the pre-extracted lens body. In at least one embodiment, the helium oxygen hydrogel contact lens has a dry weight of about 74% of the dry weight of the pre-extracted lens body. Although the pre-extracted polymeric hydrogel contact lens product of the present invention contains an extractable material, the extracted form of the oxygenated hydrogel contact lens of the present invention has a very small amount (if not significant amount) in the resulting lens body. Extract the substance. In certain embodiments, the amount of extractable material remaining in the extracted spectacles is from about 0.1% to about 4%, such as from about 〇4% to about 2% by weight, of the amount 121842.doc-41-200817471. Such additional extractables can be determined by contacting the extracted contact lens with an additional volume of a strong solvent such as chloroform. In addition, since the extractable component is present and distributed throughout the polymerizable silicone hydrogel lens precursor composition and the pre-extracted polymeric oxygenated hydrogel contact lens product, the lens product and contact lens of the present invention can be Different from surface treated helium hydrogel contact lenses. Since the extractable component can be extracted from the lens product and is substantially absent from the hydrated contact lens, the lens products and contact lenses of the present invention can be distinguished from the oxygenated hydrogel contact lens having the polymeric wetting agent IPN. The silicone hydrogel contact lenses of the present invention may comprise lens bodies obtained from non-polar resin contact lens molds having substantially the same surface morphology upon inspection in the hydrated and dehydrated state. In addition, the hydrated mirror bodies may have a surface coarseness slightly smaller than the surface roughness of the dehydrated mirror body. For example, the lens body of the glasses of the present invention may have a surface comprising a nanometer size peak, which is apparent when analyzing the root mean square (RMS) roughness data of the surface of the lens. The mirror body may comprise a region between the peaks of the differential ridges between the peaks to provide a reduced degree of sag and substantially similar surface morphology. For example, although the peak height can be reduced when the lens body is hydrated, the peak shape remains substantially the same. Alternatively or additionally, embodiments of the non-polar resin molded oxygenated hydrogel contact lenses of the present invention may comprise visually visible when viewed with an electron microscope such as a scanning electron microscope, a transmission electron microscope, or a scanning transmission electron microscope. Identify the mirrors of the rich and poor areas. Based on the chemical analysis of 121842.doc -42- 200817471, it can be seen that the barren area is a region that is substantially or completely flawless. The lean zone may be larger than the surface treated helium hydrogel contact lens or the oxygenated hydrogel contact lens comprising the polymeric wetting agent IPN. It is possible to use a disease-removing body and a device such as an image analysis system available from Bi〇qUant (Tennessee) to determine the size of the rich zone, the barren zone or both. The image analysis software system can be used to outline the boundary of the rich and barren areas and to determine the cross-sectional area, diameter, volume and the like of the areas. In certain embodiments, the barren zone has at least 50% 'at least 60%, at least 7%, at least 8%, or at least 90% of the cross-sectional area greater than the barren zone of the other hydrogel contact lenses. . The unsurfaced mirror body of the present invention generally provides acceptable surface wettability for ophthalmology. In other words, in one embodiment, the mirror body of the helium oxygen hydrogel contact lens of the present invention is a mirror body that has not been surface treated. In other words, the lens body is produced without surface treatment of the lens body to provide an ophthalmically acceptable surface wettability. For example, the illustrative scope does not include a plasma treatment or additional coating to make the surface of the mirror more acceptable to the eye. While the lenses of the present invention have an ophthalmically acceptable surface wettability, some embodiments may include surface treatment if desired. Certain embodiments of the lenses of the present invention comprise cast molded component mirrors obtained from non-polar resin contact lens molds. Polymerized Hydroxyl Hydrogel Contact Lens The product refers to a product that is polymerized or cured in a non-polar resin contact lens mold. Alternatively, in another manner, the polymeric hemihydrate hydrogel contact lens product is produced in a non-polar resin contact lens mold. As discussed herein, the contact lens molds are J, 0e^, a cookware using a non-polar or hydrophobic resin material or a non-polar or hydrophobic resin material based on 121842.doc-43-200817471. These materials typically have a relatively large contact angle on their lens forming surface. The spectacles of the present invention may comprise a stupid surface of the front table A or a contact angle of less than 9 Å on the rear surface. The hydrated mirror body. The mirror body typically has less than 75. The mirror surface advances the contact angle, for example, the mirror body has a mirror surface advancing contact angle (in terms of): 74, 73, 72, 71, 7〇, 69, 68, 67,

U 66、65、64、63、62、61、6〇、59、58 57、56 55、 54 53 ' 52、51或50。鏡體亦可具有小於約75。之鏡表面 後退接觸角。例如,鏡體可具有約以下一者之鏡表面後退 接觸角(以。計):74、73、72、71、7〇、69、68、67、66、 65、64、63、62、61、60、59、58、57、56、55、54、 53 52 51 、 50 、 49 、 48 、 47 、 46 、 45 、 44 、 43 、 42 、 41 或40。在一或多個實施例中,鏡體具有約4〇。至約。之後 退接觸角。 作為前進接觸角與後退接觸角之間的差異之滯後通常為 約5°至約25。。然而,在某些實施例,滯後在約5。至約15。 之範圍内’儘管在某些情況下,眼鏡可具有大於約25。之 滯後,但仍為臨床上可接受的。 可使用一般熟習此項技術者已知之常規方法測定前進接 觸角。舉例而言,可使用習知液滴形狀法(諸如固著液滴 法或俘獲氣泡法)來量測隱形眼鏡之前進接觸角及後退接 觸角。矽氧水凝膠隱形眼鏡之前進及後退水接觸角可使用U 66, 65, 64, 63, 62, 61, 6〇, 59, 58 57, 56 55, 54 53 '52, 51 or 50. The mirror body can also have less than about 75. The mirror surface recedes the contact angle. For example, the mirror body may have a mirror surface receding contact angle (in degrees) of about one of: 74, 73, 72, 71, 7〇, 69, 68, 67, 66, 65, 64, 63, 62, 61 , 60, 59, 58, 57, 56, 55, 54, 53 52 51 , 50 , 49 , 48 , 47 , 46 , 45 , 44 , 43 , 42 , 41 or 40 . In one or more embodiments, the mirror body has about 4 inches. To about. Then retreat the contact angle. The hysteresis as the difference between the advancing contact angle and the receding contact angle is usually from about 5° to about 25. . However, in some embodiments, the hysteresis is about 5. To about 15. Within the range 'although in some cases, the spectacles may have greater than about 25. It lags, but is still clinically acceptable. The advancing contact angle can be determined using conventional methods known to those skilled in the art. For example, a conventional drop shape method such as a sessile drop method or a trap bubble method can be used to measure the contact angle and the receding contact angle of the contact lens. The contact angle of the infusion and back water of the hydrogenated hydrogel contact lens can be used.

Kruss DSA 100 器具(Kruss GmbH,Hamburg)且如 D. A. Brandreth: &quot;Dynamic contact angles and contact angle 121842.doc -44- 200817471 hysteresis’·,Journal of Colloid and Interface Science,第 62 卷,1977,第 205-212 頁及 R· Knapikowski,Μ· Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung”,Chem. Technik, 第45卷,1993,第179-185頁及美國專利第6,436,481號中 所述來測定。 例如,前進接觸角及後退接觸角可使用俘獲氣泡法使用 填酸鹽緩衝生理食鹽水(PBS ; pH=7_2)來測定。使眼鏡平 鋪在石英表面上且在測試之前用PBS再水合1〇分鐘。使用 自動注射系統將氣泡置放於眼鏡表面上。可增加及減小氣 泡大小以獲得後退角(當增加氣泡大小時獲得平臺)及前進 角(當減小氣泡大小時獲得平臺)。 或者或另外,本發明之眼鏡可包含展示大於5秒之水驅 散時間(BUT)的鏡體。舉例而言,包含水BUT為至少15秒 (諸如20秒或更長時間)之鏡體的本發明之眼鏡的實施例可 具有眼用可接受之表面可濕性。 本發明之眼鏡一般包含模數小於丨·6 Mpa之鏡體。眼鏡 之特徵通常在於其模數在約〇·5至約1.5 mPa之間,較佳在 、、、勺〇_6至約丨.2 mPa之間。在一或多個實施例中,眼鏡具有 ,約0.8至約丨.0 MPa之間的模數。舉例而言,鏡體可具有 勺.2 MPa、MPa、i 〇 Μρ^、〇 9 MPa、〇 8 Mpa、約 〇/ M^a、約〇·6 MPa或約〇·5 Mpa之模數。選擇鏡體模數以 H ’、田置放於眼睛上時舒適之眼鏡且使眼鏡配戴者可適應 眼鏡之操作。 121842.doc -45- 200817471 可使用一般熟習此項技術者已知之常規方法測定鏡體之 模數。舉例而言,自眼鏡中心部分切下寬度約4 mm之隱形 眼鏡片,且拉伸模數(單位:MPa)可自藉由使用Instron 3342(Instron Corporation)在 25°C 下在至少 75%濕度之空氣 中以10 mm/min之速率進行拉伸測試所獲得之應力應變曲 線的初始斜率來測定。 本發明之眼鏡之鏡體的離子流通常小於約5xl〇-3 mm2/min。雖然某些本發明之眼鏡鏡體可具有高達約7χι〇-3 mm2/min之離子流,但咸信當離子流小於約5xl〇-3 mm2/min,且當隱形眼鏡不包括MPC時,可減少角膜脫水 染色。在某些實施例中,鏡體之離子流在約2x1 〇_3 mm2/min至約5xl〇_3 mm2/min之範圍内。舉例而言,離子流 可為約 2xl〇·3 mm2/min、2.5χ1(Γ3 mm2/min、3.〇xl(T3 mm2/min、3·5χ10·3 mm2/min、4·〇χ1〇·3 mm2/min、4·5χ1〇.3 mm2/min或約5xl〇-3mm2/min。然而,如本文所述,離子流 可大於7χ1〇-3 mm2/min,但仍未引起角膜脫水染色或其他 床問題。 本發明之眼鏡鏡體的離子流可使用一般熟習此項技術者 已知之常規方法來測定。舉例而言,隱形眼鏡或鏡體之離 子机可使用實質上類似於美國專利第5,849,811號中所述之 Ionoflux Technique&quot;的技術來量測。舉例而言,待量測之 艮鏡了置放在保留眼鏡之裝置中的凸形與凹形部分之間。 凸形及凹形部分包括位於眼鏡與各凸形或凹形部分之間的 可撓性密封環。在將眼鏡定位於保留眼鏡之裝置中之後, 121842.doc -46- 200817471 將保留眼鏡之裝置置放於帶螺紋之蓋中。將蓋擰至玻璃管 上以界定原料物質腔室。原料物質腔室中可填充有16 ml 0.1莫耳濃度之NaCl溶液。接收腔室可填充有80 ml去離子 水。將電導計之導線浸入接收腔室之去離子水中,且將攪 拌棒添加至接收腔室中。將接收腔室置放在恆溫箱中,且 ’ 將溫度保持在約35°C。最後,將原料物質腔室浸入接收腔 • 室中。可在將原料物質腔室浸入接收腔室後10分鐘開始, 每隔兩分鐘進行電導率之量測,歷時約20分鐘。電導率與 〇 時間之關係資料應實質上呈線性。 本發明之眼鏡之鏡體通常具有高透氧性。舉例而言,鏡 體具有Dk不小於60 barrer之透氧性。本發明之眼鏡的實施 例包含 Dk為約 80 barrer、約 90 barrer、約 100 barrer、約 110 barrer、約 120 barrer、約 130 barrer、約 140 barrer或更 大之鏡體。目艮鏡較佳具有約70至約110 barrer且更佳約80 至 100 barrer之 Dk。 可使用一般熟習此項技術者已知之常規方法來測定本發 ^ 明之眼鏡之Dk。舉例而言,Dk值可使用如美國專利第 5,817,924號中所述之Mocon方法來測定。Dk值可使用型號 ^ 名稱為Mocon Ox-Tran System之市售器具來測定。 本發明之眼鏡亦包含具有眼用可接受之水含量的鏡體。 舉例而言,本發明之眼鏡之實施例包含平衡水含量不小於 約30%之鏡體。在某些實施例中,鏡體具有在約40重量% 至約6 0重量%範圍内之平衡水含量。舉例而言,本文所提 供之眼鏡可具有約35%、約40%、約45%、約50%、約 121842.doc -47- 200817471 55%、約60%或甚至約65%之平衡水含量。在—或多個實 施例中,鏡體具有約42重量❶/❶至約50重量%之平衡水含 量。 可使用一般熟習此項技術者已知之常規方法來測定本發 明之眼鏡之水含量。舉例而言,水切氧水凝膠隱形眼鏡 可自水性液體中移除,擦拭以移除過量表面水,且稱重。 接著可將經稱重之眼鏡在烘箱中於8〇〇c真空中乾燥,且接 著可稱重經乾燥之眼鏡。藉由自水合眼鏡重量減去乾燥眼 鏡重量來測定重量差。水含量(%)為(重量差/水合重 量)χ 100。 除上文所確定之特定值以外,本發明之眼鏡可具有在上 文所確定之特定值之任何組合之間範圍内之值。 舉例而言,本發明之隱形眼鏡可具有約42%至約50%之 水含量,約3至約5(xl〇-3mm2/min)之離子流值,約52。至約 62。之前進接觸角,約4〇。至約6〇。之後退接觸角,約$。至約 15之滯後,約0.6 MPa至約1·2 MPa之楊氏模數(Y〇ung,s moduli)、至少約ι〇〇%之伸長率及其組合。在某些實施例 中’伸長率為約100〇/〇至約300%。 如本文所論述,本發明之眼鏡具有允許眼鏡配戴延長時 J之特欲及特性。舉例而言,本發明之眼鏡可作為每天配 戴眼鏡、每週配戴眼鏡、雙週配戴眼鏡或每月配戴眼鏡來 配戴。本發明之眼鏡包含具有有助於眼鏡舒適度及可用性 之表面可濕性、模數、離子流、透氧性及水含量的水合鏡 體0 121842.doc -48- 200817471 本發明之石夕氧水凝膠隱形目艮鏡為矯正視力〇曾強視力之 隱形眼鏡。眼鏡可為球面眼鏡或非球面眼鏡。眼鏡可為單 焦點眼鏡或多焦點眼鏡,包括雙焦點眼鏡。在某些實施例 中,本發明之眼鏡為旋轉穩定眼鏡,諸如旋轉穩定複曲面 隱形眼鏡。旋轉穩定隱形眼鏡可為包含包括壓載物之鏡體 的隱形眼鏡。舉例而言,鏡體可具有稜鏡壓載物、周圍壓 載物及/或一或多個薄化上方及下方區域。 本發明之眼鏡亦包含包括外周邊緣區域之鏡體。外周邊 緣區域可包括圓形部分。舉例而言,外周邊緣區域可包含 圓形後邊緣表面、圓形前邊緣表面或其組合。在某些實施 例中,外周邊緣自前表面至後表面完全成圓形。因此,可 瞭解本發明之眼鏡之鏡體可包含圓形外周邊緣。 本發明之眼鏡可包含其厚度分布解決與現有矽氧水凝膠 隱形眼鏡相關之問題但對眼鏡配戴者而言仍舒適之鏡體。 藉由改變鏡體厚度及鏡體模數,可控制鏡體之硬度。舉例 而a,隱形眼鏡之一區域的硬度可定義為眼鏡之揚氏模數 與指定區域之眼鏡厚度平方的乘積。因此,本發明之眼鏡 之某些實施例可包含中心硬度(例如眼鏡中心或視區中心 之硬度)小於約0.007 MPa-mm2、眼鏡接面硬度小於約〇 〇3 MPa-mm或其組合之鏡體。眼鏡接面可定義為眼鏡區與斜 面或(對於無斜面之眼鏡而言)距離眼鏡邊緣約12 mm之點 的接面(參見美國專利第6,849,671號)。在其他實施例中, 本發明之眼鏡可包含中心硬度大於〇·0〇7 MPa_mm2、眼鏡 接面硬度大於約〇·〇3 MPa-mm2或其組合之鏡體。 121842.doc -49- 200817471 本發明之石夕氧水凝膠隱形眼鏡可提供於密封包裳中。 例而言,本發明之魏錢㈣形眼鏡可提供於 2 包裝或適於傳遞給眼鏡配戴者之其他類似容器中 儲存在包裝内之水溶液中,諸如生理食鹽水溶液。 適/合液包括^4酸鹽緩衝生理食鹽水溶液及删酸鹽緩衝办 液。必要時,溶液可包括消毒劑或可無消毒劑或防腐劑: 必要時’溶液亦可包括界面活性劑,諸如泊 (poloxamer)及其類似物。 Ο 密封包裝内之眼鏡較佳無菌。舉例而言,眼鏡可在密封 包裝之前殺菌或可在密封包裝内殺菌。經殺菌之眼鏡可為 ^暴露於殺菌量之輻射之眼鏡。舉例而言,眼鏡可為經高 壓釜處理之眼鏡、經γ輻射之眼鏡、經紫外輻射暴露之眼 鏡及其類似物。 實例 、下實例,兒明本發明之某些態樣及優勢,然而絕不認為 本發明限於以下所述之特定實施例。 ^矛、非另外才曰出’否則本發明之實踐將採用此項技術技能 軌圍内之聚合物合成、水凝膠形成及其類似物之習知技 亥等技術在文獻中充分說明。除非相反特定說明,否 則試劑及物質為市售的。 製備开ν眼鏡(例如矽氧水凝膠隱形眼鏡)之方法進一步 描述於以下專利中:美國專利第(⑵,州號、第4,495,313 $虎第 4,565,348號、第 4,640,489號、第 4,889,664號、第 ’985’186 5虎、帛 5,〇39,459 號、帛 5,080,839 號、第 121842.doc •50- 200817471 5,094,609 號、第 5,260,000 號、第 5,607,518 號、第 5,760,100 號、第 5,850,107 號、第 5,935,492 號、第 6,099,852 號、第 6,367,929 號、第 6,822,016 號、第 6,867,245號、第6,869,549號、第6,939,487號及美國專利 公開案第20030125498號、第20050154080號及第 ’ 20050191335號。 • 在以下實例中,雖然已努力確保與所用數字(例如量、 溫度等)相關之精確性,但仍應解決某些實驗誤差及偏 () 差。除非另外指出,否則溫度以。C計,且壓力在海平面下 為大氣壓力或接近大氣壓力。 以下熟知之化學物質在實例中提及,且在某些情況下, 由其如下提出之縮寫提及。 物質及方法 縮寫 ΑΕ :烯丙氧基乙醇 DI :去離子化 〇 ΜΜΑ :甲基丙烯酸曱酯 M3U: M3-U; α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基 • 乙氧基丙基)·聚(二甲基矽氧烷)_聚(三氟丙基曱基矽氧烷)_ 聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷;含二曱基丙烯 醯基矽氧大分子單體 以下實例中所用之M3U由下式表示,其中η為121,4 7.6,h 為 4.4,ρ 為 7.4,&amp;Μη=12,8〇〇,aMw=i6 2〇〇 (Asahikasei Aime Co., Ltd.? Japan) 〇 121842.doc -51- 200817471 〒3H6(OC2H4)pOCH3 ch3 ch3 ch3 C2H4CF3 ch3 ch3 H2C=CCOOC2H4NHCOOC2H4OC3H6SiO—(Si0)n-(‘0)m-(Si0)h—Si—C3H60C2H40C0NHC2H40C0C=CH2 III I I ch3 ch3 ch3 ch3 ch3 M3U著色:β銅酞菁於M3U中之分散液(重量%)。銅酞菁 可自 BASF 以 Heliogen Blue Κ7090 獲得。 N,N-DMF : DMF ; N,N-二甲基甲醯胺 NVP: 1-乙烯基-2-吡咯啶酮(在真空下新鮮蒸餾) PDMS :聚二甲基矽氧烷 PDMS-共-PEG:聚二甲基矽氧烷與PEG之嵌段共聚物, 其含有 75% PEG 且 MW 為 600(來自 Gelest 之 DBE712) PEG :聚乙二醇 PP :丙基丙烯 EGDMA :二曱基丙烯酸乙二醇酉旨 TEGDVE :三乙二醇二乙烯醚 TPTMA :三羥甲基丙烧三甲基丙烯酸酯 UV416:丙烯酸2-(4-苯甲醯基-3-羥基苯氧基)乙酯 ϋKruss DSA 100 appliance (Kruss GmbH, Hamburg) and as DA Brandreth: &quot;Dynamic contact angles and contact angle 121842.doc -44- 200817471 hysteresis'·, Journal of Colloid and Interface Science, Vol. 62, 1977, pp. 205- Pp. 212 and R. Knapikowski, Μ Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung", Chem. Technik, Vol. 45, 1993, pp. 179-185 and U.S. Patent No. 6,436,481 For example, the advancing contact angle and the receding contact angle can be determined using a trapping bubble method using a saline buffered saline (PBS; pH = 7_2). The glasses are plated on the quartz surface and rehydrated with PBS prior to testing. 1 minute. Use the automatic injection system to place the bubbles on the surface of the glasses. Increase and decrease the bubble size to obtain the receding angle (the platform is obtained when the bubble size is increased) and the advancing angle (the platform is obtained when the bubble size is reduced) Alternatively or additionally, the spectacles of the present invention may comprise a mirror body that exhibits a water dispel time (BUT) of greater than 5 seconds. In general, embodiments of the spectacles of the present invention comprising a mirror body having a water BUT of at least 15 seconds (such as 20 seconds or more) may have an ophthalmically acceptable surface wettability. The spectacles of the present invention generally comprise a modulus A lens body smaller than 丨·6 Mpa. The glasses are generally characterized by a modulus of between about 〇5 and about 1.5 mPa, preferably between 、6 and about 22 mPa. In one or more embodiments, the spectacles have a modulus between about 0.8 and about 0.1 MPa. For example, the mirror body can have a spoon. 2 MPa, MPa, i 〇Μ ρ^, 〇9 MPa, 〇8 Mpa, about 〇 / M ^ a, about 〇 · 6 MPa or about M · 5 Mpa modulus. Select the mirror body modulus to H ', the field is placed on the eyes when comfortable glasses and make the glasses wearer Adapting to the operation of the lens. 121842.doc -45- 200817471 The modulus of the mirror body can be determined using conventional methods known to those skilled in the art. For example, a contact lens having a width of about 4 mm is cut from the center portion of the lens. And the tensile modulus (unit: MPa) can be obtained by using Instron 3342 (Instron Corporation) at 25 ° C in air at least 75% humidity The initial slope of the stress-strain curve obtained by the tensile test at a rate of 10 mm/min was measured. The ion current of the lens body of the glasses of the present invention is typically less than about 5 x 1 〇 -3 mm 2 /min. While some of the spectacle lenses of the present invention may have an ion current of up to about 7 χ ι -3 mm 2 /min, the ion current is less than about 5 x 1 〇 -3 mm 2 /min, and when the contact lens does not include MPC, Reduce corneal dehydration staining. In certain embodiments, the ion current of the mirror body ranges from about 2 x 1 〇 _3 mm 2 /min to about 5 x 1 〇 3 mm 2 / min. For example, the ion current can be about 2xl〇·3 mm2/min, 2.5χ1 (Γ3 mm2/min, 3.〇xl (T3 mm2/min, 3·5χ10·3 mm2/min, 4·〇χ1〇· 3 mm2/min, 4·5χ1〇.3 mm2/min or about 5xl〇-3mm2/min. However, as described herein, the ion current can be greater than 7χ1〇-3 mm2/min, but still does not cause corneal dehydration staining or Other Bed Problems The ion current of the spectacle lens of the present invention can be determined using conventional methods known to those skilled in the art. For example, contact lenses or mirrors can be used substantially similar to U.S. Patent No. 5,849,811. The technique of Ionoflux Technique is described in the number. For example, the frog mirror to be measured is placed between the convex and concave portions of the device for retaining the glasses. The convex and concave portions include a flexible sealing ring between the spectacles and each of the convex or concave portions. After positioning the spectacles in the device for retaining the spectacles, 121842.doc -46-200817471 placing the device for retaining the spectacles on the threaded cover The cover is screwed onto the glass tube to define the material substance chamber. The material substance chamber can be filled 16 ml 0.1 molar NaCl solution. The receiving chamber can be filled with 80 ml of deionized water. The conductor of the conductivity meter is immersed in the deionized water of the receiving chamber and the stir bar is added to the receiving chamber. The chamber is placed in the incubator and 'the temperature is maintained at approximately 35 ° C. Finally, the material chamber is immersed in the chamber/room. 10 minutes after immersing the material chamber into the receiving chamber, each Conductivity measurement is performed every two minutes for about 20 minutes. The relationship between conductivity and enthalpy time should be substantially linear. The lens of the glasses of the present invention generally has high oxygen permeability. For example, the lens body has Dk is not less than 60 barrer oxygen permeability. Embodiments of the glasses of the present invention comprise Dk of about 80 barrer, about 90 barrer, about 100 barrer, about 110 barrer, about 120 barrer, about 130 barrer, about 140 barrer or more. The mirror body preferably has a Dk of from about 70 to about 110 barrer and more preferably from about 80 to 100 barrer. The Dk of the lens of the present invention can be determined using conventional methods generally known to those skilled in the art. In terms of The Dk value can be determined using the Mocon method as described in U.S. Patent No. 5,817,924. The Dk value can be determined using a commercially available apparatus of the model name Mocon Ox-Tran System. The glasses of the present invention are also acceptable for ophthalmology. The mirror body of the water content. For example, embodiments of the glasses of the present invention comprise a lens body having an equilibrium water content of not less than about 30%. In certain embodiments, the mirror body has an equilibrium water content ranging from about 40% by weight to about 60% by weight. For example, the spectacles provided herein can have an equilibrium water content of about 35%, about 40%, about 45%, about 50%, about 121842.doc -47 - 200817471 55%, about 60%, or even about 65%. . In one or more embodiments, the lens body has an equilibrium water content of from about 42 weights ❶/❶ to about 50% by weight. The water content of the lenses of the present invention can be determined using conventional methods generally known to those skilled in the art. For example, a water-cut oxygen hydrogel contact lens can be removed from an aqueous liquid, wiped to remove excess surface water, and weighed. The weighed glasses can then be dried in an oven under vacuum at 8 ° C, and the dried glasses can be weighed. The weight difference was determined by subtracting the dry eyeglass weight from the weight of the hydrated eyeglasses. The water content (%) is (weight difference / hydration weight) χ 100. The spectacles of the present invention may have values in the range between any combination of the specific values determined above, in addition to the specific values identified above. For example, the contact lenses of the present invention can have a water content of from about 42% to about 50%, an ion current value of from about 3 to about 5 (xl - 3 mm2/min), of about 52. To about 62. Before entering the contact angle, about 4 inches. Up to about 6 baht. Then retreat the contact angle, about $. To a hysteresis of about 15, a Young's modulus (Y〇ung, s moduli) of about 0.6 MPa to about 1.2 MPa, an elongation of at least about ι〇〇%, and combinations thereof. In certain embodiments, the elongation is from about 100 angstroms per metre to about 300%. As discussed herein, the spectacles of the present invention have the desire and characteristics to allow for the wear of the spectacles. For example, the spectacles of the present invention can be worn as wearing glasses every day, wearing glasses every week, wearing bi-weekly glasses, or wearing glasses every month. The spectacles of the present invention comprise a hydrated mirror body having surface wettability, modulus, ion current, oxygen permeability and water content which contribute to the comfort and usability of the lens. 0 121842.doc -48- 200817471 The hydrogel invisible eyepiece is a contact lens that corrects vision and has strong vision. The glasses can be spherical or aspherical. The glasses can be single focus or multifocal glasses, including bifocals. In certain embodiments, the spectacles of the present invention are rotationally stable spectacles, such as rotationally stable toric contact lenses. The rotationally stable contact lens can be a contact lens comprising a lens body comprising a ballast. For example, the mirror body can have a ballast, a surrounding ballast, and/or one or more thinned upper and lower regions. The spectacles of the present invention also include a scope comprising a peripheral edge region. The outer peripheral edge region may include a circular portion. For example, the peripheral edge region can comprise a rounded trailing edge surface, a rounded leading edge surface, or a combination thereof. In some embodiments, the peripheral edge is completely rounded from the front surface to the back surface. Thus, it will be appreciated that the lens body of the eyeglasses of the present invention can comprise a rounded peripheral edge. The spectacles of the present invention may comprise a lens body whose thickness distribution solves the problems associated with prior oxyhydrogel contact lenses but is still comfortable for the wearer of the eyewear. The hardness of the mirror body can be controlled by changing the thickness of the mirror body and the modulus of the mirror body. For example, a, the hardness of one of the areas of the contact lens can be defined as the product of the Young's modulus of the lens and the square of the thickness of the specified area. Thus, certain embodiments of the spectacles of the present invention may comprise a mirror having a central hardness (e.g., the center of the eyeglass or the center of the viewing zone) of less than about 0.007 MPa-mm2, a lens joint hardness of less than about 〇〇3 MPa-mm, or a combination thereof. body. The eyeglass joint can be defined as the junction of the eyeglass area and the bevel or (for non-beveled glasses) a point of about 12 mm from the edge of the eyeglass (see U.S. Patent No. 6,849,671). In other embodiments, the spectacles of the present invention may comprise a lens body having a center hardness greater than 〇·0〇7 MPa_mm2, a lens joint hardness greater than about 〇·〇3 MPa-mm2, or a combination thereof. 121842.doc -49- 200817471 The Shixi oxygen hydrogel contact lens of the present invention can be provided in a sealed bag. For example, the Dimensional (4-) shaped eyeglasses of the present invention may be provided in an aqueous solution, such as a physiological saline solution, stored in a package in a 2 package or other similar container suitable for delivery to a lens wearer. Suitable/liquid mixture includes ^4 acid salt buffered physiological saline solution and acid salt buffer solution. If necessary, the solution may include a disinfectant or may be free of disinfectant or preservative: If necessary, the solution may also include a surfactant such as poloxamer and the like.眼镜 The glasses in the sealed package are preferably sterile. For example, the spectacles can be sterilized prior to sealing the package or can be sterilized in a sealed package. The sterilized spectacles can be glasses that are exposed to the bactericidal amount of radiation. For example, the glasses may be autoclaved glasses, gamma irradiated glasses, ultraviolet radiation exposed lenses, and the like. The present invention is not limited to the specific embodiments described below. The spears are not otherwise exemplified. Otherwise, the practice of the present invention will be fully described in the literature using techniques such as polymer synthesis, hydrogel formation, and the like in this technical skill. Reagents and materials are commercially available unless specifically stated to the contrary. Methods for preparing open spectacles (e.g., neohydrogenated hydrogel contact lenses) are further described in the following patents: U.S. Patent No. (2), State No., No. 4,495,313, No. 4,565,348, No. 4,640,489, No. 4,889,664, No. 985'186 5 Tiger, 帛5, 〇39,459, 帛5,080,839, 121842.doc •50-200817471 5,094,609, 5,260,000, 5,607,518, 5,760,100, 5,850,107, 5,935,492 No. 6,099,852, 6,367,929, 6,822,016, 6,867,245, 6,869,549, 6,939,487, and U.S. Patent Publication Nos. 20030125498, 20050154080, and '20050191335. • In the following examples, Efforts have been made to ensure accuracy with respect to the numbers used (eg, volume, temperature, etc.), but some experimental errors and partial () differences should still be resolved. Unless otherwise noted, the temperature is in C and the pressure is at sea level. Atmospheric pressure or near atmospheric pressure. The following well-known chemical substances are mentioned in the examples, and in some cases, the abbreviations are as follows References. Abbreviations for Substance and Method ΑΕ : Allyloxyethanol DI: Deionized Hydrazine: Ethyl Methacrylate M3U: M3-U; α-ω-Bis(Methethyloxy Ethyl Ethyl Carboxyl • ethoxypropyl)·poly(dimethyloxane)_poly(trifluoropropylindenyl oxane) _ poly(ω-methoxy-poly(ethylene glycol) propylmethyl矽 烷 ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 8〇〇, aMw=i6 2〇〇(Asahikasei Aime Co., Ltd.? Japan) 〇121842.doc -51- 200817471 〒3H6(OC2H4)pOCH3 ch3 ch3 ch3 C2H4CF3 ch3 ch3 H2C=CCOOC2H4NHCOOC2H4OC3H6SiO—(Si0)n- ('0)m-(Si0)h-Si-C3H60C2H40C0NHC2H40C0C=CH2 III II ch3 ch3 ch3 ch3 ch3 M3U coloring: dispersion of β copper phthalocyanine in M3U (% by weight). Copper phthalocyanine available from BASF as Heliogen Blue Κ7090 obtained. N,N-DMF : DMF ; N,N-dimethylformamide NVP: 1-vinyl-2-pyrrolidone (fresh distillation under vacuum) PDMS : polydimethyl methoxy hydride PDMS-total - PEG: block copolymer of polydimethylsiloxane and PEG, which contains 75% PEG and MW 600 (DBE712 from Gelest) PEG: polyethylene glycol PP: propyl propylene EGDMA: dimercapto acrylate B Glycol TETEGDVE: Triethylene glycol divinyl ether TPTMA: Trimethylolpropane trimethacrylate UV416: 2-(4-Benzylmercapto-3-hydroxyphenoxy)ethyl acrylate

Vazo-64 :偶氮二異丁腈(V-64 ;熱引發劑) VMA : N·乙烯基-N-曱基乙醯胺(在真空下新鮮蒸餾) VM :甲基丙烯酸乙烯酯 表徵眼鏡產物之方法 前進接觸角/後退接觸角可使用一般熟習此項技術者已 知之常規方法測定前進接觸角。舉例而言,可使用習知液 滴形狀法(諸如固著液滴法或俘獲氣泡法)來量測本文所提 供之隱形眼鏡之前進接觸角及後退接觸角。矽氧水凝膠隱 121842.doc -52- 200817471 形眼鏡之前進及後退水接觸角可使用Knxss DSA 100器具 (Kruss GmbH,Hamburg)且如 D. A. Brandreth: &quot;Dynamic contact angles and contact angle hysteresis’’,Journal of Colloid and Interface Science,第 62卷,1977,第 205-212 頁及 R. Knapikowski,M. Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur • Fehierbeurteilung’’,Chem. Technik,第 45 卷,1993,第 179-185頁及美國專利第6,436,481號中所述來測定。 〇 例如,前進接觸角及後退接觸角可使用俘獲氣泡法使用 磷酸鹽緩衝生理食鹽水(PBS ; ρΗ=7·2)來測定。使眼鏡平 鋪在石英表面上且在測試之前用PBS再水合1〇分鐘。使用 自動注射系統將氣泡置放於眼鏡表面上。可增加及減小氣 泡大小以獲得後退角(當增加氣泡大小時獲得平臺)及前進 角(當減小氣泡大小時獲得平臺)。 模數可使用一般熟習此項技術者已知之常規方法測定鏡 體之模數。舉例而言,寬度約4 mm之隱形眼鏡片可自眼鏡 〇 中心部分切割,且拉伸模數(單位:MPa)可自藉由使用 Instron 3342(Instron Corporation)在 25°C 下在至少 75%濕度 . 之空氣中以1 〇 mm/min之速率進行拉伸測試所獲得之應力 應變曲線的初始斜率來測定。 離子流本發明之眼鏡之鏡體的離子流可使用一般熟習此 項技術者已知之常規方法來測定。舉例而言,隱形眼鏡或 鏡體之離子流可使用實質上類似於美國專利第5,849,811號 中所述之’’Ionoflux Technique”的技術來量測。舉例而言, 121842.doc -53- 200817471 待量測之眼鏡可置放在保留眼鏡之裝置中的凸形與凹形部 分之間。凸形及凹形部分包括位於眼鏡與各凸形或凹形部 分之間的可撓性密封環。在將眼鏡定位於保留眼鏡之裝置 中之後,將保留眼鏡之裝置置放於帶螺紋之蓋中。將蓋擰 至玻璃管上以界定原料物質腔室。原料物質腔室中可填充 有16 ml 0.1莫耳濃度之NaC丨溶液。接收腔室可填充有肋 ml去離子水。將電導計之導線浸入接收腔室之去離子水 中,且將攪拌棒添加至接收腔室中。將接收腔室置放在恆 溫箱中,且將溫度保持在約35。〇。最後,將原料物質腔室 浸入接收腔室中。可在將原料物質腔室浸入接收腔室後1〇 分鐘開始,每隔兩分鐘進行電導率之量測,歷時約2〇分 鐘。電導率與時間之關係資料應實質上呈線性。 透氧性可使用一般熟習此項技術者已知之常規方法來測 定本發明之眼鏡之Dk。舉例而言,Dk值可使用如美國專 利第5,817,924號中所述之Mocon方法來測定。Dk值可使用 型號名稱為Mocon Ox-Tran System之市售器具來測定。 平衡水含量可使用一般熟習此項技術者已知之常規方法 來測定本發明之眼鏡之水含量。舉例而言,水合石夕氧水凝 膠隱形眼鏡可自水性液體中移除,擦拭以移除過量表面 水,且稱重。接著可將經稱重之眼鏡在烘箱中於8〇它真空 中乾燥’且接著可稱重經乾燥之眼鏡。藉由自水合眼鏡重 量減去乾燥眼鏡重量來測定重量差。水含量(%)為(重量差/ 水合重量)χ100。 實例1 121842.doc -54- 200817471 可聚合發氧水凝膠隱形眼鏡前驅趙組合物之製備 使用以下指定之試劑及相對量來製備可聚合⑦氧水凝膠 隱形眼鏡前驅體組合物。此調 乃配物在本文稱為,,ΗΜ調配 物,,。Vazo-64: azobisisobutyronitrile (V-64; thermal initiator) VMA: N·vinyl-N-mercaptoacetamide (fresh distillation under vacuum) VM: vinyl methacrylate characterization of lens products Method of Advancing Contact Angle/Retraction Contact Angle The advancing contact angle can be determined using conventional methods generally known to those skilled in the art. For example, a conventional droplet shape method such as a sessile drop method or a trapping bubble method can be used to measure the contact angle and the receding contact angle of the contact lens provided herein. Hydrogenated hydrogel hidden 121842.doc -52- 200817471 The front and back water contact angles of the glasses can be used with Knxss DSA 100 appliances (Kruss GmbH, Hamburg) and such as DA Brandreth: &quot;Dynamic contact angles and contact angle hysteresis'' , Journal of Colloid and Interface Science, Vol. 62, 1977, pp. 205-212 and R. Knapikowski, M. Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur • Fehierbeurteilung'', Chem. Technik, 45th Measured as described in Vol., 1993, pp. 179-185 and U.S. Patent No. 6,436,481. 〇 For example, the advancing contact angle and the receding contact angle can be measured using a trapped bubble method using phosphate buffered saline (PBS; ρΗ = 7.2). The lenses were spread on a quartz surface and rehydrated with PBS for 1 minute before testing. The bubble is placed on the surface of the lens using an automatic injection system. The bubble size can be increased and decreased to obtain a receding angle (a platform is obtained when the bubble size is increased) and an advancing angle (a platform is obtained when the bubble size is reduced). The modulus can be determined using conventional methods known to those skilled in the art to determine the modulus of the lens. For example, a contact lens having a width of about 4 mm can be cut from the center portion of the eyeglass, and the tensile modulus (in MPa) can be at least 75% at 25 ° C by using Instron 3342 (Instron Corporation). Humidity. The initial slope of the stress-strain curve obtained by tensile testing at a rate of 1 〇 mm/min was measured. Ion Current The ion current of the lens body of the glasses of the present invention can be determined using conventional methods known to those skilled in the art. For example, the ion current of the contact lens or lens body can be measured using a technique substantially similar to the ''Ionoflux Technique' described in U.S. Patent No. 5,849,811. For example, 121842.doc -53-200817471 The spectacles can be placed between the convex and concave portions of the device that retains the spectacles. The male and female portions include a flexible sealing ring between the spectacles and each of the convex or concave portions. After positioning the glasses in the device for retaining the glasses, place the device that retains the glasses in the threaded cover. Screw the cover onto the glass tube to define the material chamber. The material chamber can be filled with 16 ml 0.1 Moer concentration of NaC solution. The receiving chamber can be filled with ribbed ml of deionized water. The wire of the conductivity meter is immersed in the deionized water of the receiving chamber, and the stir bar is added to the receiving chamber. Place in the incubator and maintain the temperature at about 35. Finally, the material chamber is immersed in the receiving chamber. It can be started every two minutes after immersing the material chamber in the receiving chamber for 1 minute. Carry out electricity The measurement of the rate takes about 2 minutes. The relationship between conductivity and time should be substantially linear. Oxygen permeability can be determined using conventional methods known to those skilled in the art to determine the Dk of the glasses of the present invention. The Dk value can be determined using the Mocon method as described in U.S. Patent No. 5,817,924. The Dk value can be determined using a commercially available instrument of the model name Mocon Ox-Tran System. The equilibrium water content can be used generally in the art. Conventional methods are known for determining the water content of the lenses of the present invention. For example, a hydrated oxalate hydrogel contact lens can be removed from an aqueous liquid, wiped to remove excess surface water, and weighed. The weighed glasses are dried in an oven at 8 Torr in vacuum and then the dried glasses can be weighed. The weight difference is determined by subtracting the weight of the dry spectacles from the weight of the hydrated spectacles. The water content (%) is ( Weight difference / hydration weight) χ 100. Example 1 121842.doc -54- 200817471 Preparation of polymerizable oxygenated hydrogel contact lens precursor composition Zhao using the reagents and relative amounts specified below ⑦ The polymerizable hydrogel contact lens precursor composition. This adjustment is referred to herein is the composition with the formulation ,, ,, ΗΜ.

表1Table 1

總計 稱重表1中之組份且混合以形成混合物。經由〇.2_2〇〇微 米注射過濾器將混合物過濾至瓶中,且儲存長達約2週。 Ο (此混合物在本文稱為可聚合矽氧水凝膠隱形眼鏡前驅體 組合物)。在表1中,除各自重量百分比(以重量/重量表 示;重量比)以外,提供單位量之各化合物。由於各組份 之相對份總計高達接近100之總數,因此在此情況下,各 組份之重量百分比與相對份基本上相同。可聚合組合物中 ΜΜΑ與VMA之比率為〇·36:1。 實例2 矽氧水凝膠隱形眼鏡之製造 使用重複真空/氮沖洗程序使來自實例1之大量前驅體組 合物脫氣。接著將經脫氣之前驅體組合物置放至凹形非極 121842.doc -55- 200817471 性樹脂模具構件中。接著藉由在達成緊密配合所需之壓力 下與非極性樹脂凸形模具構件接觸置放來封閉經填充之凹 形模具構件。接著在氮批料烘箱中以如下循環進行固化: 室溫下30 mm Ν2淨化,65°C下60 min及100°C下30 min。藉 由敲擊隱形眼鏡模具之凹形模具構件進行脫模,以使得凸 形杈具構件自其釋放,其中聚合矽氧水凝膠隱形眼鏡產物 黏附於凸形模具構件。藉由浮離法或使用機械脫鏡設備進 行脫鏡。浮離法包括將含有乾燥眼鏡之凸形模具構件浸泡Total The components in Table 1 were weighed and mixed to form a mixture. The mixture was filtered into a vial via a 2.2_2 〇〇 microinjection filter and stored for up to about 2 weeks. Ο (This mixture is referred to herein as a polymerizable silicone hydrogel contact lens precursor composition). In Table 1, each unit amount of each compound is provided in addition to the respective weight percentages (expressed by weight/weight; weight ratio). Since the relative shares of the components total up to a total of nearly 100, in this case, the weight percentages of the components are substantially the same as the relative components. The ratio of hydrazine to VMA in the polymerizable composition is 〇·36:1. Example 2 Manufacture of a Hydroxyl Hydrogel Contact Lens A large number of precursor compositions from Example 1 were degassed using a repeated vacuum/nitrogen rinse procedure. The degassed precursor composition was then placed in a concave non-polar 121842.doc -55-200817471 resin mold member. The filled female mold member is then closed by contact with a non-polar resin male mold member under the pressure required to achieve a tight fit. The curing was then carried out in a nitrogen batch oven in the following cycle: 30 mm Ν2 purification at room temperature, 60 min at 65 °C and 30 min at 100 °C. The demolding is performed by tapping the concave mold member of the contact lens mold such that the convex cookware member is released therefrom, wherein the polymeric oxygenated hydrogel contact lens product adheres to the male mold member. The mirror is removed by floatation or using a mechanical lens removal device. The floatation method involves soaking a convex mold member containing dry glasses

Ο 於一桶水中。眼鏡通常在約1〇分鐘.内離開模具。藉由壓縮 及方疋轉t合石夕氧水凝膠隱形眼鏡產物黏附至其之凸形模具 構件,引導氣體介於隱形眼鏡產物與旋轉凸形模具構件之 間且對隐形眼鏡產物之暴露表面施加真空來進行機械脫 鏡。接著將經分離之眼鏡負載至塑料盤上以進行萃取及水 合〇 於室溫下,將含有聚合矽氧水凝膠隱形眼鏡產物之眼鏡 盤浸入溶劑液體(諸如含有95%乙醇及5%甲醇之工業甲基 化酒精(IMS))中歷時45 min。接著排幻容劑且用新鮮祕 代替,且用IMS(3次)、1:1醇/水(1#)ADI水(3次)重複該方 法0 將水合眼鏡儲存於含㈣水之玻璃小瓶或發泡包裝中或 儲存於pH為7.1-7.5之磷酸鹽緩衝生理食鹽水中。在12汔 下將密封容器高壓釜處理3〇 min。在高壓釜處理Μ h後, 進行眼鏡量測。稱重所得水切氧水凝膠隱形眼鏡,且接 著在烘箱巾脫水,且再錢重㈣定經脫水切氧水凝膠 121842.doc •56· 200817471 隱形眼鏡之乾重。 如本文所述,測定眼鏡特性,諸如接觸角(包括動態接 觸角及靜態接觸角)、透氧性、離子流、模數、伸長率、 拉伸強度、水含量及其類似特性。水合矽氧水凝膠隱形眼 鏡之可濕性亦藉由量測眼鏡之水驅散時間來檢測。 在分配研究期間,進一步檢測眼睛相容性,其中將隱形 眼鏡置放於人眼上歷時丨小時、3小時或6小時或更長時 間,且接著進行臨床評估。 由本發明之調配物所產生之矽氧水凝膠隱形眼鏡具有眼 用可接受之表面可濕性。該等矽氧水凝膠隱形眼鏡具有 44-47%之平衡水濃度(Ewc),且經測定具有約26%(重量 比)之可萃取物含量。 所得水合隱形眼鏡具有以下特性: 表2 特性--— 1 &quot;P t * πτ &quot;&quot; - 「值 — 1平衡水含量(EWC) 45-47% ~ 氧性(Dk) —- 91 barrer 靜態接觸角(俘獲氣泡濕潤角) 36-38° 動態接觸角(前進接觸角) 58° 動態接觸角(後退接觸角) 50° 滯後(刚進-後退) 8° 折射率 1.40 ¥子流_ -- 3 -4 0.8-1 ·0 MPa 拉伸強度 1 - - - , 一 〇·6_0·7 MPa 熟習本發明所屬領域之技術者將瞭解,本發明之多種修 改及其他實施例具有前述描述中呈現之教示的益處。因 此,應瞭解本發明不限於本文所揭示之特定實施例,如藉 121842.doc -57- 200817471 助於實例所呈現之該望眷A y丨 但應理解前述實施方1 雖然論述例示性實施例, 二替代及等效物,如其他揭示案所定義可屬於本:= 内。雖然本文採用特定術語,但其僅以通用及 描述性意義使用且非限制目的。 、用及 已在上文引用大量公閱垒 碣案及專利。所引用之公開案及專 利各自以全文引用的方式併入本文中。 【圖式簡單說明】 Γ) 囷為次明產生矽氧水凝膠隱形眼鏡之例示性方法的方 塊圖。 圖2為說明本發明之組合物、眼鏡產物及隱形眼鏡的方 塊圖。 【主要元件符號說明】 102 置放 104 封閉 106 固化 108 脫模 110 脫鏡 112 萃取 114 水合 116 封裝 118 密封及殺菌 202 可聚合矽氧水凝膠眼鏡前驅體組 合物 Ο 121842.doc -58- 200817471 204 預萃取之聚合矽氧水凝膠隱形眼 鏡產物 206 經萃取之矽氧水凝膠隱形眼鏡產物 208 水合矽氧水凝膠隱形眼鏡Ο In a bucket of water. The glasses usually leave the mold within about 1 minute. The gas is interposed between the contact lens product and the rotating male mold member and the exposed surface of the contact lens product by compressing and rotating the conjugated talc hydrogel contact lens product to its convex mold member. A vacuum is applied to perform mechanical removal. The separated glasses are then loaded onto a plastic tray for extraction and hydration at room temperature, and the spectacle disk containing the polymerized hydrogel contact lens product is immersed in a solvent liquid (such as 95% ethanol and 5% methanol). Industrial methylated alcohol (IMS) lasted 45 minutes. Then line up the magic agent and replace it with fresh secret, and repeat the method with IMS (3 times), 1:1 alcohol/water (1#) ADI water (3 times). Store the hydrated glasses in a glass vial containing (4) water. Or in a foamed package or stored in phosphate buffered saline at pH 7.1-7.5. The sealed vessel autoclave was treated at 12 Torr for 3 Torr. After the autoclave treatment Μ h, the glasses were measured. The obtained water-cut oxygen hydrogel contact lenses were weighed, and then dehydrated in an oven towel, and the weight was again (4) Dehydrated oxygenated hydrogel 121842.doc • 56· 200817471 The dry weight of the contact lens. Spectacle characteristics such as contact angle (including dynamic contact angle and static contact angle), oxygen permeability, ion current, modulus, elongation, tensile strength, water content, and the like are measured as described herein. The wettability of the hydrated hydrogel hydrogel is also detected by measuring the water dispersing time of the glasses. Eye compatibility was further tested during the dispensing study, where the contact lenses were placed on the human eye for hours, 3 hours or 6 hours or longer, and then clinical evaluation was performed. The oxygenated hydrogel contact lenses produced by the formulations of the present invention have an ophthalmically acceptable surface wettability. The hydroxyl hydrogel contact lenses have an equilibrium water concentration (Ewc) of 44-47% and have been determined to have an extractables content of about 26% by weight. The resulting hydrated contact lens has the following characteristics: Table 2 Characteristics - 1 &quot;P t * πτ &quot;&quot; - "Value - 1 equilibrium water content (EWC) 45-47% ~ Oxygen (Dk) - 91 barrer Static contact angle (capture bubble wetting angle) 36-38° Dynamic contact angle (forward contact angle) 58° Dynamic contact angle (reverse contact angle) 50° Hysteresis (forward-reverse) 8° Refractive index 1.40 ¥Substream _ - - 3 -4 0.8-1 · 0 MPa Tensile Strength 1 - - - , 〇·6_0·7 MPa Those skilled in the art to which the present invention pertains will appreciate that various modifications and other embodiments of the present invention are presented in the foregoing description. The benefit of the teachings. Accordingly, it is to be understood that the invention is not limited to the specific embodiments disclosed herein, such as the teachings of FIG. The exemplified embodiments, the two alternatives and the equivalents, as defined by the other disclosures, may be within the meaning of: =. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not limiting. Has cited a large number of public shackles The publications and patents cited are hereby incorporated by reference in their entirety in their entirety in their entirety in the entirety the the the the the the the the the the the the the the the the The block diagram of the composition, the lens product and the contact lens of the present invention. [Main component symbol description] 102 Placement 104 Closure 106 Curing 108 Stripping 110 Mirror 112 Extraction 114 Hydration 116 Package 118 Sealing and Sterilization 202 Polymerizable 矽Oxygen hydrogel glasses precursor composition Ο 121842.doc -58- 200817471 204 Pre-extracted polymeric oxime hydrogel contact lens product 206 Extracted oxime hydrogel contact lens product 208 Hydrated oxime hydrogel invisible glasses

U 121842.doc -59-U 121842.doc -59-

Claims (1)

200817471 十、申請專利範圍: 〜&quot;聚σ組合物,其包含α-ω-雙(甲基丙烯醯氧基乙基 亞胺基敌基乙氧基丙基)一聚(二甲基石夕氧补聚(三氣丙基 一夕氧烷)_聚(ω_甲氧基_聚(乙二醇)丙基甲基矽氧 烷)Ν乙烯基*甲基乙醯胺、甲基丙烯酸甲酯、二甲 基丙烯酸乙二醇酯、烯丙氧基醇及自由基引發劑。 - 月求項1之可聚合組合物,其進一步包含紫外線吸收 劑、著色劑或其組合。 (, 月求員2之可聚合組合物,其中該紫外線吸收劑為2-羥 基-4-丙稀醯氧基乙氧基二苯甲酮。 4·如明求項2之可聚合組合物,其中該著色劑為酞菁顏 料。 5·如明求項4之可聚合組合物,其中該著色劑為酞菁藍。 6.如明求項1之可聚合組合物,其中該自由基引發劑為2,2,_ 偶氮二異丁腈。 η 7·如請求項1至6中任一項之可聚合組合物,其包含約34重 ^ ® %之α_ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙 基兴聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷聚(〇)_甲 氧基-聚(乙二醇)丙基甲基矽氧烧)。 8·如請求項1至7中任一項之可聚合組合物,其包含約牝重 量%之&gt;1-乙烯基-Ν·曱基乙醯胺。 9.如请求項1至6中任一項之可聚合組合物,其包含約丨7重 量%之甲基丙烯酸甲酯。 10·如請求項1至6中任一項之可聚合組合物,其包含約〇·5重 121842.doc 200817471 量%之' Ψ jj: τ丞丙烯酸乙二醇酯。 月求項1至6中任一項之可聚合組合物,其包含約1重 量%之烯丙氧基醇。 /、 ,、之可聚合組合物,其包含約0.9重量%之2-經 基丙烯醯氧基乙氧基二苯甲酮。 ,項5之可聚合組合物,其包含約0 · 1重量%之酜菁 藍。 Ο u 如明求項1之可聚合組合物,其包含約0.3重量%之自由 基引發劑。 15· 士喷求項1之可聚合組合物,其包含約34重量%2α_ω_雙 (甲土丙烯醯氧基乙基亞胺基緩基乙氧基丙基)_聚(二甲 土夕氧烷 &gt; 聚(二氟丙基甲基矽氧烷)_聚(ω-甲氧基-聚(乙 醇)丙基甲基石夕氧烧)、約46重量❶/〇之Ν-乙烯基甲基 乙醯fe約17重量〇/〇之甲基丙烯酸甲酯、約〇·5重量%之 甲基丙烯酸乙二醇酯、約丨重量%之烯丙氧基醇、約 0.9重量%之基_4一丙稀醯氧基乙氧基二苯甲酮 '約 0.1重里%之酞菁藍及約0 3重量%之2,2,_偶氮二異丁腈。 16·如晴求項1之可聚合組合物,其中不存在聚氧化稀石夕氧 可萃取組份。 17. —種矽氧水凝膠隱形眼鏡,其係由如丨至16中任一項之 可聚合組合物而產生。 18. —種矽氧水凝膠隱形眼鏡,其係由如請求項丨至丨了中任 一項之組合物而形成,其實質上無可萃取組份。 19. 一種矽氧水凝膠隱形眼鏡,其包含如請求項丨至“中任 121842.doc 200817471 一項之組合物的反應產物。 20. —種矽氧水凝膠隱形眼鏡,其係藉由以下步驟而產生: 聚合如請求項1至16中任一項之可聚合組合物以形成包 含可萃取組份之預萃取聚合矽氧水凝膠隱形眼鏡,自該 預萃取之隱形眼鏡萃取該可萃取組份以形成經萃取之聚 # 合眼鏡產物,且水合該經萃取之聚合眼鏡產物以形成矽 •氧水凝膠隱形眼鏡。 21. 如請求項20之矽氧水凝膠隱形眼鏡,其具有在約42重量 〇 %至約50重量%之範圍内的平衡水含量及在約8 (Μιο barrer之範圍内的透氧性(Dj^xio·11)。 22·如請求項20或21之矽氧水凝膠隱形眼鏡,其具有約〇.6至 約1.2 MPa之模數。 23.如請求項20之矽氧水凝膠隱形眼鏡,其中該聚合包含將 该可聚合組合物加熱至大於約5 5之溫度。 24· —種矽氧水凝膠隱形眼鏡,其具有在約42重量%至約5〇 重量%之範圍内的平衡水含量、在約80-100 barrei^S 圍内的透氧性(DkXlO·11)、約〇·6至約12 Mpa之模數、約 2_5(xl0·3 mm2/min)之離子流、約π。至約62。之前進接觸 角、約40至60。之後退接觸角及約5。至約15。之滯後。 25·如請求項18至24中任一項之矽氧水凝膠隱形眼鏡,其中 該鏡體包含圓形外周邊緣。 26·如請求項18至24中任一項之矽氧水凝膠隱形眼鏡,其係 選自由以下各物組成之群:⑴球面眼鏡、(ii)非球面眼 鏡、(111)單焦點眼鏡、(iv)多焦點眼鏡及(v)旋轉穩定複 121842.doc 200817471 曲面隱形眼鏡。 27·如請求項18至26中任一項之矽氧水凝膠隱形眼鏡,其係 在密封包裝中。 ^ 28· —種未經表面處理之如請求項18至27中任一項之矽氧水 凝膠隱形眼鏡。 29. —種產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物之方 法,該方法包含:組合α-ω-雙(甲基丙烯醯氧基乙基亞胺 基緩基乙氧基丙基)-聚(二甲基石夕氧燒)_聚(三氟丙基甲基 矽氧烷聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷卜… 乙烯基-Ν·曱基乙醯胺、甲基丙烯酸甲酯、二甲基丙烯酸 乙一醇自曰、烯丙氧基醇及自由基引發劑,以藉此產生可 聚合矽氧水凝膠隱形眼鏡前驅體組合物。 3 0·如請求項29之方法,在該組合步驟中進一步包含紫外線 吸收劑。 31·如請求項29或30之方法,在該組合步驟中進一步包含著 色劑。 32·如請求項30之方法,其中該紫外線吸收劑為2_羥基_4_丙 烯醯氧基乙氧基二苯甲酮。 33·如請求項31之方法,其中該著色劑為酞菁顏料。 34·如請求項33之方法,其中該酞菁顏料為酞菁藍。 35_如請求項29至34中任一項之方法,其中該自由基引發劑 為2,2’-偶氮二異丁腈。 3 6·如請求項29之方法,其中該組合步驟包含組合: (1)約3 0-40重量•…雙(甲基丙烯醯氧基乙基亞胺 121842.doc 200817471 基羧基乙氧基丙基)-聚(二曱基矽氧烷)-聚(三氟丙基甲基 矽氧烷)-聚(ω-曱氧基-聚(乙二醇)丙基甲基矽氧烷), (ii) 約40-50重量%之Ν-乙烯基-Ν-甲基乙醯胺, (iii) 約10-25重量%之曱基丙烯酸甲酯,及 (iv) 小於約5重量。/◦之二曱基丙烯酸乙二醇酯、烯丙氧 基醇、2-羥基-4-丙烯醯氧基乙氧基二苯曱酮、酞菁藍與 2,2f-偶氮二異丁腈之組合。 3 7_如請求項36之方法,其中該組合步驟包含組合約34重量 %之心〇〇-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙 基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)_聚(仍·甲 氧基-聚(乙一醇)丙基曱基石夕氧烧)、約46重量%之义乙烯 基-N-甲基乙醯胺、約1 7重量%之甲基丙烯酸甲酯、約 0_5重量%之二甲基丙烯酸乙二醇酯、約i重量%之烯丙氧 基醇、約〇.9重量%之2_羥基丙烯醯氧基乙氧基二苯甲 酮、約〇·1重量%之酞菁藍及約〇·3重量%之2,2,-偶氮二異 丁腈。 38·如請求項29至37中任一項之方法,其進一步包含聚合該 可聚合之眼鏡前驅體組合物以形成預萃取之聚合矽氧水 凝膠隱形眼鏡。 39. 如請求項38之方法’其中該聚合步驟包含加熱該可聚合 之眼鏡前驅體組合物。 40. 如請求項38之方法,盆逢一半—人丄u 、 八進步包含在該聚合之前將該可 聚合之眼鏡前驅體组合物署放+人, 瓶、丑口物置放於非極性樹脂隱形眼鏡模 具中。 、 121842.doc 200817471 41·如請求項4〇之方法,其進一步包含萃取該預萃取之聚合 隱形眼鏡以形成實質上不存在可萃取組份之經萃取之聚 合眼鏡產物’且水合該經萃取之聚合眼鏡產物以形成矽 氧水凝膠隱形眼鏡。 42· 一種石夕氧水凝膠隱形眼鏡,其包含如請求項1至17中任 一項之可聚合組合物的反應產物,其實質上無可萃取組 份0 Ο 121842.doc200817471 X. Patent application scope: ~&quot;Poly-sigma composition, which contains α-ω-bis(methacryloxyethylethylenimine-based ethoxypropyl)-poly(dimethyl oxime Oxygen polycondensation (trimethyl propyl oxane) _ poly (ω_methoxy-poly (ethylene glycol) propyl methyl oxirane) Ν vinyl * methyl acetamide, methacrylic acid The ester, the ethylene glycol dimethacrylate, the allyloxy alcohol, and the radical initiator. The polymerizable composition of the above item 1, which further comprises a UV absorber, a colorant or a combination thereof. The polymerizable composition of claim 2, wherein the ultraviolet absorber is 2-hydroxy-4-propyl decyloxy ethoxybenzophenone. The polymerizable composition of claim 2, wherein the colorant The polymerizable composition of the invention, wherein the coloring agent is phthalocyanine blue. 6. The polymerizable composition according to claim 1, wherein the radical initiator is 2, 2 _ azobisisobutyronitrile. η 7. The polymerizable composition according to any one of claims 1 to 6, which comprises about 34% by weight of α_ω-bis(methacryl oxime) Ethylethylimidocarboxyethoxypropyl poly(dimethyloxane)-poly(trifluoropropylmethyloxirane poly(indenyl)-methoxy-poly(ethylene glycol) The polymerizable composition according to any one of claims 1 to 7, which comprises about 1% by weight of &gt; 1-vinyl-indole mercaptoacetamide. The polymerizable composition according to any one of claims 1 to 6, which comprises about 7% by weight of methyl methacrylate. The polymerizable composition according to any one of claims 1 to 6, which comprises约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约 约a polymerizable composition comprising: about 0.9% by weight of 2-perylene propylene oxyethoxy benzophenone. The polymerizable composition of item 5, which comprises about 0. 1% by weight of phthalocyanine blue. The polymerizable composition of claim 1, which comprises about 0.3% by weight of a free radical initiator. 15. The polymerizable composition of claim 1 comprising about 3 4% by weight 2α_ω_ bis (methane propylene oxyethyl imino yl ethoxy propyl) _ poly (xymethane) &gt; poly(difluoropropylmethyl decane) _ Poly(ω-methoxy-poly(ethanol) propylmethyl oxime), about 46% ❶/〇 Ν-vinylmethyl hydrazine fe about 17 weight 〇 / 〇 methyl methacrylate , about 5% by weight of ethylene glycol methacrylate, about 9% by weight of allyloxy alcohol, about 0.9% by weight of _4 propylene oxy oxy benzophenone 0.1% by weight of phthalocyanine blue and about 0.3% by weight of 2,2,-azobisisobutyronitrile. 16. The polymerizable composition of claim 1, wherein the polyoxohydrate oxygen extractable component is absent. 17. A hydroxyl hydrogel contact lens produced by the polymerizable composition of any one of 丨 to 16. 18. An oxygenated hydrogel contact lens formed by the composition of any one of the preceding claims, which is substantially free of extractable components. 19. A helium-oxygen hydrogel contact lens comprising the reaction product of the composition of any one of the items of 121842.doc 200817471, as claimed in claim 1. 20. A hydroxyl hydrogel contact lens by The following steps are: polymerizing the polymerizable composition of any one of claims 1 to 16 to form a pre-extracted polymeric hydrogel contact lens comprising an extractable component, extractable from the pre-extracted contact lens The components are extracted to form an extracted poly spectacles product, and the extracted polymeric spectacles product is hydrated to form a hydrazine oxy-hydrogel contact lens. 21. The oxygenated hydrogel contact lens of claim 20, Having an equilibrium water content in the range of from about 42% by weight to about 50% by weight and an oxygen permeability (Dj^xio·11) in the range of about 8 (Μιο barrer). 22, as claimed in claim 20 or 21. A hydroxyl hydrogel contact lens having a modulus of from about 66 to about 1.2 MPa. 23. The oxygenated hydrogel contact lens of claim 20, wherein the polymerizing comprises heating the polymerizable composition to greater than A temperature of about 5 5 . Spectacles having an equilibrium water content in the range of from about 42% by weight to about 5% by weight, an oxygen permeability (DkXlO·11) in the range of from about 80 to 100 barrei, and from about 6 to about 12 The modulus of Mpa, the ion current of about 2_5 (xl0·3 mm2/min), about π. to about 62. The previous contact angle, about 40 to 60. The back contact angle and about 5 to about 15. The oxime hydrogel contact lens of any one of claims 18 to 24, wherein the lens body comprises a circular peripheral edge. 26. The oxygen hydrogel of any one of claims 18 to 24 Contact lenses are selected from the group consisting of: (1) spherical glasses, (ii) aspherical glasses, (111) monofocal glasses, (iv) multifocal glasses, and (v) rotationally stable complex 121842.doc 200817471 curved surface The contact lens of any one of claims 18 to 26, which is in a sealed package. ^ 28·A type that has not been surface treated as in any of claims 18 to 27矽 矽 水 hydrogel contact lens. 29. A method of producing a polymerizable silicone hydrogel contact lens precursor composition, the method Including: a combination of α-ω-bis(methacryloxyethylethylenimino yloxypropyl)-poly(dimethyl oxime)-poly(trifluoropropylmethyloxime) Alkyl poly(ω-methoxy-poly(ethylene glycol) propylmethyl oxime... vinyl-fluorene-mercaptoacetamide, methyl methacrylate, ethylene glycol dimethacrylate An allyloxy alcohol and a free radical initiator are employed to thereby produce a polymerizable hydrogel hydrogel contact lens precursor composition. 30. The method of claim 29, further comprising an ultraviolet absorber in the combining step. 31. The method of claim 29 or 30, further comprising a coloring agent in the combining step. 32. The method of claim 30, wherein the ultraviolet absorber is 2-hydroxy-4-indolyloxyethoxybenzophenone. The method of claim 31, wherein the colorant is a phthalocyanine pigment. The method of claim 33, wherein the phthalocyanine pigment is phthalocyanine blue. The method of any one of claims 29 to 34, wherein the free radical initiator is 2,2'-azobisisobutyronitrile. 3. The method of claim 29, wherein the combining step comprises a combination: (1) about 30-40 weights • ... bis (methacryloxyethyl imine 121842.doc 200817471 carboxy ethoxy propyl propyl ())-poly(didecyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-decyloxy-poly(ethylene glycol)propylmethyloxane), ( Ii) about 40-50% by weight of cerium-vinyl-indole-methylacetamide, (iii) about 10-25% by weight of methyl methacrylate, and (iv) less than about 5 parts by weight. /◦Dimercapto ethylene glycol acrylate, allyloxy alcohol, 2-hydroxy-4-propenyloxy ethoxy dibenzophenone, phthalocyanine blue and 2,2f-azobisisobutyronitrile The combination. The method of claim 36, wherein the combining step comprises combining about 34% by weight of cardio-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly(dimethyl矽 矽 ) - - - - - 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍 仍N-methylacetamide, about 17% by weight of methyl methacrylate, about 0-5 wt% of ethylene glycol dimethacrylate, about i% by weight of allyloxy alcohol, about 〇.9 by weight 2% hydroxypropenyloxyethoxybenzophenone, about 1% by weight of phthalocyanine blue, and about 3% by weight of 2,2,-azobisisobutyronitrile. The method of any one of claims 29 to 37, further comprising polymerizing the polymerizable lens precursor composition to form a pre-extracted polymeric silicone hydrogel contact lens. 39. The method of claim 38, wherein the polymerizing step comprises heating the polymerizable lens precursor composition. 40. According to the method of claim 38, half of the pots - human 丄u, eight progresses are included in the polymerization prior to the polymerization of the polymerizable lens precursor composition + person, bottle, ugly substance placed in the non-polar resin invisible In the glasses mold. The method of claim 4, further comprising extracting the pre-extracted polymeric contact lens to form an extracted polymeric lens product substantially free of extractable components and hydrating the extracted The lens product is polymerized to form a helium oxygen hydrogel contact lens. 42. A lithothere hydrogel contact lens comprising the reaction product of the polymerizable composition of any one of claims 1 to 17, which is substantially free of extractable components 0 Ο 121842.doc
TW96121940A 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods TWI429713B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80491106P 2006-06-15 2006-06-15
US88751307P 2007-01-31 2007-01-31
US89460907P 2007-03-13 2007-03-13

Publications (2)

Publication Number Publication Date
TW200817471A true TW200817471A (en) 2008-04-16
TWI429713B TWI429713B (en) 2014-03-11

Family

ID=39007968

Family Applications (4)

Application Number Title Priority Date Filing Date
TW96121940A TWI429713B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods
TW96121908A TWI444408B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods
TW96121939A TWI443116B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods
TW103118502A TWI512017B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods

Family Applications After (3)

Application Number Title Priority Date Filing Date
TW96121908A TWI444408B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods
TW96121939A TWI443116B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods
TW103118502A TWI512017B (en) 2006-06-15 2007-06-15 Wettable silicone hydrogel contact lenses and related compositions and methods

Country Status (2)

Country Link
JP (4) JP5224090B2 (en)
TW (4) TWI429713B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2240804B1 (en) * 2008-01-14 2023-02-15 CooperVision International Limited Polymerizable contact lens formulations and contact lenses obtained therefrom
MY159465A (en) * 2009-10-01 2017-01-13 Coopervision Int Holding Co Lp Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses
KR20130018894A (en) * 2010-04-23 2013-02-25 존슨 앤드 존슨 비젼 케어, 인코포레이티드 Method of improving lens rotation
US9156214B2 (en) 2010-07-09 2015-10-13 Coopervision International Holding Company, Lp Polar thermoplastic ophthalmic lens molds, ophthalmic lenses molded therein, and related methods
KR101647543B1 (en) 2010-07-30 2016-08-10 쿠퍼비젼 인터내셔날 홀딩 캄파니, 엘피 Ophthalmic lens molds, ophthalmic lenses molded therein, and related methods
KR101386293B1 (en) * 2010-07-30 2014-04-24 노파르티스 아게 A silicone hydrogel lens with a crosslinked hydrophilic coating
KR101759373B1 (en) * 2011-02-28 2017-07-18 쿠퍼비젼 인터내셔날 홀딩 캄파니, 엘피 Silicone hydrogel contact lenses
HUE044131T2 (en) * 2011-02-28 2019-09-30 Coopervision Int Holding Co Lp Silicone hydrogel contact lenses
KR101743801B1 (en) 2011-02-28 2017-06-05 쿠퍼비젼 인터내셔날 홀딩 캄파니, 엘피 Silicone hydrogel contact lenses having acceptable levels of energy loss
MY170510A (en) * 2011-02-28 2019-08-08 Coopervision Int Ltd Phosphine-containing hydrogel contact lenses
CN103403608B (en) * 2011-02-28 2015-11-25 库柏维景国际控股公司 Silicone hydrogel contact lenses
JP5980626B2 (en) * 2011-08-31 2016-08-31 三洋化成工業株式会社 Active energy ray-curable resin composition
US9588258B2 (en) 2011-12-23 2017-03-07 Johnson & Johnson Vision Care, Inc. Silicone hydrogels formed from zero diluent reactive mixtures
US9156934B2 (en) 2011-12-23 2015-10-13 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising n-vinyl amides and hydroxyalkyl (meth)acrylates or (meth)acrylamides
US8937110B2 (en) 2011-12-23 2015-01-20 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having a structure formed via controlled reaction kinetics
US9140825B2 (en) 2011-12-23 2015-09-22 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels
US8937111B2 (en) 2011-12-23 2015-01-20 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising desirable water content and oxygen permeability
TWI496838B (en) * 2012-11-30 2015-08-21 Pegavision Corp Silicone hydrogel composition and silicone hydrogel contact lenses made of the composition
US9161598B2 (en) * 2012-12-21 2015-10-20 Coopervision International Holding Company, Lp Ophthalmic devices for delivery of beneficial agents
KR101640725B1 (en) * 2013-04-30 2016-07-18 쿠퍼비젼 인터내셔날 홀딩 캄파니, 엘피 Primary amine-containing silicone hydrogel contact lenses and related compositions and methods
JP5452756B1 (en) 2013-07-02 2014-03-26 Hoya株式会社 Method for producing silicone-containing copolymer molded article having hydrophilic surface and silicone hydrogel contact lens having hydrophilic surface
JP6329005B2 (en) * 2014-06-05 2018-05-23 株式会社メニコン Ophthalmic lens
TWI571670B (en) * 2015-01-09 2017-02-21 Composite contact lenses
KR101786302B1 (en) * 2016-03-03 2017-10-17 (주)메디오스 The method for producing blue light blocking soft contact lens
US10301451B2 (en) * 2016-10-11 2019-05-28 Novartis Ag Chain-extended polydimethylsiloxane vinylic crosslinkers and uses thereof
AU2018282054B2 (en) * 2017-06-07 2021-01-14 Alcon Inc. Silicone hydrogel contact lenses
CA3061585C (en) * 2017-06-07 2021-11-16 Alcon Inc. Silicone hydrogel contact lenses
JP6907845B2 (en) * 2017-09-13 2021-07-21 日油株式会社 Monomer composition for contact lenses, polymers for contact lenses and methods for producing them, and contact lenses and methods for producing them.
CA3097124A1 (en) 2018-05-15 2019-11-21 Bausch & Lomb Incorporated Water extractable ophthalmic devices
US11767401B2 (en) 2018-06-27 2023-09-26 Sumitomo Chemical Company, Limited Gel containing condensation product of reactive silicon compound
WO2020009747A1 (en) * 2018-07-03 2020-01-09 Bausch & Lomb Incorporated Water extractable ophthalmic devices
JP7243731B2 (en) 2018-09-14 2023-03-22 日油株式会社 Monomer composition for contact lens, polymer thereof, contact lens and method for producing the same
JP7639702B2 (en) 2019-12-27 2025-03-05 日油株式会社 Phosphorylcholine group-containing polysiloxane monomer
TWI779275B (en) * 2020-03-31 2022-10-01 望隼科技股份有限公司 Anti-blue light contact lens, composition and manufacturing method thereof
US11822153B2 (en) * 2020-09-28 2023-11-21 Johnson & Johnson Vision Care, Inc. Optical lens design for flattening a through-focus curve
EP4296761A4 (en) 2021-04-21 2025-02-19 NOF Corporation MONOMER COMPOSITION FOR CONTACT LENSES, POLYMER MADE FROM THIS MONOMER COMPOSITION, CONTACT LENS AND METHOD FOR PRODUCING THIS CONTACT LENS
TW202440693A (en) * 2022-12-27 2024-10-16 日商三菱化學股份有限公司 Curable composition, formed body, polysilicone hydrogel and method for producing the same
WO2025012624A2 (en) * 2023-07-11 2025-01-16 Coopervision International Limited Contact lens formulation and contact lens

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678838A (en) * 1986-08-04 1987-07-07 Ciba-Geigy Corporation Particulate hydroperoxidized poly-N-vinyl lactam, its preparation and use thereof
CA2009668A1 (en) * 1989-02-16 1990-08-16 Ashok R. Thakrar Colored contact lenses and method of making same
US5310779A (en) * 1991-11-05 1994-05-10 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5760100B1 (en) * 1994-09-06 2000-11-14 Ciba Vision Corp Extended wear ophthalmic lens
JPH10195324A (en) * 1997-01-16 1998-07-28 Hoya Corp Yellow reactive dye and spectacle lens containing the same
US6367929B1 (en) * 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US7052131B2 (en) * 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6359024B2 (en) * 1998-05-15 2002-03-19 Bausch & Lomb Incorporated Method for polymerizing contact lenses
HK1047117B (en) * 1999-10-07 2007-01-19 庄臣及庄臣视力保护公司 Soft contact lenses
AU779729B2 (en) * 1999-12-16 2005-02-10 Coopervision International Limited Soft contact lens capable of being worn for a long period
JP2001201723A (en) * 2000-01-18 2001-07-27 Asahi Kasei Aimii Kk Soft contact lens for continuous wearing
JP4438162B2 (en) * 2000-02-24 2010-03-24 東レ株式会社 Method for producing polymer for ophthalmic lens and ophthalmic lens
JP4441998B2 (en) * 2000-07-14 2010-03-31 日油株式会社 Contact lens material, contact lens and manufacturing method thereof
US7879267B2 (en) * 2001-08-02 2011-02-01 J&J Vision Care, Inc. Method for coating articles by mold transfer
JP2004085655A (en) * 2002-08-23 2004-03-18 Asahi Kasei Aimii Kk Fouling resistant hydrous soft contact lens
ATE507501T1 (en) * 2003-01-10 2011-05-15 Menicon Co Ltd HIGHLY SAFE MATERIAL CONTAINING SILICONE FOR AN EYECULAR LENS AND MANUFACTURING PROCESS THEREOF
BRPI0514733B1 (en) * 2004-08-27 2018-11-13 Asahikasei Aime Co Ltd silicone hydrogel contact lens
US7249848B2 (en) * 2004-09-30 2007-07-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
JP2007183697A (en) * 2005-12-31 2007-07-19 Mitsuyo Nakagami Portable medical chart display device, portable medical chart display program and computer-readable recording medium

Also Published As

Publication number Publication date
TWI429713B (en) 2014-03-11
JP2008003612A (en) 2008-01-10
TW200813102A (en) 2008-03-16
JP5982684B2 (en) 2016-08-31
JP2014089477A (en) 2014-05-15
JP2008020918A (en) 2008-01-31
TWI443116B (en) 2014-07-01
JP5224090B2 (en) 2013-07-03
TW201434885A (en) 2014-09-16
TW200815501A (en) 2008-04-01
JP2008050576A (en) 2008-03-06
TWI444408B (en) 2014-07-11
JP5024702B2 (en) 2012-09-12
TWI512017B (en) 2015-12-11

Similar Documents

Publication Publication Date Title
TW200817471A (en) Wettable silicone hydrogel contact lenses and related compositions and methods
TWI825015B (en) Medical device
TWI506334B (en) Silicone hydrogel contact lenses having acceptable levels of energy loss
US7540609B2 (en) Wettable silicone hydrogel contact lenses and related compositions and methods
CN101918865B (en) Polymerizable contact lens formulations and contact lenses obtained therefrom
EP1870735B1 (en) Wettable silicone hydrogel contact lenses and related compositions and methods
TW201125915A (en) Wettable hydrogel materials for use in ophthalmic applications and methods
TW201241504A (en) Silicone hydrogel contact lenses
CN103582841B (en) Silicone hydrogel contact lenses
CN101473263B (en) Wettable silicone hydrogel contact lenses and related compositions and methods
US20090143499A1 (en) Actinically-crosslinkable silicone-containing block copolymers
TWI548905B (en) Silicone hydrogel contact lenses with high freezable water content and preparation method thereof
TW201122618A (en) Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses
TW201239450A (en) Wettable silicone hydrogel contact lenses
MX2007007361A (en) Polymerizable surfactants and their use as device forming comonomers.
JP4772939B2 (en) Polymerizable monomer composition and contact lens
WO2020121940A1 (en) Medical device and method of manufacturing same
TW202229377A (en) Modifier for ophthalmological device
HK1128532B (en) Wettable silicone hydrogel contact lenses and related compositions and methods
HK1196671A (en) Silicone hydrogel contact lenses with high freezable water content
HK1128533B (en) Wettable silicone hydrogel contact lenses and related compositions and methods